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Abstract 
Electrospun soy protein-based scaffolds for 
skin tissue engineering and wound healing 
Leko Lin 
Peter I. Lelkes, Ph.D. 
 
 
 
 
In order to bypass some of the limitations of currently available skin substitutes and wound 
dressings, we explored the use of bioactive scaffolds made of plant-derived proteins. We 
hypothesized that these “green” materials may confer bioactive properties to enhance wound 
healing and skin regeneration. We optimized the parameters for electrospinning fibrous scaffolds 
from soy protein isolate (SPI) with addition of 0.05% poly(ethylene oxide) (PEO) dissolved in 
1,1,1,3,3,3-hexafluoro-2-propanol, and characterized these scaffolds based on their physical and 
mechanical properties, degradation behavior, and in vitro biocompatibility. SPI/PEO scaffolds 
remained stable without further cross-linking, possessing mechanical properties similar to those 
reported for human skin, and supported the adhesion and proliferation of cultured primary 
human dermal fibroblasts alone and in organotypic co-culture with primary human epidermal 
keratinocytes. Using targeted PCR arrays and qPCR validation, we found similar gene expression 
profiles of fibroblasts cultured for 2h and 24h on SPI substrates and on collagen type I at both 
time points. On both substrates there was a pronounced time-dependent up-regulation of 
xvi 
 
several genes related to extracellular matrix (ECM) remodeling, including MMP-10, MMP-1, 
collagen VII, integrin-α2 and laminin-β3, indicating that both plant- and animal-derived materials 
induce similar responses from the cells after initial adhesion, degrading substrate proteins and 
depositing ECM in a “normal” remodeling process. 
 
Electrospun SPI/PEO scaffolds were evaluated in vivo against Tegaderm™ wound dressing, a 
standard in wound care, in a full-thickness excision wound model in the hairless rat. SPI/PEO 
scaffolds promoted a slightly but not significantly faster initial wound closure than Tegaderm™. 
The similar quantitative response in both groups was corroborated by non-invasive optical 
measurements using functional near infrared spectroscopy (fNIR). Electrospun SPI/PEO scaffolds 
provided qualitative benefits over Tegaderm™, including greater compliance to the wound shape, 
and the tendency to absorb wound exudates. SPI/PEO scaffolds integrated well with the wound 
and detached naturally with the formed encrustation at day 7 that occurred in both treatment 
groups. SPI/PEO scaffolds are therefore promising as a new type of treatment for non-healing 
wounds, and further studies will help to elucidate potential mechanisms by which it promotes 
wound healing at a cellular and/or molecular level. 
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Executive Summary 
 
The work proposed in this thesis is focused on the long-term goal of developing a novel, 
acellular, plant protein-based scaffold for skin tissue engineering and wound healing applications. 
Non-healing wounds afflict millions of people worldwide and translate into billions of dollars in 
healthcare costs each year. Currently available skin substitutes have only limited clinical success 
and present several disadvantages including the risk of immune rejection or disease transfer 
from allogeneic or xenogeneic sources, long (2-6 weeks) culture times where cellular 
components are involved, mismatching mechanical properties, and high cost. We explore the 
use of soy protein isolate (SPI) as a “green” raw material to bypass some of these limitations 
associated with animal-derived and/or synthetic materials. Soy protein is abundant, produced 
from renewable sources, and has well documented bioactivity in vitro and in vivo. It is also a 
versatile biomaterial that can be fabricated into various forms of scaffold including fibrous 
scaffolds, hydrogels and films. Our overall hypothesis is that soy protein-based scaffolds will 
promote a cellular and wound healing response similar to or better than other well-established 
biomaterials. 
 
Toward our long-term goal, three specific aims are proposed: 1) Fabricate a novel soy 
protein-based electrospun fibrous scaffold and characterize its mechanical properties, 
2 
 
degradation behavior and in vitro biocompatibility. 2) Identify initial adhesion mechanisms of 
human dermal fibroblasts to SPI/PEO. 3) Evaluate electrospun SPI/PEO scaffolds in vivo using a 
rat wound healing model. 
 
For Specific Aim 1, we chose electrospinning as our fabrication technique based on its ability to 
produce biomimetic structures. We discovered that SPI alone in solution could not be 
electrospun into fibers, but that a minimal addition of the inert synthetic polymer, poly(ethylene 
oxide) (PEO), enabled fiber formation by virtue of increased chain entanglements. The optimal 
solvent was determined to be 1,1,1,3,3,3 Hexafluoro-2-propanol (HFP), which produced stable 
solutions with indefinite shelf lives. Importantly, resultant electrospun fibers were resistant to 
hydrolysis in aqueous media without further cross-linking. Electrospun SPI/PEO scaffolds were 
ductile and their mechanical and tactile properties became more “skin-like” in hydrated 
condition. Although hydrolysis-resistant, SPI/PEO scaffolds were able to be degraded 
proteolytically. SPI/PEO scaffolds promoted the attachment and proliferation of primary human 
dermal fibroblasts in a similar manner to scaffolds electrospun from more well-established 
materials such as poly(lactic-co-glycolic acid) (PLGA) and gelatin. 
 
Specific Aim 2 was proposed to address the mechanistic question of “how” mammalian cells 
3 
 
attached to and interacted with foreign materials, and we approached it with the hypothesis 
that initial cellular adhesion to foreign substrates such as SPI was at least partially mediated by 
integrins and/or other cell adhesion molecules. Human dermal fibroblasts were seeded onto 
substrates coated with SPI and collagen type I, to compare the cellular response to SPI with a 
native ECM protein. A global analysis of gene expression related to human ECM and adhesion 
molecules, using targeted PCR arrays, was followed by validation with PCR analysis of specific 
genes up-regulated or highly expressed by fibroblasts on these substrates after 2 h and 24 h of 
seeding. Surprisingly, no substrate-significant differences were found at either time point. 
However, on both substrates, certain genes were similarly up-regulated at 24 h compared to 2 h. 
MMP-10 was the most highly up-regulated, approx. 1152-fold on SPI and 471-fold on collagen I. 
MMP-1 was also very highly up-regulated, 54-fold on SPI and 37-fold on collagen I. ECM proteins 
collagen and laminin, as well as integrin subunit α2, the predominant cell surface receptor for 
collagen, were also up-regulated at 24 h. Taken together, these results point to an aggressive 
remodeling response by the fibroblasts to their immediate extracellular environment. 
Importantly, SPI elicited a similar gene expression profile as the native ECM protein collagen and 
also on the synthetic PLGA, suggesting that SPI as a biomaterial may be as suitable as these 
other well-established materials. 
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Specific Aim 3 was fulfilled at a preliminary level in evaluations that were carried out to the end 
of study at complete wound closure. Electrospun SPI/PEO scaffolds were evaluated against 
Tegaderm™ wound dressing, a standard in wound care, as a control in a full-thickness excision 
wound model in the hairless rat. SPI/PEO scaffolds promoted a slightly but not significantly faster 
initial wound closure than the control, although wounds in both groups healed completely by 
post-operative day 18, while the neodermis continued to be replaced by thicker scar tissue up to 
the end of our study at day 31. The similar quantitative response in both groups was 
corroborated by non-invasive optical measurements using functional near infrared spectroscopy 
(fNIR). 
 
Electrospun SPI/PEO scaffolds provided qualitative benefits over the control, including greater 
compliance to the wound shape, and the tendency to absorb wound exudates thus preventing 
irritation at the wound site. SPI/PEO scaffolds integrated well with the wound and detached 
naturally with the formed encrustation at day 7 that occurred in both treatment groups. These 
scaffolds provide a “breathable” interface between the wound and the external environment, 
which allow for a normal course of healing without the disadvantages of occlusive dressings that 
do not come in direct contact with the open wound. By design as a permanent scaffold, 
electrospun SPI/PEO is able to present structural and molecular cues to the cells in a 
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regenerating wound environment. It is therefore promising as a new type of treatment for 
non-healing wounds, and further studies will help to elucidate potential mechanisms by which it 
promotes wound healing at a cellular and/or molecular level. 
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Chapter 1. Background and Introduction 
 
1.1. Skin 
 
1.1.1. Anatomy 
Skin is the largest organ in the vertebrate body and makes up approximately one-tenth of the 
body mass in humans (Metcalfe and Ferguson, 2007). Skin (Figure 1.1) consists of two main cell 
layers, the upper being stratified epidermis and the lower being the dermis, connected to the 
subcutaneous fatty layer separating the skin from the rest of the body. The two layers are 
separated by a basement membrane (BM) comprising BM-specific extracellular matrix (ECM) 
proteins such as laminin and collagen IV. The epidermis can be further divided into fine layers of 
progressively differentiated keratinocytes—the stratum basale or stratum germinativum, 
stratum spinosum, stratum granulosum and stratum corneum, with the uppermost stratum 
corneum being the most differentiated and first to slough off. Keratinocytes (KC) are the major 
cell type of the epidermis and make up approximately 95% of the total cell population. Also 
scattered throughout the epidermis are melanocytes, which secrete melanin and account for the 
pigmentation of skin. The dermis consists of fibroblasts, which confer the tensile strength and 
connective tissue function of the skin (McGrath et al., 2004). 70% - 80% of the dry weight of 
dermis is comprised of collagens, mainly type I collagen, with the ratio of collagen type III to type 
I increasing with age (Waller and Maibach, 2006). While both collagen I and collagen III are 
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fibril-forming collagens, collagen I is a heterotrimer that contributes to tensile stiffness in tissues, 
and collagen III is a homotrimer that contributes to elasticity (Gelse et al., 2003). Elastin is the 
other predominant protein, responsible for the resilience and suppleness of skin, but accounts 
for only a small proportion (2-4%) of the bulk volume of dermis (Waller and Maibach, 2006). 
Embedded within the dermis are also other functional components such as eccrine (sweat) 
glands, sebaceous glands, vasculature, nerves and hair follicles (McGrath et al., 2004). 
 
 
 
 
Figure 1.1. Various components of human skin. a) Schematic diagram of skin cross-section (Taken 
from http://en.wikipedia.org/wiki/Image:3DScience_skin_section_labeled.jpg) b) Histological 
section of cellular components of human skin from the eyelid; 1) epidermis, 2) dermo-epidermal 
junction, 3) dermis (collagen fibers stained green), 4) striated skeletal muscle, 5a) sebaceous 
gland, 5b) isthmus of hair follicle, 5c) hair shaft, 5d) infundibulum, 5e) external follicular sheath, 
5f) hair root, 5g) hair bulb (taken from Prost-Squarcioni, 2006). 
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Dermal fibroblasts show differences in matrix molecule production depending on their region. 
Fibroblasts in the superficial, papillary dermis produce low levels of the proteoglycan versican 
and high levels of decorin. Conversely, fibroblasts in the deeper, reticular dermis produce high 
levels of versican and low levels of decorin (Nolte et al., 2008). Versican is a large proteoglycan 
with a 265 kDa core protein attached to 12-15 chondroitin sulfate type glycosaminoglycans 
(GAGs), and appears in the basal layer of adult skin epidermis as well as in association with 
elastic fibers in the dermis. By contrast, decorin is a small proteoglycan with a 36 kDa core 
protein attached to a single GAG, usually of the dermatan sulfate type, and is found in 
association with dermal collagen fibers (Carrino et al., 2000). Decorin is also a crucial mediator of 
collagen fibrillogenesis, as it binds to collagen near the C-terminus of a newly forming fibril, 
regulating lateral fusion and maintaining uniform interfibrillar spacing. It also binds to 
transforming growth factor-β (TGF-β) and inhibits fibrotic stimulation of collagen production by 
TGF-β (Reed and Iozzo, 2002). 
 
Dermal fibroblasts may be grouped into two major populations based on their mitotic status. 
The first, replicative progenitor fibroblasts, are mitotically active and in human, rat and mouse 
skin has been shown both in vivo and in vitro to differentiate along this lineage until 
spontaneous terminal differentiation into irreversible postmitotic fibrocytes. These fibrocytes 
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produce approximately 5-8 times more total collagen than the replicative fibroblasts and 
maintain the homeostasis of interstitial tissues by maintaining the correct ratio of collagens 
(Nolte et al., 2008). 
 
Epidermal keratinocytes are connected by various intercellular junctions that are responsible for 
signaling between epithelial cells. Desmosomes bridge adjacent keratinocytes by anchoring the 
cell membrane with keratin intermediate filaments, and space adjacent cells by approx. 30 nm. 
Adherens junctions also link adjacent keratinocytes via the transmembrane glycoprotein 
E-cadherin. Within the cell, they associate with the actin cytoskeleton mainly through α-catenin. 
Gap junctions connect adjacent keratinocytes with each other and other cells in the form of 
clusters of intracellular channels known as connexons. Gap junctions permit ion exchange and 
the passing of low molecular mass (<1000 Da) metabolites between cells. Tight junctions are 
intercellular proteins that regulate barrier permeability and include occludin, junction adhesion 
molecule and claudins (McGrath et al., 2004). 
 
A small population of different stem cells exist within the skin, located in clusters at the bulge 
region of hair follicles. Keratinocyte stem cells divide infrequently, and some become transient 
amplifying cells that proliferate before undergoing terminal differentiation. The stem cells show 
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increased β1 integrin expression as well as high levels of Notch ligand Delta 1 (McGrath et al., 
2004). Neighboring cells may express Notch 1 but not Delta 1, and be committed to 
differentiation into mature keratinocytes. Delta 1 inhibits Notch 1 receptor expression in the 
same cells but activate neighboring transit amplifying cells which express Notch 1 but not Delta 
1; thus, cells expressing only Notch 1 are “responding cells” (Thélu et al., 2002). Notch-Delta 
signaling is absent during the temporary hyperproliferative phase of wound healing in the 
epidermis, but is restored once the epidermis is regenerated and stratified, with keratinocytes 
once again committed to differentiation (Thélu et al., 2002). 
 
1.1.2. Function 
The skin serves to protect the underlying layers from exposure to the outside environment, a 
function fulfilled mainly by the epidermis. The tight packing of corneocytes (anucleated, 
flattened cells) to each other, as well as the arrangement of lipids in the uppermost stratum 
corneum prevents transepidermal water loss (TEWL). The skin also protects against other 
exogenous stressors, which include ultraviolet radiation, chemicals and mechanical forces. The 
dermis plays an active role in wound healing as dermal fibroblasts synthesize new collagen and 
also produce proteolytic enzymes necessary for remodeling. Underneath the dermis, the 
hypodermis consists of well-vascularized adipose tissue that also contributes to the mechanical 
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properties of the skin as well as the ability of the skin to regulate body temperature (Metcalfe 
and Ferguson, 2007). 
 
1.2. Wound healing 
 
Wound healing of the injured skin is divided into three main phases: hemostasis and 
inflammation, re-epithelialization and granulation tissue formation, and finally tissue remodeling 
(Figure 1.2). Hemostasis begins locally at the site of the wound, as bleeding occurs from the 
disrupted blood vessels and platelets are activated. Soluble fibrinogen is cleaved by thrombin to 
form insoluble fibrin fibers, which bind to platelets to form a fibrin clot to stop the bleeding and 
serve as a provisional matrix (Toriseva and Kähäri, 2009). The first inflammatory response will be 
induced by the resident mast cells in the wound, which help recruit neutrophils by signaling with 
tumor necrosis factor (TNF) and leukotrienes, which also stimulate vasodilation during 
inflammation (Baum and Arpey, 2005). Within two days of the injury in humans, monocytes are 
also recruited and become activated macrophages, which secrete transforming growth factors 
(TGF-β and TGF-α), basic fibroblast growth factor (bFGF) and platelet-derived growth factor 
(PDGF). During re-epithelialization, keratinocytes migrate from the wound edge into the wound 
bed and proliferate. A few days after injury, dermal fibroblasts are stimulated by growth factors 
such as TGF-β and PDGF to proliferate and migrate, and to secrete extracellular matrix (ECM) 
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proteins, initially fibronectin and hyaluronan, and later proteoglycans and collagens I and III, 
when the wound is more stable. Fibroblasts also adopt a myofibroblast phenotype to contract 
and create mechanical tension, which serves to physically close the wound gap (Toriseva and 
Kähäri, 2009). 
 
Both keratinocytes and fibroblasts secrete matrix metalloproteases (MMPs), which degrade 
disrupted ECM and whose proteolytic activity is necessary for angiogenesis in the remodeled 
wound site. The remodeling process in humans may take several months, as initially there may 
be an excess deposition of ECM proteins that will need to be removed. Proteolytic cleavage of 
the ECM also serves to release soluble bioactive factors such as basic fibroblast growth factor 
(bFGF), vascular endothelial growth factor (VEGF) and insulin-like growth factor (IGF) to the cells, 
making them available to stimulate further wound healing processes (Toriseva and Kähäri, 2009). 
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Figure 1.2. Timeline for normal human cutaneous wound healing (image taken from Toriseva and 
Kähäri, 2009). KC = keratinocyte, Contr. = contraction. 
 
 
 
1.3. Non-healing wounds 
 
Non-healing skin wounds afflict nearly 5 million Americans each year, and translate into 
multi-billion dollar healthcare costs, with global wound care expenditures amounting to $13 to 
$15 billion annually (Fonder et al., 2008). In Europe, their treatment accounts for an estimated 
2 – 4% of the total healthcare budget (Gottrup et al., 2010). Clinically, non-healing wounds 
include venous leg ulcers, pressure sores and diabetic foot ulcers. The pathogenesis of these 
wounds is not fully understood; they encompass abnormalities in the healing processes of 
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inflammation, cell migration and remodeling. Sustained inflammation and bacterial infection are 
key players in the chronicity of such wounds (Pukstad et al., 2010). For example, wound fluids 
from non-healing venous leg ulcers have higher levels of interleukins IL-1α and IL-1β and lower 
levels of IL-8 than healing wounds (Pukstad et al., 2010). 
 
In normal healing wounds, activated neutrophils do not persist after 72 hours—however, in the 
continuous inflammatory state of non-healing wounds, activated neutrophils are constantly 
present, leading to excessive amounts of MMPs, especially MMP-8, and neutrophil-derived 
elastase (Menke et al., 2007). The MMPs are not balanced by adequate amounts of tissue 
inhibitors of matrix metalloproteases (TIMPs), leading to a pattern of abnormally high wound 
degradation (Menke et al., 2007). Inflammatory cytokines such as tumor necrosis factor alpha 
(TNF-α) are increased and proliferation-promoting growth factors such as platelet-derived 
growth factor (PDGF) and matrix deposition stimulators such as transforming growth factor beta 
(TGF-β) are reduced. Not only is new matrix formation hindered, fibroblasts also become 
abnormal in the non-healing wound, undergoing premature senescence and lowered 
responsiveness to growth factors (Menke et al., 2007). Figure 1.3 schematically shows the 
abnormal progression of the healing processes in chronic, non-healing wounds. 
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Figure 1.3. Abnormal progression of healing processes in impaired wound healing (figure taken 
from Menke et al., 2007). 
 
 
 
1.4. State of the art in skin substitutes and bioactive wound dressings 
 
The lack of structural and molecular cues to promote normal healing in pathological wound 
scenarios as discussed above, and the lack of availability of donor tissue to replace damaged or 
lost skin, points to the need for bioengineered skin substitutes and/or bioactive wound dressings 
that can deliver these cues exogenously. They may present a matrix on which cells can attach, as 
well as deliver cells and/or growth factors in situ (“smart matrix technology”) (Metcalfe and 
Ferguson, 2007). This section details advances in these technologies. 
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1.4.1. Commercially available skin substitutes 
Tissue engineering approaches using cell-based dermal substitutes (e.g. Dermagraft and 
Transcyte) and epidermal (e.g. Epicel, Laserskin, EpiDex and Myskin) or full-thickness (e.g. 
Apligraf and OrCel) skin substitutes to treat acute burn wounds and chronic diabetic ulcers have 
shown clinical success; however, their limitations include long culture times, restricted 
availability and/or the risk of immune rejection of cell sources (Metcalfe and Ferguson, 2007; 
Shevchenko et al., 2010). The majority of currently available skin substitutes and bioactive 
wound dressings (Table 1.1) use acellular collagen scaffolds alone or in conjunction with 
fibroblasts and/or keratinocytes (Powell et al., 2008). Epicel®, Epidex™ and Myskin™ are 
epidermal cell sheets cultured from autologous keratinocytes, often grown in the presence of 
murine feeder fibroblasts. Apligraf® and Orcel® are composite skin substitutes, used mostly for 
chronic wounds and consist of cellularized layers containing human allogeneic keratinocytes and 
fibroblasts. AlloDerm®, Integra® and Matriderm® are acellular dermal substitutes that are 
incorporated directly into the wound bed (Böttcher-Haberzeth et al., 2010). Since these acellular 
skin substitutes incorporate animal-derived de-cellularized extracellular matrix (ECM), they 
possess an intrinsic disease transfer risk (Metcalfe and Ferguson, 2007). These treatments also 
come at a very high cost—for example, Apligraf costs $28 per cm2 (Shevchenko et al., 2010). As 
another obstacle to the use of such skin substitutes, certain segments of the population needing 
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treatment may also be barred by religious or ethical restrictions from using components 
involving, for example, bovine, porcine, fetal or cadaver derived material, which comprise many 
commercially available skin substitutes (Enoch et al., 2005). Synthetic polymers do not bridge 
this need gap due to incompatible biodegradation profiles of synthetic components as well as 
the lack of biochemical signals to the cells (Metcalfe and Ferguson, 2007). 
 
Besides the efficacy of the treatment itself, the surgical requirements for the application of such 
treatment must also be taken into account. It is preferable both for the surgeon and the patient 
to be able to apply the treatment in one surgical intervention as opposed to many. Dermal and 
epidermal substitutes may be applied separately, 3-4 weeks apart, especially where the dermal 
component is thicker than 1mm, as in the case of Integra® and Matriderm®. This is in order to 
allow for vascularization of the dermal component to ensure perfusion to the epidermal 
component, to avoid epidermal necrosis. However, cultured epidermal substitutes have shown 
disappointing results in the “take” rate onto dermal matrices, with an average of 50% or less. 
Other disadvantages are the long (approximately 3 weeks) culture times, fragility of handling and 
high production costs (Böttcher-Haberzeth et al., 2010). 
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Table 1.1. Examples of commercially available skin substitutes and their components (table 
adapted from Böttcher-Haberzeth et al., 2010). 
 
 
 
 
1.4.2. Experimental research in novel skin scaffolds 
With the need for reproducibility, “off-the-shelf” availability, and reduction in regulatory and 
cost burdens, companies are increasingly interested in acellular scaffolds (Böttcher-Haberzeth et 
al., 2010). Several research groups are actively investigating new synthetic materials with 
improved properties for skin tissue engineering. Poly(lactic-co-glycolic acid) (PLGA) has been 
used in recent years due to its biocompatibility and the ability to control degradation rate 
according to copolymer composition. PLGA scaffolds have been electrospun for dermal tissue 
Product Company Type
Cellular/
Acellular
Natural component(s)
Synthetic
component(s)
Epidermal Epicel® Genzyme Corp. Autograft cellular keratinocytes
Epidex™ Euroderm GmbH Autograft cellular
outer root sheath hair
follicle cells
Myskin™ Celltran Ltd. Autograft cellular keratinocytes
ReCell®
Clinical Cell Culture
(C3), Ltd.
Autologous
cell suspension
cellular keratinocytes
Dermal AlloDerm® LifeCell Corp. Allograft acellular acellular dermis
Dermagraft®
Advanced
BioHealing Inc.
Allogeneic/
synthetic
cellular neonatal fibroblasts
polyglactin
mesh
Integra®
Integra
LifeSciences Corp.
Xenogeneic/
synthetic
acellular
bovine collagen I and
shark chondroitin-6-
sulfate
polysiloxane
(silicone)
Matriderm®
Dr. Suwelack Skin &
Health Care AG
Xenogeneic acellular
bovine collagen I, III, V
and elastin
Composite Apligraf® Organogenesis Inc. Allogeneic cellular
neonatal keratinocytes;
bovine collagen I
containing neonatal
fibroblasts
OrCel®
Forticell
Bioscience, Inc.
Allogeneic cellular
neonatal keratinocytes;
bovine collagen sponge
containing neonatal
fibroblasts
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engineering purposes (Blackwood et al., 2008; Kumbar et al., 2008). Poly(D,L-lactide) (PDLLA), 
which degrades at a slower rate than PLGA, has also been of interest since it is also approved by 
the Food and Drug Administration (FDA) for clinical applications, shows excellent 
biocompatibility, and its degradability can be tailored by varying the ratios of D- and L-lactides, 
with increased D-lactides increasing hydrolytic degradability (Kluger et al., 2010; Leong et al., 
2010). Poly(caprolactone) (PCL) has recently become a popular choice of scaffold material either 
alone or as part of a hybrid due to the ability to tailor its physical properties (Powell and Boyce, 
2009; Chen et al., 2011). Chen et al. (2011) created electrospun chitosan-graft-poly 
(ε-caprolactone)/poly (ε-caprolactone) scaffolds that combine the benefits of mechanical 
properties and fiber-forming ability of poly (ε-caprolactone) (PCL) with the antibacterial and 
wound healing activity of natural chitosan, while counterbalancing the shortcomings of poor 
hydrophilicity of PCL and poor electrospinnability and brittleness of chitosan. Synthetic polymers 
such as polyurethane do not confer biological benefit by themselves, but may be considered as 
carriers for biologically active agents, such as growth factors. Li et al. (2009) incorporated PDGF 
into molded polyurethane scaffolds and showed that the addition of PDGF promoted 
significantly greater granulation tissue formation and polymer resorption accompanied by 
replacement with new collagenous tissue than polyurethane alone in a rat excisional wound 
model. Table 1.2 provides a brief summary of recent research developments in scaffolds for skin 
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tissue engineering and wound healing applications. 
 
 
 
Table 1.2. Recently developed scaffolds intended for skin tissue engineering. 
 
 
 
 
  
Materials Form of scaffold
Cell type used for
biocompatibility testing
Special properties Reference
polyurethane Reactive liquid molded
MC3T3 mouse osteoblast
precursor cells
Platelet-derived growth factor
(PDGF) incorporated
Li et al. (2009)
collagen-poly(caprolactone) Electrospun
Primary human dermal
fibroblasts and epidermal
keratinocytes
PCL can inhibit contraction of
scaffold
Powell and Boyce (2009)
synthetic human elastin Electrospun
Primary human dermal
fibroblasts
Rjnak et al. (2009)
poly-N-acetyl glucosamine
Filtered and dried
nanofibers
HUVECs; human gingival
fibroblasts
Scherer et al. (2009)
collagen-chitosan Freeze-dried Primary rat dermal fibroblasts Wang et al. (2009)
chitosan-graft -poly (ɛ-
caprolactone)/poly (ɛ-
Electrospun L929 mouse fibroblasts Chen et al. (2010)
poly(D/L-lactide-co -L-lactide)
(50:50)
Electrospun
Primary human dermal
fibroblasts
Porous fiber surface Kluger et al. (2010)
poly(D,L-lactide) Electrospun
Porcine esophageal epithelial
cells and smooth muscle cells
Bilayer with top layer being
more porous to allow for
culture of two or more cell
types separated by a
basement membrane
Leong et al. (2010)
chitosan-gelatin Electrospun N/A
Dhandayuthapani et al.
(2010)
collagen-chitosan/fibrin glue Freeze-dried
Primary human dermal
fibroblasts and HaCaT
keratinocytes
Different pore sizes on either
side (5-20μm on top layer, 80-
150μm on bottom layer)
Han et al. (2010)
collagen-chondroitin sulfate Freeze-dried
Primary human epidermal
keratinocytes
Liang et al. (2010)
collagen/chondroitin
sulfate/hyaluronic acid
Freeze-dried Primary rat dermal fibroblasts Wang et al. (2010)
rat abdominal wall
fasciocutaneous flap
Decellularized N/A
Vascular structure intact with
a pedicle containing inflow
and outflow channels
Henderson et al. (2010)
silk fibroin/chitosan-
hyaluronic acid
Pressed microparticles
Primary human dermal
fibroblasts
Chung and Chang (2010)
pullulan-collagen Hydrogel
Primary human dermal
fibroblasts; primary mouse
mesenchymal stem cells;
bEnd.3 mouse brain
endothelial cells
KCl crystallization-induced
pore formation
Wong et al. (2010)
collagen-chitosan/silicone
membrane
Freeze-dried
Human umbilical vein
endothelial cells (HUVECs)
DNA incorporated Guo et al. (2011)
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1.5. Methods of scaffold preparation 
 
1.5.1. Electrospinning 
Electrospinning has gained widespread popularity in the area of scaffold fabrication, and more 
and more advanced setups have been developed for specific structural needs or for the 
incorporation of other components such as microspheres for drug or growth factor delivery. The 
most typical setup is a horizontal electrospinning setup (Figure 1.4) that produces non-woven, 
randomly oriented fibers. Here, the path of the extruded fiber is horizontal between the needle 
tip and the target. Another common setup is vertical or orthogonal, where gravity helps pull the 
fiber toward the target. Aligned fibers can be obtained by using a high-speed (approximately 
4500 rpm or higher) rotating mandrel as the target. This arrangement has been preferred for 
vascular graft fabrication, as it provides the ability to tailor graft vessel wall thickness and 
promotes cellular alignment and migration along the direction of the fibers. Fibers with a 
core-shell structure can be created using a co-axial dual capillary spinneret. The usefulness of 
this structure is that drugs or enzymes can be incorporated in the core, and release profiles can 
be controlled by the degradation rates of the shell, or the shell surface can be functionalized 
with bioactive or inductive molecules (for a recent review, see Cui et al., 2010). 
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Figure 1.4. Horizonal electrospinning setup (image taken from Bhardwaj and Kundu, 2010). 
 
 
 
Electrospinning has been a highly desirable platform technology in scaffold fabrication due to 
the ability to tailor fiber diameter and architecture by varying simple parameters such as 
polymer solution viscosity, applied voltage, solution flow rate, and the air gap distance between 
the needle tip and the target (Li et al., 2005, 2006; reviews by Lelkes et al., 2008; Cui et al., 2010; 
Bhardwaj and Kundu, 2010). The morphology of electrospun fibrous scaffolds mimics the 
structure of native extracellular matrix (ECM), allowing for enhanced cellular interaction with the 
scaffold (Li et al., 2005, 2006; Lelkes et al., 2008; Han et al., 2011). In order to increase the 
porosity of electrospun scaffolds, Leong et al. (2006) developed a technique termed “cryogenic 
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electrospinning”, in which ice crystals are allowed to form continuously on a chilled mandrel, 
onto which the polymer is electrospun. The scaffold is then freeze-dried to remove the 
embedded ice crystals, resulting in large pore diameters ranging from approx. 34 to 80 µm to 
improve cellular infiltration and vascularization compared to typical electrospun scaffolds with 
average pore diameter ~5 µm (Leong et al., 2006, 2009). 
 
From a process standpoint, electrospinning is advantageous in being relatively mild and thus 
able to change the form of a material (from solution to fibrous) while preserving the molecular 
structure and bioactivity (Cui et al., 2010). For instance, the monomers of collagen remain intact 
after electrospinning, and do not become fragmented like gelatin, the denatured form of 
collagen (Sell et al., 2009). Even living cells have been shown to remain viable after undergoing 
the electrospinning process (van Aalst et al., 2008). Human fibroblasts either in suspension or 
mixed in solution with poly(vinyl alcohol) (PVA) were electrosprayed (alone) or incorporated with 
electrospun PVA fibers, and remained intact in both cases (van Aalst et al., 2008). For drug 
delivery applications, electrospun fibers can serve as carriers for antibiotics or other drugs that 
are mixed in with the polymer solution, if a burst release profile is desired. Alternatively, 
microspheres encapsulating the drugs can be co-electrospun with the fibers, either in the same 
solution or co-axially with a dual or multiple syringe setup (Wang et al., 2009; Zabrodin, 2009). 
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In the past, our laboratory have thoroughly optimized electrospinning of natural proteins such as 
collagen and elastin (Li et al., 2005, Lelkes et al., 2008). Larger fiber diameters generally 
correspond to greater porosity and thus, greater ease of cell infiltration. Han et al. (2011) 
demonstrated that in co-electrospun blends of PLGA, gelatin and elastin, the elastin content did 
not significantly affect the mechanical properties of the hybrid scaffold, while increased PLGA 
content increased the tensile properties and conversely, increased gelatin content increased the 
elasticity, fiber diameters and also effective pore area, allowing for greater cell penetration. 
However, submicron to nano-scale fibers are desirable for our intended applications in skin 
tissue engineering, as a greater surface area-to-volume ratio of the fibers provides more 
topology for cellular support for a more organized, continuous epithelium (Powell and Boyce, 
2007). Powell et al. (2008) investigated differences in cellular behavior and wound contraction 
between freeze-dried and electrospun bovine collagen skin substitutes, and found that while 
cellular proliferation and organization in vitro were similar, electrospun scaffolds had shrunk 
significantly less than freeze-dried grafts at 8 weeks post-grafting (68.8 ± 2.8% vs. 39.2 ± 8.8% of 
original area, respectively). Fibrous scaffolds are superior to conventional collagen gel scaffolds 
for skin equivalent culture, in terms of reduced shrinkage and increased stability leading to 
prolonged culture times, with keratinocytes continuing to proliferate and differentiate after 12 
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weeks on electrospun structures while collagen gel-based structures degenerate after only 3 
weeks (Stark et al., 2006). From a biological vantage point, expression of collagen types I and III 
in fibroblasts bears closer resemblance to the pattern of collagen expression in native dermis 
when cultivated on a hyaluronan-based fibrous scaffold, than when cultured on pre-formed 
collagen gels (Stark et al., 2006). These findings support the use of electrospun material in 
designing skin substitutes. 
 
1.5.2. Hydrogels 
Scaffolds for soft tissue engineering can take the form of pliable, hydrophilic hydrogels, of which 
a large proportion of the composition is water (Van Tomme et al., 2008). Hydrogels can either be 
pre-formed before implantation, or injected as a liquid for gelling in situ. In situ polymerizing 
systems provide the advantage of conforming to the shape of the defect. These systems include 
photopolymerizable hydrogels and self-assembling hydrogels, which may be cross-linked 
enzymatically or chemically or through ionic or hydrophobic interactions or by 
stereocomplexation (Van Tomme et al., 2008). Bell et al. (1979) developed the original collagen 
hydrogel for human dermal fibroblast culture. While this system promoted cell growth and 
served as a platform for numerous studies on cellular contraction and physiological behavior, it 
was always functionally limited by poor mechanical properties. Helary et al. (2010) revisited 
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collagen hydrogels by increasing its initial concentration, from the low concentration (0.66 
mg/ml) of “classical” collagen gels to 1.5, 3 and 5 mg/ml. They found 3 mg/ml to be optimal, 
with little benefit of increasing to 5 mg/ml since at such a high concentration, the gels were 
non-homogeneous and tended to creep and be less elastic. Collagen gels at 3 mg/ml promoted a 
higher growth rate of human dermal fibroblasts between days 7 and 14 of culture than gels of 
1.5 mg/ml or 0.66 mg/ml. The major advantage of this higher concentration hydrogel is the 
reduction in contraction and increase in stiffness, allowing it to be able to be sutured onto a 
wound bed and more importantly, provide sufficient porosity for neovascularization to occur 
after implantation. This potentially elevates its usefulness from a temporary dressing to a 
permanent scaffold for wound healing. However, the outcome benefits of hydrogels are often 
derived from the cells that they carry, i.e. the cytokines and growth factors that these cells 
secrete, rather than from the hydrogels themselves. 
 
Zawko and Schmidt (2010) developed a “crystal templating” technique to fabricate hydrogels 
with dendritic pore networks, a structure found naturally in the human body in the form of the 
microvasculature within tissues. Hyaluronic acid (HA) was photocrosslinked around dendritic 
urea crystals, which were subsequently dissolved to yield the dendritic porous structure. The 
disadvantage was that these scaffolds had to be coated with poly-L-lysine in order to become 
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cell adhesive; human dermal fibroblasts and epidermal keratinocytes both showed strong 
adhesion and cytotypic morphology on the coated scaffolds. 
 
Completely synthetic hydrogels have also been researched for tissue engineering, such as 
RADA16 (PuraMatrix™), a synthetic peptide material made of 1% amino acid and 99% water. It 
consists of the standard amino acids arginine (R), aspartic acid (D), and alanine (A) and has a 
short, 16–amino acid sequence with alternating hydrophobic and hydrophilic side chains. The 
RAD motif is similar to the cell adhesion ligand RGD. RADA16 self-assembles into a fibrous 
scaffold upon pH changes. Kao et al. (2009) developed a synthetic dermis by mixing human 
dermal fibroblasts with the peptide hydrogel, and cultured 3-5 layers of keratinocytes on top to 
form an epidermal component. However, the process of polymerization requires changing the 
pH to 3 and then de-acidifying the solidified gel, damaging many of the fibroblasts during 
preparation. 
 
1.5.3. Freeze-drying 
Where high porosity is desired, freeze-drying may be employed as a scaffold fabrication method. 
Freeze-dried scaffolds are suitable in applications where thicker defects need to be filled, such as 
cartilage or bone. Porous scaffolds are formed by phase separation, where the mixture is 
28 
 
separated into frozen solvent and concentrated polymer. The ice crystals of the frozen solvent 
become sacrificial material, leaving behind pores of their size after ice sublimation. Cao et al. 
(2010) developed a porous scaffold based on a freeze-dried mixture of poly(L-glutamic acid) and 
chitosan, with chitosan being the more hydrophilic material. They attributed a greater tendency 
for swelling in the scaffolds with higher chitosan content to its greater hydrophilicity. These 
freeze-dried scaffolds supported the culture of articular chondrocytes for 2 weeks, although they 
were distributed unevenly throughout the structure. Coimbra et al. (2011) combined the 
properties of negatively charged pectin and positively charged chitosan in a polyelectrolyte 
complex to produce a freeze-dried scaffold for bone tissue engineering, supporting the culture of 
human osteoblasts. The advantage of the phase separation technique followed by freeze drying 
is the tight control over pore size and structure depending on the porogen—however, problems 
include residual porogen not being thoroughly extracted, and limited ability to scale up 
production (Ayres et al., 2010). 
 
1.6. Plant proteins and their uses in regenerative medicine 
 
Given the limitations of animal-derived and synthetic materials in tissue engineering applications, 
as discussed in Section 1.4.1, plant proteins are a particularly attractive potential alternative 
class of biomaterial. Plant proteins are abundantly available from renewable sources, are 
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non-toxic and biodegradable, and are versatile in their ability to be formed into different 
structures such as films, fibers and gels (Lelkes et al., 2008). They also offer the benefit of being 
intrinsically bioactive as edible nutritive sources (e.g. Miyoshi et al., 1991; Holzbeierlein et al., 
2005), and it is reasonable to hypothesize that this bioactivity may potentially be harnessed in in 
vitro applications. 
 
1.6.1. Soy protein 
Soybean-derived products have been consumed in Asian diets for centuries, and strong 
correlations have been made between this consumption and a lower incidence of various 
cancers in the Asian population compared to Western populations (Holzbeierlein et al., 2005). 
This observation led to extensive in vitro studies trying to identify some of the individual 
bioactive components within soybean products that might inhibit cancer formation or 
metastasis. The best-characterized amongst these are trypsin inhibitors, such as Bowman Birk 
inhibitor (BBI) and Kunitz trypsin inhibitor (KTI) (Armstrong et al., 2003), the peptide lunasin (de 
Lumen, 2005), and some of the isoflavones, particularly genistein, daidzein and glycitein (Magee 
and Rowland, 2004). The biologic effects of these compounds is discussed in Section 1.6.1.1. 
 
Soy protein isolate (SPI) is commercially purified to a purity of greater than 90% and consists of 
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two main fractions of protein, namely a 7S fraction comprising mostly β-conglycinin and an 11S 
fraction which is pure glycinin, as well as small quantities of γ-conglycinin, lipoxygenases, 
α-amylases, and hemagglutenins (Nielsen, 1985). The molecular weights of the 7S and 11S 
fractions are roughly 180 and 350 kDa (Hua et al., 2005). SPI can be processed into films (Jiang et 
al., 2007) and gels (Mauri and Añon, 2006; Maltais et al., 2007, 2010; Caillard et al., 2008, 2010), 
and extruded into fibers (Zhang et al., 2003). 
 
1.6.1.1. Bioactivity of soy protein 
Soy protein isolate contains approximately 6.92 ± 0.14 mg lunasin/g protein (Wang et al., 2008b). 
Wang et al. (2008a) found that after simulated gastrointestinal digestion, 3% of lunasin was still 
active. Interestingly, gastrointestinal enzyme digestion greatly increased cytotoxicity of soy 
protein for L1210 leukemia cells. At 7 mg/ml, soy protein hydrolysate from simulated digestion 
inhibited cell growth by ~ 80 %, whereas a negative control of nonhydrolyzed soy protein isolate 
(from the same defatted soy flour) and nonhydrolyzed defatted soy flour itself showed no 
inhibition. This “indicated that bioactive peptides released from the hydrolysis might be 
important for the observed cytotoxicity of soy on L1210 leukemia cells” (Wang et al., 2008a). 
These authors also determined that the isoflavones may have been partially responsible for the 
observed cytotoxicity, but the peptides lunasin and BBI had only a “modest effect” at the 
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concentrations they tested. When purified lunasin (98%) and BBI (95%) were tested, they found 
a dose-dependent inhibition of L1210 cell growth, with IC50 values of 78 μg/ml (13.9 μΜ) for 
lunasin and 180 μg/ml (22.5 μΜ) for BBI. Wang et al. suggested that β-conglycinins, the 150 – 
200 kDa trimer fraction of soy protein, contained more bioactive, tryptic peptides than glycinins, 
the 320 – 375 kDa hexamer fraction, due to possessing more acidic and basic amino acids as well 
as aromatic amino acids, compared to glycinins, which have more sulfur-containing amino acids. 
However, purified β-conglycinins and glycinins showed lower cytotoxity to L1210 leukemia cells 
than soy flour hydrolysates, suggesting that other active compounds such as isoflavones are also 
responsible. 
 
Park et al. (2007) suggest that BBI may help to protect lunasin from gastric digestion, since 
lunasin in soy protein was found to be resistant to in vitro digestion by simulated gastric and 
intestinal fluids, but purified or synthetic lunasin was not. By contrast, pure BBI was stable even 
up to 120 minutes of digestion. They saw this protective effect above lunasin/BBI ratios of 1:20, 
but conceded that the Kunitz trypsin inhibitor may also have played a role, although this was not 
measured. Of potential relevance to our applications, both lunasin and BBI were found to be 
able to be internalized into the nuclei of NIH3T3 mouse fibroblasts after simulated digestion 
(Park et al., 2007). Of particular interest, soy protein already contains an Arg-Gly-Asp (RGD) motif 
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in its 43-amino acid bioactive peptide lunasin, which has been identified as responsible for the 
internalization of lunasin into the nuclei of NIH3T3 mouse fibroblasts (Hernández-Ledesma et al., 
2009). 
 
When lunasin was removed from BBI, the BBI showed significantly reduced ability to inhibit the 
carcinogenic transformation of mouse embryo-derived C3H lymphocytes. Also, lunasin was 
found to be more potent (effective as low as 10 nM) than BBI in preventing carcinogen-induced 
tumor formation. This strongly suggests that lunasin “is a major if not the major active 
chemopreventive molecule” in BBI concentrate (BBIC) (de Lumen and Galvez, 2002). Deletion of 
the acidic carboxyl end and the RGD cell adhesion motif of lunasin also removes the inhibition 
effect, indicating that the bioactivity of lunasin is dependent on these domains. Internalization 
into the cell also only occurs when the RGD motif is present. Once inside the nucleus, lunasin 
binds to the core histones and repress transcription, thus preventing carcinogen-induced 
transformation (de Lumen and Galvez, 2002). 
 
In a comprehensive study on the chemopreventive property of lunasin, Galvez et al. (2001) 
showed that C3H cells transfected with the viral oncogene E1A became apoptotic if treated with 
20 µM lunasin for 24 h before transfection, whereas treatment of normal C3H or NIH3T3 cells 
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did not affect cell proliferation or morphology. In the female SENCAR mouse model, shaved 
dorsal skin was treated with lunasin dissolved in 250 µl of ethanol at three doses, low (2.5 
µg/week), medium (25 µg/week), and high (250 µg/week), twice/week for 1 week before 
application of the initiator DMBA to induce skin tumorigenesis. This was followed by treatment 
with lunasin twice a week for 19 weeks. It was shown that the highest lunasin dose (250 
µg/week) reduced skin tumor incidence by 70% (p < 0.01), decreased tumor yield/mouse (p < 
0.005), and delayed the appearance of tumors by 2 weeks relative to the positive control (no 
lunasin treatment). The lower doses did not show a statistically significant difference. 
 
BBI has also been shown to confer resistance to radiation-induced terminal differentiation in 
normal human fibroblasts, when they were pre-treated for 2 h with 10 µM of BBI before 
continuing culture without BBI for 8 days and then irradiated. However, this protective effect 
was not observed when the same treatment was given to transformed human fibroblasts 
(Dittmann et al., 1995). 
 
Genistein derived from soy was shown by Sienkiewicz et al. (2008) to protect human dermal 
fibroblasts from oxidative stress that inhibits collagen biosynthesis. Genistein can modulate 
insulin-like growth factor-I (IGF-I) receptor signaling via inhibition of tyrosine kinases. It was 
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found that incubation for 1 h per day with 1 µM of genistein blocked the inhibitory effect of 
oxidative stress on collagen synthesis. However, increasing the dose to 10 µM and 100 µM 
decreased collagen synthesis to approximately 60% and 40% of the control, respectively. A 
similar decrease was seen with IGF-I receptor expression at those doses (55% and 46% of the 
controls, respectively). This suggests that at low doses, genistein serves a protective function by 
preventing disturbances to the IGF-I receptor-mediated pathway and phosphorylated ERK, but at 
higher doses, the tendency of genistein to inhibit tyrosine kinases may outweigh its protective 
effects. 
 
In terms of combating inflammation in chronic diseases, soy protein peptides and isoflavones 
have also been shown to inhibit inducible nitric oxide synthase (iNOS)/nitric oxide (NO) and 
cyclooxygenase-2 (COX-2)/prostaglandin E2 (PGE2) inflammatory pathways in 
lipopolysaccharide-stimulated macrophages (Dia et al., 2008). BBI can prevent the release of 
oxygen free radicals, and genistein has also been reported to reduce reactive oxygen species 
(ROS) by decreasing the expression of ROS-producing enzymes. The activity is also synergistic. 
The mix of soy isoflavone glycosides (84% genistein glucoside, ~16% daidzein glucoside, and 
0.3% glycitein glucoside) was more potent than any of the three isoflavones alone, followed by 
either genistein or daidzein alone (Dia et al., 2008). 
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The protective effects of soy isoflavones on skin directly, as well as against systemic 
inflammation as discussed in this section, all support the use of soy-derived biomaterials in skin 
tissue engineering and wound healing. Recently, soy genistein has been shown to accelerate skin 
wound healing directly in an ovariectomized (Ovx) mouse model treated with subcutaneous 
injections of genistein, via suppressing inflammatory activity of neutrophils and macrophages, 
and accelerating re-epithelialization via interaction with the estrogen receptor (Emmerson et al., 
2010). It is reasonable to surmise that these effects may be translated in soy-derived scaffolds 
for wound healing. 
 
1.6.1.2. Use of soy protein in regenerative medicine 
The suitability of soy protein for biomedical applications has been well demonstrated by Vaz et al. 
(2003a, b, c) and Silva et al. (2003, 2005). Vaz et al. compared cast films made from soy protein 
with those made from gelatin, casein and sodium caseinate, and found that soy films were most 
resistant to hydrolysis whether they were crosslinked or not. This was attributed to the globular 
structure of soy protein, unlike the coiled or helical structure of other proteins (Vaz et al., 2003a). 
Soy protein matrices formed by melt extrusion and injection molding have shown the ability for 
controlled drug release in single (Vaz et al., 2003c) or bilayer skin-core (Vaz et al., 2004) 
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formations. Soy films supported the spreading and proliferation of mouse L929 fibroblast cells 
(Silva et al., 2003), as did chitosan/soy blend films but not chitosan films alone (Silva et al., 2005). 
The suitability of SPI films for use in a controlled release drug delivery system has also been 
investigated (Chen et al., 2008). More recently, others and we developed the methodology to 
electrospin soy proteins (Lelkes et al., 2008; Vega-Lugo and Lim, 2008; Fung et al., 2010). 
 
Soy protein isolate has also been shown to increase the viability of L929 mouse fibroblasts 
cultured on cellulose/SPI composite sponges compared to the same cells cultured on cellulose 
sponges alone (Luo et al., 2010). The authors attributed this effect to SPI hydrolysis in the cell 
culture medium, both rendering the sponges more porous for cell infiltration and providing 
nutrients in the form of SPI degradation products. Lee et al. (2008) have also demonstrated that 
soybean protein hydrolysates provide a source of nutrients for adherent primary human 
epidermal keratinocytes in culture at low concentrations (1 g/L) and stimulated cell proliferation 
by approx. 200%. Soybean protein in the form of non-woven fabric promoted epithelialization of 
full-thickness skin excisional wounds in a Wistar rat model when used as the upper layer in a 
bilayer composite wound dressing with a genipin-crosslinked chitosan film as the lower layer (Liu 
et al., 2008). As a biofilm by itself, SPI crosslinked with formaldehyde has been shown to support 
the culture of normal human fibroblasts and keratinocytes for 4 days, although viability of 
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fibroblasts decreased with increasing concentrations of formaldehyde (Curt et al., 2009). SPI has 
also been formed into a hydrogel with poly(ethylene glycol) (PEG) (Snyders et al., 2007) and 
shown to have an elastic modulus of 1-16 kPa, although no cell culture studies were done with 
these gels. Reddy and Yang (2009) developed soy protein fibers using wet spinning without 
additives or crosslinking. These fibers with diameters 50-150 µm supported the growth of mouse 
fibroblasts for 7 days. 
 
1.6.2. Zein 
Zein is the major storage protein of corn, isolated directly from corn gluten meal as an industrial 
polymer. It comprises roughly 6% of the corn kernel and under polyacrylamide gel 
electrophoresis (PAGE) analysis shows strong protein bands at 21 kDa with a main band at 18 
kDa, and minor bands at 12, 46, 41 kDa (Selling et al., 2004). Zein comprises mainly α and β 
fractions from 14-24 kDa (Shukla and Cheryan, 2001). 
 
Corn zein has been shown to be suitable as a biomaterial in the form of films (Sun et al., 2005) 
and porous scaffolds (Wang et al., 2007), and has been electrospun by different groups (Yao et 
al., 2007; Selling et al., 2007; Jiang et al., 2010) using a variety of solvents. The water stability of 
electrospun zein scaffolds, as well as the ability to promote cell attachment and proliferation, 
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can be enhanced by crosslinking with citric acid (Jiang et al., 2010). The ability of zein to be 
formed into hydrophobic coatings and its antibacterial activity has led to its increased use in the 
food industry and these benefits may be conferred to biomedical applications (Shukla and 
Cheryan, 2001). 
 
As a film, zein has been shown to promote the adhesion of HL-7702 human liver cells to a 
greater extent than a collagen coating, and its degradation products were shown to stimulate 
proliferation of HL-7702 cells when added to cell culture medium (Sun et al., 2005). Rat 
mesenchymal stem cells (MSCs) have been shown to grow and differentiate towards osteoblasts 
on a porous zein scaffold (Gong et al., 2006). Microspheres formed by homogenizing zein in an 
ethanol-water mixture have shown capability for sustained drug release (Liu et al., 2005; Lai and 
Guo, 2011). Microspheres of soy protein, zein, and blends of both have been created for 
nutraceutical delivery, with soy/zein complex being optimal as it is capable of near zero-order 
release kinetics, while soy or zein microspheres alone released too rapidly in the presence of 
simulated gastric fluid (Chen and Subirade, 2009; Chen et al., 2010). Tablets based on zein 
microspheres are capable of sustained delivery of the drug ivermectin via oral administration, 
with bioavailability of the drug ~133% that of commercial formulations (Gong et al., 2010). Zein 
has been combined with PLGA to form hybrid microspheres to deliver amoxicillin for root canal 
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disinfection, with zein contributing to the ability of the matrix to diffuse the drug (Sousa et al., 
2010). 
 
A porous 3-D scaffold prepared by salt leaching was seen to promote healing of bone defects in 
rabbits by 12 weeks, with the effect much more pronounced and full when combined with MSCs 
(Tu et al., 2009). Xu et al. (2010) recently developed a porous zein gel for periodontal tissue 
engineering, and observed that periodontal ligament cells grow along the edges of the pores. 
 
Zein has also been hydrolyzed to yield the bioactive angiotensin converting enzyme (ACE) 
inhibiting peptide (Miyoshi et al., 1991), which incidentally can also be derived from soy protein 
(Mallikarjun Gouda et al., 2006). Of relevance to wound healing, ACE upregulation has been 
implicated in fibrotic remodeling in pathologic scars as it appears to have significantly higher 
activity in fibrotic scars than in normal and wounded skin tissue (Morihara et al., 2006). Hence, 
we surmise that wound dressings made of plant proteins might suppress scar formation and 
contribute to a more natural healing process with reduced scarring 
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1.6.3. Wheat gluten 
Gluten is the protein, starch, and lipid nutrient storage component of grain endosperm cells. 
Commercial wheat gluten is highly heterogeneous, with a large range of molecular weight from 
104-106 Da where the high molecular weight glutenin polymers and low molecular weight gliadin 
monomers in wheat gluten exist as coiled or folded chains (Lelkes et al., 2008). Wheat gluten 
was most likely the first plant protein to have been electrospun (Woerdeman et al., 2005), 
paving the way for fabrication of nanofibrous or submicron fibrous scaffolds from other 
plant-derived proteins. Gliadin as wet spun fibers (Reddy and Yang, 2007) and glutenin as films 
have been investigated for tissue engineering applications, with glutenin potentially more 
suitable as gliadin has been found to be cytotoxic (Reddy et al., 2010). 
 
1.7. Plant cell signaling mechanisms 
 
Signal transduction in plant cells is mediated by pathways that are surprisingly similar to some of 
those in mammals, including humans. Among these are calcium-based signaling, 
G-protein-mediated signaling and inositol phospholipid influenced signaling (review by Clark et 
al., 2001). The calcium-binding protein calmodulin was found to be necessary for pollen tube 
growth and could stimulate cell wall regeneration and cell division in protoplasts. The ECM of 
light-grown plants has been shown to contain a NTPase that binds calmodulin and belongs to the 
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ecto-apyrase family of NTPases, which in animal counterparts is responsible for turning off the 
hormonal activity of extracellular ATP and ADP. Another similarity between animal and plant 
cells is the role of annexins, which are distributed throughout the endomembrane and 
associated with the cytoskeleton, ECM and nucleus in animals, and associated with the plasma 
membrane, Golgi membranes, the ECM and nuclei in plants. Annexin is an important Ca2+ 
regulatory motif in plants, and has F-actin binding ability. Heteromeric GTP-binding proteins (G 
proteins) are activated when they bind GTP and dissociate into subunits that transmit 
downstream intracellular signals. Well characterized in animals, they have also later been found 
in plants, with roles in the regulation of pollen germination and tube growth and possibly of 
inwardly-rectifying K+ channels controlling stomatal opening (review by Clark et al., 2001). 
 
Of particular interest in our case, plants possess cell adhesion sites termed plasmalemmal 
control centers that are similar to integrin clusters in animals. Plants, like animals, perceive 
mechanical stresses such as tension and compression through the ECM-cytoskeletal interface. 
While plant integrin-like receptors have not been well characterized, RGD-binding sites have 
been identified in certain plants such as the small flowering plant Arabidopsis. Plant RGD 
receptors have also been shown to cross-react with animal anti-β1 integrin antibodies. Plants 
also possess fibronectin- and vitronectin-like protein sequences (Clark et al., 2001). Soybean root 
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cells possess a 70-72 kDa RGD-binding polypeptide that cross-reacts with antibodies against 
human vitronectin receptor but not human fibronectin receptor, and promotes cell 
membrane-cell wall attachment (Schindler et al., 1989). As mentioned earlier, soy protein also 
contains an RGD motif in its peptide lunasin (Hernández-Ledesma et al., 2009). 
 
The plasmalemmal reticulum, which connects the cortical cytoplasm to the cell wall, is home to 
adhesion sites that resemble animal cell adhesion sites. Arabidopsis thaliana contains an 
ortholog of β1-integrin, as well as extracellular proteins which are functionally similar to animal 
ECM proteins. Adhesion can be disrupted by exogenous RGD peptide as it is in animal cells 
(review by Pickard, 2008). Arabidopsis also has epidermal growth factor (EGF) repeats in its wall 
associated domain, which may be involved in ligand recognition. In addition to similarities 
between plant and animal cells with respect to ECM and adhesion molecules, plants also possess 
matrix metalloproteases (MMPs), which may be implicated in pathogen defense, senescence, 
growth and flowering (review by Brownlee, 2002). For example, the GmMMP2 gene in soybean 
(Glycine max) is upregulated in the soybean plant in response to pathogen infection as well as 
wounding and dehydration, but not in correlation to senescence or programmed cell death (Liu 
et al., 2001). 
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Given the parallels—or at least analogies—between plant and mammalian signal transduction 
mechanisms, it is not unreasonable to surmise that mammalian cells may interact with plant 
ECM similarly to how they interact with mammalian ECM. 
 
1.8. Mammalian integrins 
 
Mammalian cells attach to natural substrates (e.g. extracellular matrix proteins) mainly via a 
class of transmembrane receptors called integrins (Ingber, 1991; Assoian and Klein, 2008). So far, 
18 α and 8 β subunits have been identified, which assemble into 24 different integrins each 
having a specific, nonredundant function (Hynes, 2002). Specifically, dermal fibroblasts attach to 
extracellular matrix (ECM) proteins predominantly with β1 integrin subunits, specifically α2β1 
for collagen and α5β1 for fibronectin, and these integrin-ligand interactions play a key role in 
contraction during wound healing (Sethi et al., 2002). Impaired α2β1 function, as can occur in 
aged fibroblasts, can correlate to poor migration and thus deficient wound healing (Reed et al., 
2001). Specific to the wound matrix, fibroblasts have been shown to bind to fibrinogen via 
integrin αvβ3 independently of fibronectin in the matrix (Gailit et al., 1997), and fibroblast 
binding to the provisional matrix protein vitronectin has been shown to be inhibited by 
antibodies to αvβ3 and αvβ5 when used together (Gailit and Clark, 1996). Integrin subunit αv 
has also been seen to be up-regulated in subepidermal fibroblasts, papillary dermis, and blood 
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vessels in the wounds of human skin (Noszczyk et al., 2002). Up-regulation of integrin subunits 
occurs concurrently with up-regulation of their corresponding ECM ligands (Noszczyk et al., 
2002). 
 
In the epidermis, α6β4 is crucial for basal keratinocyte adhesion to the underlying basement 
membrane. It is concentrated in the keratin-rich trailing edge in re-epithelializing wounds. The 
ubiquitous subunit β1 mediates keratinocyte adhesion and proliferation, although its absence 
may be compensated for by α6β4. Integrin α2β1 is required for keratinocyte adhesion to 
collagens in vitro, but no epidermal defects are seen in mice lacking this integrin. Integrins α2β1, 
α3β1 and α6β4 are highly expressed by epidermal stem cells, which are characterized by rapid 
adhesion in vitro (Margadant et al., 2010). Table 1.3 shows combinations of integrin subunits and 
their expression in the epidermis. 
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Table 1.3. Integrin subunits and their respective ECM ligands in the epidermis (adapted from 
Margadant et al., 2010). 
 
β-ig-h3, TGF-β-inducible gene-h3; FN, fibronectin; HF, hair follicle; LAP, latency-associated 
protein; RGD, arginine-glysine-aspartate; TN, tenascin; VN, vitronectin. 
 
 
 
In the native extracellular matrix environment, cells attach to ECM proteins via various discrete 
adhesion motifs. The advantage of preferential attachment to specific peptides, mediated by 
integrins, can be harnessed in the functionalization of scaffold surfaces. For example, Lee et al. 
(2006) showed that PPy functionalized with a carboxylic acid group by which an RGD motif was 
grafted promoted greater attachment and spreading of human umbilical vascular endothelial 
cells. Wang et al. (2010) grafted RGD-containing peptides onto electrospun chitosan nanofibrous 
scaffolds and observed significantly greater viability of NIH3T3 cells on RGD-modified scaffolds 
compared to non-modified scaffolds at 3 and 5 days post-seeding. 
Integrin Ligand Expression in epidermis
β1
α2 Collagens Constitutive, up-regulated during wound healing
α3 Laminins Constitutive, up-regulated during wound healing
α5 FN Induced during wound healing
α6 Laminins Uncertain
α8 RGD In developing HFs and the arrector pili muscle
α9 RGD, mainly of FN and TN Weak constitutive, up-regulated during wound healing
αv
β1 RGD Uncertain
β5 RGD, mainly of VN Weak constitutive, up-regulated during wound healing
β6 RGD, mainly of FN, TN and LAP-1/-3
In stem cells in HF, induced during wound healing in
interfollicular epidermis
β8 RGD, mainly of VN and LAP-1/-3 Weak, suprabasal
α6β4 Laminins Constitutive
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1.9. Matrix metalloproteases (MMPs) and their role in wound healing 
 
Matrix metalloproteases (MMPs) play a versatile role in wound repair, with functions including 
proteolytic degradation of ECM as well as activation of other proteases, cytokines and growth 
factors. They are further categorized as collagenases, gelatinases, stromelysins, matrilysins, and 
membrane-type MMPs (Toriseva and Kähäri, 2009). Their activity is blocked by endogenous 
tissue inhibitors of matrix metalloproteases (TIMPs). Figure 1.5 shows the MMPs and TIMPs 
secreted during wound healing, and their cell sources. MMP expression is also mediated by 
growth factors; for example MMP-1 expression in human fibroblasts is up-regulated by PDGF 
and down-regulated by TGF-β (Toriseva and Kähäri, 2009). 
 
Intact skin shows low constitutive expression of MMPs. In normally healing skin wounds, 
collagenases MMP-1 and MMP-8, gelatinases MMP-2 and MMP-9, stromelysins MMP-3 and 
MMP-10, metalloelastase MMP-12, MT1-MMP, MMP-19, MMP-26 and MMP-28, as well as 
TIMP-1, -2 and -3, but not TIMP-4, have been reported (Toriseva and Kähäri, 2009). MMP-1 is 
expressed by fibroblasts in granulation tissue, and may also aid in wound healing by cleaving 
collagen to reveal “cryptic binding sites” for integrins such as αv to increase binding and promote 
cell survival in the new matrix. It also promotes human keratinocyte migration on fibrillar 
collagen, and is induced in wound basal keratinocytes to move off the basement membrane by 
47 
 
ligation of α2β1 integrin with dermal collagen (Chen and Parks, 2009). MMP-8 was found to be 
the most abundant collagenase in human excisional wounds, mainly expressed by neutrophils. 
MMP-26, the smallest MMP, was expressed during re-epithelialization in the epithelial tip of 
both normally healing acute wounds as well as chronic ulcers, but not in granulation tissue 
(Toriseva and Kähäri, 2009). 
 
In terms of TIMPs, the regulators of MMPs, expression also varies with the type of wound. 
TIMP-1 has been detected in wound fibroblasts, whereas TIMP-2 and TIMP-3 has been found in 
skin epithelial cells as well as fibroblasts. TIMP-4 expression has not been detected in acute 
human wounds, but has been in fibroblasts from chronic ulcers (Toriseva and Kähäri, 2009). 
 
ADAMs, a disintegrin and metalloproteinase, are a special family of transmembrane proteins, 
most of which have both adhesive and proteinase activity. Their substrates are mainly cell 
membrane associated proteins. In humans, ADAMs 9, 10 and 15 may aid cell migration or 
release growth factors from ECM by cleaving fibronectin and type IV collagen. ADAMTS 
proteases, a disintegrin and metalloproteinases with thrombospondin type 1 motifs, are 
secreted, rather than transmembrane proteins, and their substrates are ECM proteins. Only 
ADAMTS-1 has been specifically associated with cutaneous wound healing—it is first 
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up-regulated in dermal wound macrophages, and by day 5 the expression shifts to the 
granulation tissue fibroblasts (Toriseva and Kähäri, 2009). 
 
In wound fluid from chronic ulcers, MMP-2, -9, -1, and -8 levels have been found to be elevated. 
MMP-13 expression is “a distinct feature” of chronic ulcer fibroblasts, and appears to be 
elevated in keloid tissues as well. Intriguingly, MMP-13 is expressed by human fetal wound 
fibroblasts and may be involved in activation of TGF-β3, which plays an important role in scarless 
wound healing (Toriseva and Kähäri, 2009). 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.5. Diagram of cellular expression of MMPs and TIMPs in an acute cutaneous wound 
(taken from Toriseva and Kähäri, 2009). 
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1.9.1. Interaction between MMPs and soy protein 
The major bioactive polypeptide component of soy protein, the Bowman-Birk inhibitor (BBI), is 
both a metalloprotein (containing magnesium, calcium and zinc) and concomitantly a 
metalloproteinase inhibitor that inhibits not only the serine proteases trypsin and chymotrypsin 
but also human MMPs. BBI inhibits trypsin at its Lys16-Ser17 domain and chymotrypsin at its 
Leu43-Ser44 domain. BBI also contains four Glu and seven Asp residues that bind metals, 
especially zinc. BBI dose-dependently inhibited the MMP-1 hydrolysis of gelatin, with complete 
inhibition at 115 nM for mineralized BBI and 30 nM for demineralized BBI (Losso et al., 2004). 
BBI not only inhibits the activity of MMP-1 but also the activation of pro-MMP-1, as well as 
pro-MMP-9 (Bawadi et al., 2004). The ability of BBI concentrate (BBIC), a soybean extract 
enriched in BBI, to reduce the activity of MMP-2 and MMP-9 has been investigated for the 
treatment of multiple sclerosis in a rat model (Gran et al., 2006). Hence BBI might be an 
important soy-derived regulator of MMP1 activity in vivo and as such a modulator of wound 
healing. 
 
1.10. Animal models 
 
The information that in vitro and in silico experiments can give us is limited to the specific 
interactions that we target, by isolating chosen variables with specific conditions that we define. 
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However, our intended applications in biomedical engineering are almost always in a dynamic 
interface with the human body in all its intricacy. Thus, a living organism is required to test any 
medical product before it can be deemed safe and effective in humans. 
 
Different species offer different advantages in studying wound healing, both scientific and 
practical. The pig is classically considered to have the most similarities to humans in physiology 
and certain anatomical features, such as the attachment of skin to subdermal tissues (Sullivan et 
al., 2001), in contrast to rodents (Cross et al., 1995; Dorsett-Martin and Wysocki, 2008). However, 
pigs have the disadvantages of a slower life cycle and large size, making them more difficult and 
costly to maintain. Rats are a convenient species that allow for comparisons between treatment 
modalities. Table 1.4 lists some of the advantages and disadvantages of different species. 
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Table 1.4. Summary of commonly used animal models and their relative advantages and 
disadvantages (adapted from Lindblad, 2008). 
 
 
 
 
No animal model exists that can perfectly replicate the complexity of human wounds. However, 
different animal models approximate different aspects of wound healing more closely than 
others. To investigate the effects of external treatments, the physical similarity between the 
animal skin and human skin will be important. To determine the role of a certain endogenous 
growth factor or pathway on wound healing, knockout studies may be employed in more 
genetically controllable models such as the mouse (Reid et al., 2004). Parameters that are 
analyzed to measure the degree of wound healing include wound contraction, 
re-epithelialization, vascularization, inflammatory response, macroscopic and histological 
appearance of the scar, and mechanical strength of the scar (Birch et al., 2005). 
 
Animal Advantages Disadvantages
Rat/Mouse
Small; genetic mutants readily available;
easy to handle; low cost
Heal mainly by contraction,
dissimilar to human skin
Rabbit Useful in fetal studies
No large benefit over the
cheaper, smaller rodent model
Pig
Greater similarity to human skin in
structure and physiology; larger size
allows for fewer animals to generate
statistically significant results; useful in
fetal studies
Large size increases difficulty in
housing and handling;
expensive
Human Most accurate Ethical limitations
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Several models attempt to simulate chronic impairment, including chemically induced diabetes 
(Davidson, 1998; Weingarten et al., 2006), genetic mutations for diabetes, ischemia, 
glucocorticoid administration, immune deficiency, malnutrition, aging, radiation and bacterial 
infection (Davidson, 1998). Each of these has limitations for example in systemic effects or 
variability in the model. In choosing an animal model for the desired aspect of wound healing to 
study, cost and convenience also often play a large role, especially since the ability of researchers 
to accommodate the animals and perform the studies depends on institutional approval and 
availability of facilities. 
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Chapter 2. Research Aims and Objectives 
 
Pairing the need for readily available, “off-the-shelf” affordable bioactive scaffolds from 
renewable sources with the potential for inexpensive plant proteins to confer bioactivity and 
interact favorably with human skin at a cellular and molecular level, our long-term goal is to 
develop an acellular, plant protein-derived scaffold for skin tissue engineering and wound repair. 
We have chosen soy protein due to its versatility in processing, its abundance, and its long 
history of dietary benefits and recently documented in vitro anti-carcinogenic, anti-inflammatory 
and anti-oxidative properties as described in Chapter 1. We hypothesize that soy protein as a 
raw material will promote skin wound healing in a manner similar to or better than currently 
available treatments. 
 
Toward this long-term goal, the work in this thesis addresses three specific aims: 
 
1) Fabricate a novel soy protein-based electrospun fibrous scaffold and characterize its 
mechanical properties, degradation behavior and in vitro biocompatibility. 
  
2) Identify initial adhesion mechanisms of human dermal fibroblasts to SPI/PEO. 
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3) Evaluate electrospun SPI/PEO scaffolds in vivo using a rat wound healing model. 
 
For Specific Aim 1, we chose electrospinning as our fabrication method for soy protein-based 
scaffolds based on the desirability of the biomimetic structure it produces. This method is also 
especially suitable for thin layer defects such as can be found in the skin. For Specific Aim 2, we 
investigated the initial cellular adhesion response to our scaffold material, as this will determine 
how well the scaffold integrates with the cell-mediated wound environment in later interactions. 
Finally, for Specific Aim 3, we evaluated the wound healing response to our SPI/PEO scaffold in a 
well-established full-thickness skin excision model in the hairless rat. 
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Chapter 3. Fabrication and Characterization of Soy Protein-Based Scaffolds 
 
3.1. Introduction 
 
Our initial desired approach was to form an electrospun scaffold based on soy protein isolate 
(SPI) alone, without any additives. Thus, a variety of solvents were explored to find one most 
suitable to dissolve SPI, and concentrations of SPI were varied to achieve a solution with the 
viscosity of “corn syrup” in order to electrospin consistent, bead-free fibers. However, it was 
found that SPI alone at any concentration in any solvent we tested would yield electrospraying 
behavior at best. This may be due to soy protein being a globular protein and tending to form gel 
networks when aggregated (Curt et al., 2009), instead of interconnected chains. Therefore, the 
synthetic inert polymer poly(ethylene oxide) (PEO) was added to increase chain entanglements 
in solution (Shenoy et al., 2005) and enable the formation of continuous fibers. We then 
optimized the fabrication of SPI/PEO scaffolds by varying the key electrospinning parameters of 
SPI concentration, ratio of SPI to PEO, syringe pump delivery rate, accelerating voltage, and air 
gap distance between the ejection needle tip and the target collector. SPI/PEO scaffolds were 
then characterized based on morphology, fiber diameters, tensile properties, and degradation 
behavior in various aqueous media with and without a proteolytic component. 
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3.2. Materials and Methods 
 
3.2.1. Production of the scaffolds 
 
3.2.1.1. Preparation of protein solutions: Initially, soy protein isolate (SPI) (obtained from Cargill 
Health and Food Technologies, Minneapolis, MN) was dissolved without any additives in a 
variety of aqueous and organic solvents (Table 3.1) to determine the most suitable solvent for 
electrospinning. 
 
 
 
Table 3.1. Solvents investigated for dissolving SPI for electrospinning. 
Solvent type Solvent Dissolve? Remarks 
Aqueous Acetic acid No  
Ethanol No  
Acetic acid/ethanol (50/50) No  
Hydrochloric acid No  
Acetone No  
Sodium hydroxide Yes Solution unstable 
Ammonium hydroxide Yes  
Water No  
Organic Dimethylformamide (DMF) No Evaporated very quickly 
Tetrahydrofuran (THF) No Evaporated very quickly 
1,1,1,3,3,3 Hexafluoro-2-propanol 
(HFP) 
Yes Solution stable 
indefinitely 
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It was found that pure SPI solutions would not electrospin into fibers—they only yielded 
electrospraying behavior. A range of concentrations between 3 – 20% (w/v) SPI was tested. 
Therefore, poly(ethylene oxide) (PEO) (Sigma, St. Louis, MO) was added to the solutions and the 
amount parametrically adjusted between 0.01% (w/v) to 2% (w/v) to determine the minimal 
amount required to yield an electrospinnable solution. 
 
The first “optimal” solution consisted of 10% (w/v) SPI and 1% (w/v) PEO in 0.1 N sodium 
hydroxide (NaOH). However, due to limitations discussed in the Results section (Section 3.3), the 
concentrations were re-optimized using 1,1,1,3,3,3 Hexafluoro-2-propanol (HFP) (Sigma) as the 
solvent of choice. SPI was varied between 5 – 10% (w/v) and PEO between 0.05 – 0.2% (w/v). 
 
Once the “optimal” amount of PEO was determined by characterization of resultant fibers to be 
0.05% (w/v) (see Results, Section 3.3), solutions were made by first dissolving 0.5% (w/v) PEO in 
HFP and adding appropriate volumes from this stock solution to 5, 6, 7, and 8% (w/v) SPI in HFP 
respectively. Blend solutions were left to stir at RT for at least 48 h and up to approximately 2 
weeks before electrospinning to ensure complete and homogeneous dissolution, although the 
quality of resultant electrospun fibers was not reduced when solutions were left to stir for more 
than 2 weeks. 
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For comparison in cell culture experiments, corn zein (obtained from Freeman Industries LLC, 
Tuckahoe, New York) was dissolved at 35%, 40% and 45% (w/v) in glacial acetic acid (Fisher 
Scientific, Pittsburgh, PA) and left to stir at least 3 h and up to approximately 1 week before 
electrospinning. Solutions were not kept for longer as bead formation was observed when 
solutions older than 1 week were electrospun. Fabrication and characterization of zein scaffolds 
were performed by Devika Varma. 
 
3.2.1.2. Electrospinning of protein solutions: Fibers were electrospun in a horizontal setup, as 
previously described (Li et al., 2005) (Figure 3.1). In brief, a precision syringe pump (KD Scientific 
Single Syringe Infusion Pump, Fisher) was used to eject solution from a disposable 3 ml syringe 
(BD Biosciences, Franklin Lakes, NJ) through a blunt 18-gauge needle. Parametric studies were 
conducted to identify optimal settings that would yield consistent, bead-free fibers. SPI/PEO 
blend solutions were electrospun at delivery rates between 0.5 to 1.2 ml/h, air gap distance 
between 10 - 20 cm, and accelerating voltage between 10 to 27 kV. For zein solutions, the 
optimized delivery rate was 0.5 ml/h, air gap distance was 15 cm, and accelerating voltage was 
20 kV for 35% and 40% solutions and 25 kV for 45% solutions. As a synthetic material for 
comparison in cell culture studies, 20% (w/v) 90:10 poly(lactic-co-glycolic acid) (PLGA) was 
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electrospun at 0.5 ml/h, 15 kV and 15 cm. As a natural, animal-derived material for comparison, 
8% (w/v) gelatin (Sigma) was electrospun at 0.8 ml/h, 12 kV and 20 cm. To capture the 
electrospun fibers, circular glass cover slips (Fisher), 15 mm in diameter, were attached to a 
rectangular aluminum collector. For microscopic analysis of individual fibers, 0.2 ml of solution 
was electrospun; as cell culture substrates, 1 ml was electrospun onto the cover slips, yielding 
scaffolds of approx. 20 μm thickness. For mechanical testing, organotypic skin equivalent 
co-culture experiments, and in vivo experiments, fibrous mats (~ 0.1 – 0.2 mm thickness) were 
electrospun and collected directly on the aluminum collector. 
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Figure 3.1. Electrospinning setup in our laboratory (a) and schematic (b) (from 
http://www.che.vt.edu/Wilkes/electrospinning/electrspinning.html). 
 
 
 
3.2.2. Materials characterization 
 
3.2.2.1. Measurement of fiber diameters: Glass cover slips coated with electrospun fibers were 
mounted onto metal stubs with carbon tape and sputter-coated for 30 s with platinum and 
palladium (Pt/Pd) prior to visualization in an environmental scanning electron microscope (ESEM, 
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XL-30 SEM-FEG) (FEI, Hillsboro, OR) at an accelerating voltage of 10 kV and spot size 3. For each 
sample at least 10 measurements per image were taken from 10 images of random areas. Fiber 
diameters were measured using University of Texas Health Science Center at San Antonio 
(UTHSCSA) ImageTool 3.0 software (n=100 for each sample). 
 
Dry samples were mounted as spun. To investigate the degree of swelling with hydration, 
samples of SPI/PEO were immersed in sterile distilled deionized water, 1X phosphate buffered 
saline (PBS) solution without calcium and magnesium (Mediatech Inc., Herndon, VA), or 
Dulbecco’s modified Eagle’s medium (DMEM) (Mediatech) supplemented with 10% fetal bovine 
serum (FBS) (Atlanta Biologicals, Lawrenceville, GA) at 37⁰C and 5% CO2 for 3 h, 7 days and 14 
days. Samples were washed with distilled deionized water and dehydrated before mounting for 
SEM. SPI/PEO samples were dehydrated first in 100% ethanol (EtOH) before critical point drying 
(CPD7501, SPI Supplies, West Chester, PA) to preserve structural morphology.  
 
3.2.2.2. Surface analysis of electrospun scaffolds: Elemental analysis was performed using 
Oxford energy-dispersive X-ray microanalysis on a scanning electron microscope (Zeiss Supra 
50VP, Carl Zeiss, AG, Germany) and SmartSEM™ software (Zeiss). 
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3.2.2.3. Mechanical testing: Mats were electrospun and cut into rectangular strips 
(approximately 5mm x 25mm x 0.1mm). Tensile tests were performed in triplicate for at least 3 
independent samples using an Instron 5564 in dry and hydrated states. For testing hydrated 
samples with various concentrations of SPI, the mats were immersed in sterile DMEM + 10% FBS 
for 3 h to simulate a physiological condition where proteases would be present. For testing the 
effect of hydration on tensile properties over time, scaffolds electrospun from 7% SPI/0.05% PEO 
were immersed in DMEM + 10% FBS, 1X PBS, or water for 3 h (0 days), 7 days and 14 days at 
37⁰C and 5% CO2. Samples were tested to breakage at a gauge length of 15 mm on a 10 N load 
cell. Crosshead speed was 1 mm/min for dry samples and 10 mm/min for wet samples as the 
higher speed was more appropriate to account for the higher ductility of wet samples. 
 
3.2.2.4. In vitro degradation: SPI/PEO mats were electrospun and cut into rectangular pieces 
(approximately 10mm x 25mm x 0.1mm). Each piece was placed in a 60mm diameter petri dish 
and its dry weight was taken as a baseline. Pieces were then sterilized by UV exposure and 
divided into 4 groups with at least 3 specimens per group per time-point, to be hydrated in 3 ml 
distilled deionized water, DMEM, DMEM + 10% FBS, and DMEM/equine serum (ES) in a 1:1 ratio 
respectively. Samples were kept in a humidified incubator at 37⁰C and 5% CO 2; the hydration 
media were changed daily. At time-points of 1, 4, 7, 14, 21, 28, 35 and 42 days, the media were 
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removed, the specimens were washed twice with water to remove residual salts and placed in a 
vacuum oven at 50⁰C overnight for complete dehydration. Specimens were weighed again in 
their dishes and the percentage mass loss was calculated as: 
% mass loss = 100*(original mass - final mass) / original mass 
To confirm that SPI/PEO scaffolds could be degraded proteolytically, strips were immersed in 1 
mg/ml collagenase (415 units/mg solid of collagen digestion activity; Sigma) dissolved in 1X PBS 
(Mediatech) for 1 h, 2 h and 4 h. Native SPI powder was subjected to the same conditions for 
comparison. 
 
3.2.2.5. Characterization of in vitro degradation products: Supernatants from the degradation 
study were collected at time-points of 1, 4, 7, 14, 21, 28, 35 and 42 days and frozen at -20。C to 
be analyzed later using sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). 
After thawing, 15 µl of each supernatant was mixed with 15 µl of 2X Laemmli buffer (Bio-Rad, 
Temecula, CA) in a microcentrifuge tube and boiled for 5 min to denature the proteins. The 
mixtures were then allowed to cool for approximately 5 min before loading into each well of a 
4–20% Mini-PROTEAN TGX Precast Gel (Bio-Rad). The proteins were run through the gel at a 
constant voltage of 100 V for 70 min. The gel was fixed for 20 min in 25% isopropanol and 10% 
acetic acid in 50 ml distilled deionized water, stained with Coomassie Brilliant Blue solution 
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overnight and destained in 10% acetic acid overnight before imaging on a Molecular Imager 
ChemiDoc XRS+ System (Bio-Rad). 
 
3.2.2.6. Quantitation of protein in in vitro degradation products: Supernatants from the 
degradation study were analyzed using the bicinchoninic acid (BCA) assay (Pierce, Rockford, IL) 
for a 96-well plate according to the manufacturer’s instructions. Calibration curves correlating 
absorbance at 562 nm to protein content were prepared using SPI and bovine serum albumin 
(BSA). A 10 µl aliquot of each supernatant was diluted with 10 µl of distilled deionized water in a 
96-well plate before adding 150 µl of freshly prepared BCA reagent to each well. The plate was 
sealed and incubated at 37。C in a water bath for 20 min before reading the absorbance at 562 
nm on a spectrophotometric plate reader (Biotek, Winooski, VT). 
 
3.3. Results and Discussion 
 
3.3.1. Fabrication of SPI/PEO scaffolds 
 
3.3.1.1. Preparation of protein solutions: Of the solvents we investigated, sodium hydroxide 
(NaOH), ammonium hydroxide, and HFP dissolved SPI. Initially 0.1 N NaOH was selected and the 
concentrations of SPI and PEO were varied between a range of 5 – 12% (w/v) SPI and 0.05 - 2% 
(w/v) PEO. Beaded fibers were formed with 5% SPI, 1% PEO solutions (Figure 3.2a), due to 
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“capillary breakup of the electrospinning jets by surface tension” that occurs at low solution 
viscosities (Fong et al., 1999). While 10% and 12% SPI with 1% PEO both electrospun into 
smooth, bead-free fibers (Figure 3.2 b and c respectively), the 12% solutions tended to clog the 
needle. 10% SPI, 1% PEO in 0.1 N NaOH was determined to be the optimal solution. 
 
 
 
 
Figure 3.2. Scanning electron micrographs of electrospun SPI/PEO fibers with varying 
concentrations of SPI. (a) 5% SPI, 1% PEO; (b) 10% SPI, 1% PEO; (c) 12% SPI, 1% PEO electrospun 
from solutions dissolved in 0.1 N NaOH. Scale bars 5 µm. 
 
 
 
However, this solvent system had several disadvantages. Firstly, solutions were unstable and the 
protein tended to degrade within days, such that beaded, broken fibers were formed or only 
electrospraying occurred. Also, even the smooth fibers were brittle and dissolved upon contact 
with any aqueous media unless they were chemically crosslinked, with 0.4% (w/v) 
1-ethyl-3-[3-dimethylaminopropyl]carbodiimide hydrochloride (EDC) (Pierce, Rockford, IL). Since 
solutions in HFP tend to be stable indefinitely and fibers electrospun from SPI and PEO dissolved 
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in HFP in an initial trial were ductile to the touch, the parametric optimization of solute 
concentrations was repeated for HFP. 
 
An important discovery made during this process was that SPI/PEO scaffolds formed by 
electrospinning solutions in HFP remained stable in aqueous media without any need for further 
cross-linking. This is a significant benefit as chemical crosslinkers and even “natural” crosslinkers 
such as genipin may confer a certain degree of cytotoxicity, and increase the stiffness of the 
scaffold, which may adversely affect cell culture and in vivo applications. 
 
In HFP, 1% (w/v) PEO formed a gel. Therefore, the concentration was lowered to a range 
between 0.05 – 0.5%. Figure 3.3 shows some of the various concentrations tested. 5% SPI, 0.05% 
PEO electrospun into smooth fibers (Figure 3.3a), but higher concentrations of PEO yielded 
incompletely formed fibers in addition to regular fibers (Figure 3.3 b – d). It was therefore 
determined that 0.05% PEO was a maximal concentration required to form fibers, and further 
investigation would explore lower concentrations to find the minimal. Conversely, a maximal SPI 
concentration was desired in order to increase the amount of protein fibers produced from the 
same volume of solution. 
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Figure 3.3. Scanning electron micrographs of electrospun SPI/PEO fibers with varying 
concentrations of PEO. a) 5% SPI, 0.05% PEO; b) 5% SPI, 0.1% PEO; c) 5% SPI, 0.5% PEO; d) 10% 
SPI, 0.1% PEO. Scale bars 2 µm. 
 
 
 
Further parametric studies were performed with 5 – 8% SPI and 0.025 – 0.05% PEO. Above 8% 
SPI, the solution agglomerated at the needle tip during electrospinning. At every concentration 
of SPI tested, 0.025% PEO appeared to be too low to form consistently smooth fibers, as 
represented by Figure 3.4. Therefore, 0.05% PEO was also determined to be the minimum 
concentration required. 
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Figure 3.4. Representative images showing the dependence of consistent SPI/PEO fiber 
formation on a threshold amount of PEO. a) 5% SPI, 0.025% PEO; b) 5% SPI, 0.05% PEO; c) 8% SPI, 
0.025% PEO (inset shows fine strands overlapping fibers); d) 8% SPI, 0.05% PEO (inset shows 
ribbon-like flat morphology). Scale bar 5 μm (insets 1 μm). 
 
 
 
3.3.1.2. Electrospinning parameters: For each set of protein concentrations tested, 
electrospinning parameters were varied to determine which set yielded consistent, bead-free 
fibers. Increasing flow rate increases fiber diameter, while increasing air gap distance decreases 
fiber diameter. Increasing accelerating voltage may or may not increase fiber diameter (reviewed 
by Bhardwaj and Kundu, 2010). These key parameters can also make the difference between 
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smooth fibers and beaded fibers. The optimal parameters for 5 – 8% SPI, 0.05% PEO in HFP were 
flow rate 0.8 ml/h, voltage 15 kV, and air gap distance 12 cm. 
 
3.3.2. Characterization of SPI/PEO scaffolds 
 
3.3.2.1. Variation of fiber diameter with SPI concentration: Higher SPI concentration correlated 
to a larger size of fibers. Table 3.2 shows the fiber diameters obtained with SPI/PEO electrospun 
from NaOH solution. The increase in diameter is not proportionate to the increase in SPI 
concentration, which could be explained by taking into account the fact that the 12% SPI solution 
was much closer to gelation and therefore had a much higher resistance. After our completion of 
this work, Vega-Lugo and Lim (2008) independently published a report on similar work with 
similar results. Their optimized values were 15% SPI as it was the highest concentration they 
attained before the solution gelled, 0.8% PEO, and 0.5% TritonX-100 as a surfactant, dissolved in 
1% NaOH. Their nanofibers ranged from approximately 200 – 260 nm in diameter. More recently, 
Fung et al. (2010) electrospun soy protein isolated from the soluble fraction of factory agrowaste 
of “okara” or soybean, using 1 N NaOH as a solvent and adding 5% (w/v) PEO. They attained 
continuous tubular nanofibers <500 nm in diameter. The main reason for the differences 
between their results and ours is most likely their addition of surfactant, as this would allow for 
reduced protein resistance resulting in a higher concentration of SPI being electrospinnable and 
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also smaller fiber diameters. 
 
 
 
Table 3.2. Variation of fiber diameter with SPI concentration in solutions dissolved in 0.1 N NaOH 
(n = 30). 
% SPI with 1% PEO Fiber diameter (nm) 
5 253 ± 69 
10 296 ± 75 
12 497 ± 101 
 
 
 
Figure 3.5 shows increasing fiber diameter with SPI concentrations, with PEO concentration kept 
constant at either 0.025% or 0.05% for our HFP-dissolved solutions. Surprisingly, lower content of 
PEO did not correlate with smaller fiber diameters (Figure 3.5) compared to higher PEO content. 
This may be because the increased chain entanglements in solution with the higher PEO content 
(Shenoy et al., 2005) led to decreased protein aggregation, allowing for extrusion into finer fibers. 
Across the range of concentrations of SPI tested, SPI/PEO blend solutions yielded submicron to 
micron-sized fibers, with approximately 702 ± 201 nm width (heterogeneity 29%) at 5% SPI, 
0.05% PEO and 1251 ± 306 nm width (heterogeneity 24%) at 8% SPI, 0.05% PEO. These values 
are much higher than the ~200 - 300 nm obtained from the solutions dissolved in NaOH. HFP is a 
volatile solvent, with much lower surface tension compared to NaOH, and this leads to rapid 
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evaporation when the polymer leaves the needle tip, collapsing to form fibers with flat, 
ribbon-like morphology (Koombhongse et al., 2001). 
 
 
 
Figure 3.5. Variation of fiber diameter with relative SPI and PEO concentrations in HFP. While 
increasing the concentration of SPI increases fiber diameter, increasing the concentration of PEO 
from 0.025% to 0.05% resulted in decreased diameters for 6%, 7% and 8% SPI (n = 100, asterisks 
show statistical significance, p<0.05). Between percentages, all groups are statistically 
significantly different (p<0.05) except 7% vs. 8% SPI with 0.025% PEO and 5% vs. 6% SPI with 
0.05% PEO. 
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3.3.2.2. Increase in fiber diameter with hydration: SPI/PEO fibers swelled upon hydration in 
water, PBS, and DMEM + 10% FBS. Figure 3.6 shows a whole scaffold hydrated in DMEM. 
Between 3 h and 7 days of hydration, only fibers in water swelled significantly more at 7 days, 
and only fibers in PBS swelled significantly more at 14 days of hydration compared to 3 h (Figure 
3.7). This indicates that SPI/PEO fibers absorb fluids rapidly and remain stable in aqueous media, 
as also shown by their morphology after hydration over time (Figure 3.8). 
 
 
 
 
Figure 3.6. Electrospun SPI/PEO scaffold hydrated in DMEM. 
 
73 
 
 
Figure 3.7. Variation of SPI/PEO fiber diameter with hydration time. Asterisks (*) indicate 
statistically significant (p<0.05) increase in swelling compared to day 0. 
 
 
 
Figure 3.8. Scanning electron micrographs of hydrated 7% SPI/0.05% PEO scaffolds. 
Representative images of 7% SPI/0.05% PEO scaffolds after hydration for 3 hours in a) DMEM + 
10% FBS; b) 1X PBS; c) water, and for 14 days in d) DMEM + 10% FBS; e) 1X PBS; f) water (scale 
bars 10 µm). 
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3.3.2.3. Elemental surface analysis of SPI/PEO scaffolds: The predominant elements detected 
on the surfaces of SPI/PEO scaffolds are shown in Table 3.3. Fluorine was detected on 
as-electrospun scaffolds (Table 3.3 and Figure 3.9), indicating residue from HFP that did not 
sufficiently evaporate during electrospinning. Molybdenum and sulfur were also sporadically 
present (Figure 3.9). After immersing scaffolds in 1X PBS without calcium and magnesium for 1 h, 
fluorine was no longer detectable (Table 3.3 and Figure 3.9). Therefore, concern about residual 
HFP that may be cytotoxic in vitro or in vivo may be addressed by washing scaffolds with sterile 
saline solution before use, as part of surgical preparation in the operating room. Magnesium, 
calcium and potassium also appeared to have been washed away by PBS. 
 
 
 
Table 3.3. Percentages of elements detected on electrospun SPI/PEO scaffolds as spun and after 
immersion in PBS for 1 h.
 
As spun PBS 1h
Element Avg Weight % St. Dev. Avg Atomic % St. Dev. Avg Weight St. Dev. Avg Atomic % St. Dev.
   
C K 63.00 3.77 69.62 3.69 65.06 6.76 70.05 6.08
N K 13.90 3.38 13.19 3.29 21.13 3.51 19.56 3.37
O K 17.16 2.28 14.23 1.83 11.29 4.34 9.19 3.68
F K 1.71 0.93 1.20 0.66
Na K 1.21 0.22 0.70 0.13 1.16 0.15 0.66 0.09
Mg K 0.33 0.10 0.18 0.06
P K 1.22 0.30 0.52 0.13 0.54 0.27 0.23 0.12
S K 0.48 0.27 0.20 0.11 0.69 0.05 0.28 0.02
K K 0.97 0.20 0.33 0.07
Ca K 0.52 0.15 0.17 0.05
Mo L 0.71 0.10
Cl K 0.32 0.00 0.12 0.00
Totals 100 100
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Figure 3.9. Energy-dispersive spectra of electrospun SPI/PEO scaffolds. Representative spectra of 
as-electrospun SPI/PEO scaffold surfaces (a and b), and after 1 h in PBS, with the fluorine peak 
absent (c). 
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3.3.2.4. Mechanical testing: SPI/PEO scaffolds were tensile tested to break. No significant 
difference was observed between mechanical properties of dry SPI/PEO scaffolds with variation 
in the protein concentrations investigated (Table 3.4). Hydrated samples had ultimate tensile 
strengths roughly one order of magnitude lower than dry samples (Figure 3.10a), with a strain at 
break one order of magnitude higher than dry samples (Figure 3.10b). Pig skin was also tested 
for comparison. Importantly, the strain at break values for hydrated SPI/PEO scaffolds (~83%) are 
in the same order of magnitude as the reported values for human skin, which is approximately 
100% (Diridollou et al., 2000). The ultimate tensile strengths (UTS) of hydrated SPI/PEO scaffolds  
(~0.1 MPa) are roughly two orders of magnitude less than that reported for skin, approximately 
7.7 MPa (Adekogbe and Ghanem, 2005). However, this may not be cause for concern if SPI/PEO 
scaffolds used as wound dressings are not stretched to the maximum in a treatment scenario. 
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Table 3.4. Ultimate tensile strength (UTS) and strain to break values for dry and hydrated (3 h in 
DMEM + 10% FBS) scaffolds with varying concentrations of SPI. 
Scaffold Condition UTS (MPa) Strain to Break (%) 
5% SPI, 0.05% PEO 
dry 1.06 ± 0.23 10.67 ± 3.11 
hydrated 0.06 ± 0.03 73.35 ± 26.98 
6% SPI, 0.05% PEO 
dry 0.90 ± 0.38 7.45 ± 2.92 
hydrated 0.07 ± 0.03 84.88 ± 27.67 
7% SPI, 0.05% PEO 
dry 0.91 ± 0.39 7.53 ± 1.29 
hydrated 0.10 ± 0.05 83.33 ± 21.18 
8% SPI, 0.05% PEO 
dry 0.95 ± 0.31 7.51 ± 1.99 
hydrated 0.11 ± 0.03 81.25 ± 22.47 
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Figure 3.10. Variation of tensile properties of electrospun SPI/PEO scaffolds with SPI 
concentration. Ultimate tensile strength (a) and strain to break (b) of electrospun SPI/PEO 
scaffolds at different concentrations of SPI in dry and hydrated conditions. 
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7% SPI/0.05% PEO scaffolds were hydrated for 3 h (0 days), 7 days and 14 days in DMEM + 10% 
FBS, PBS and water to test the effects of hydration on tensile properties over time. Both UTS and 
strain at break were statistically significantly (p<0.05) lower at 7 days and 14 days compared to 3 
h in DMEM + 10% FBS, while UTS was statistically significantly higher at 7 days and 14 days 
compared to 3 h in PBS and extremely statistically significantly (p<0.01) higher in water (Figure 
3.11). Strain at break was statistically significantly lower at 7 days compared to 3 h in PBS and 
extremely statistically significantly higher in water (Figure 3.11b). These differences may be 
explained by PBS and DMEM both being osmotically balanced, while water not only causes 
osmotic pressure for the proteins in the scaffold but is also a poor solvent for SPI, which may 
cause aggregation of the hydrophobic units over time (Kuipers and Gruppen, 2008). This would 
result in both higher strength and ductility of the scaffolds as the aggregates are being stretched. 
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Figure 3.11. Variation of ultimate tensile strength (UTS) (a) and strain at break (b) with hydration 
time in various media. Asterisk (*) shows statistically significant difference (p<0.05) and double 
asterisk (**) shows extremely statistically significant difference (p<0.01) from day 0. 
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3.3.2.5. In vitro degradation: SPI/PEO scaffolds lost ~10% of their original mass in the 50/50 mix 
of DMEM and equine serum (ES), ~25% in DMEM with or without FBS, and ~40% in distilled 
deionized water within the first day of hydration (Figure 3.12). After that they remained stable 
for 42 days. Scaffolds may have degraded more in water due to hydrolysis coupled with osmotic 
imbalance, whereas the effect of hydrolysis in DMEM was reduced by the osmotic pressure 
balancing presence of salts. The presence of serum did not increase scaffold degradation in the 
case of both 10% and 50% serum in the buffer, indicating that certain factors present in serum 
may have inhibited the activity of serum proteases. The stability of these SPI/PEO scaffolds in the 
presence of serum may be attributed both to the protective effects of serum against proteolytic 
degradation, as well as to the intrinsic protease inhibitors in the structure of soy protein. The 
inhibitory effect of serum on serine proteases is a known phenomenon in the in vitro digestion 
of extracellular matrix (ECM) proteins in mammalian cells. For example, Wang and Zheng (2009) 
recently quantified the inhibition of FBS on trypsin digestion of bovine articular cartilage 
explants using ultrasound biomicroscopy. 
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Figure 3.12. Variation of percentage mass loss of SPI/PEO scaffolds over time in water, DMEM, 
DMEM + 10% FBS and 50/50 DMEM/ES. Asterisk (*) indicates statistical significance (p<0.05). No 
statistically significant differences were observed between 42 days and 1 day for any of the 
conditions. 
 
 
 
Vaz et al. (2003) tested the degradation of SPI extruded into thermoplastic pellets with and 
without crosslinking by glyoxal or heat treatment at 80。C for 24 h. To investigate non-enzymatic 
degradation, the authors immersed SPI pellets in isotonic saline solution for 0, 1, 3, 5, 7 and 14 
days. While un-crosslinked pellets showed approximately 14% weight loss over 14 days, weight 
loss was reduced with increasing concentrations of glyoxal, and less than 2% weight loss 
occurred with heat-treated pellets over 14 days. They attributed the degradation of SPI materials 
to surface erosion, as also evidenced by a decrease in thickness of pellets with immersion time. 
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In our case, although our SPI/PEO scaffolds were not crosslinked, they may also have degraded 
only slightly and by surface erosion. It appears that an initial rapid surface erosion occurred 
within the first day of immersion, after which the scaffolds remained mostly stable. These results 
were also confirmed by characterization of the degradation products, as discussed in the next 
section. 
 
3.3.2.6. Characterization of degradation products of SPI/PEO scaffolds: Supernatants of water, 
DMEM, DMEM + 10% FBS, or DMEM/ES in which SPI/PEO scaffolds were immersed were 
analyzed by SDS-PAGE. As controls, native SPI powder and electrospun SPI/PEO scaffold were 
dissolved in 0.1 N NaOH. Importantly, the characteristic bands of soy protein appeared in both 
these lanes (Figure 3.13, box), indicating that SPI retained its molecular structure even after the 
process of electrospinning. The strongest bands correspond to the 18 kDa basic (B) polypeptide 
of glycinin (the 11S fraction), the 31 kDa acidic (A) polypeptide of glycinin, and the 70 kDa α and 
α’ subunits—which share a 90% homology—of β-conglycinin (the 7S fraction), respectively 
(Curciarello et al., 2008). A faint band also appears around 50 kDa that may correspond to the AB 
subunit of glycinin (Curciarello et al., 2008). 
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Figure 3.13. SDS-PAGE of supernatants from Day 1 of immersion of SPI/PEO scaffolds in water, 
DMEM, DMEM + 10% FBS and DMEM/ES. Boxed lanes show characteristic bands of soy protein 
after dissolving SPI powder and electrospun SPI/PEO scaffold in 0.1 N NaOH. 
 
 
 
Figure 3.13 shows the protein bands of supernatants at day 1. Fewer characteristic bands of soy 
protein appeared in any of the supernatant lanes compared to the controls, but the same soy 
protein bands appeared in all the supernatant lanes that could be seen clearly, and were absent 
from the lanes with the media alone. DMEM/ES lanes were too smeared to read any bands due 
to protein overload from serum. This suggests incomplete degradation from surface erosion on 
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day 1. Vaz et al. (2003) also performed SDS-PAGE analysis on degradation products of soy pellets 
from immersion supernatants, and showed the same characteristic bands on days 0, 3, and 14 of 
continuous immersion. In our case, media were changed daily, and no SPI products could be 
detected in the supernatants after day 1, as represented by bicinchoninic acid (BCA) assay of 
water supernatants (Figure 3.14). According to the standard curve of SPI (Figure 3.14a), 0 mg 
protein corresponded to an absorbance at 562 nm of 0.0785. Therefore, negligible or no protein 
was detectable at any of the time points after day 1 of immersion (Figure 3.14b).
86 
 
 
Figure 3.14. BCA assay for protein content in the supernatants from the degradation study. a) 
Standard curves using bovine albumin serum (BSA) and SPI. b) Protein content in water 
supernatants over time with immersion of electrospun SPI/PEO scaffolds. The (42) in 
parentheses indicate the same sample used at each of the different time points, kept for a period 
of 42 days.  
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Although these SPI/PEO scaffolds are stable in aqueous media and in the presence of serum, 
they are not completely resistant to proteolysis. Soy protein has specific sites where it can be 
cleaved enzymatically. Shutov et al. (1996) identified four cleavage points in the α-chain A2 of 
glycinin (the 11S fraction) as well as in the α’-chain of β-conglycinin (the 7S fraction). The 
C-terminal domain in 7S and N-terminal domain in 11S globulin subunits, as well as hydrophilic 
inserts within the chains, are susceptible to proteolytic attack (Shutov et al., 1996). 
 
Collagenase, which is present in skin wounds, cleaves collagen after the Gly residue in the 
sequence of Gly~[Ile/Leu]-[Ala/Leu] (Xiao et al., 2010). In our experiments, SPI/PEO scaffolds 
were susceptible to degradation by 1 mg/ml collagenase, but only 2 bands of soy protein were 
detected by SDS-PAGE (Figure 3.15a). These appear to correspond to the subunits of intact 
β-conglycinin, with 70 kDa α and 50 kDa β subunits (Figure 3.15b, Shutov et al., 1996; Oliveira et 
al., 2002).
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Figure 3.15. SDS-PAGE of proteolytically digested soy protein. a) SDS-PAGE of soy protein powder 
and scaffold digested by 1 mg/ml collagenase at 1h, 2h and 4h. b) Lane 1: intact β-conglycinin; 
Lane 2: 3-min trypsin hydrolysate; lane 3: 2h trypsin hydrolysate, with 1:600 mass ratio of trypsin 
to protein substrate (image taken from Shutov et al., 1996). 
 
 
 
The hydrolytic stability of electrospun SPI/PEO scaffolds in aqueous environments, 
complemented by the ability to be degraded by proteolytic cleavage, is an encouraging property 
for a scaffold intended to promote skin wound repair. Although our focus is on using SPI/PEO 
scaffolds alone, these discoveries raise the possibility of investigating them as potential carriers 
for slow release bioactive components. 
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3.4. Conclusions 
 
We developed a system for the production of electrospun submicron fibrous scaffolds based on 
soy protein isolate (SPI) with a minimal addition of PEO, using HFP as a solvent. Our system 
provides several advantages over our previous system and those reported by others (Vega-Lugo 
and Lim, 2008; Fung et al., 2010) who have independently electrospun soy protein using NaOH 
as a solvent. Namely, the solutions remain stable indefinitely, the fibers are more ductile to 
handle, the amount of PEO required is approximately 2 orders of magnitude less, and most 
importantly, fibers remain stable for over 7 weeks in aqueous media without any further 
crosslinking treatment. Tensile properties of hydrated SPI/PEO scaffolds are comparable to those 
reported for human skin, and degradation in aqueous media appears to occur by surface erosion 
within the first day of hydration, perhaps by removing protein debris that is not fully entangled 
within the fibers. SPI/PEO scaffolds retain the molecular structure of native SPI as evidenced by 
identical protein band patterns in SDS-PAGE. Taken together, these results present electrospun 
SPI/PEO scaffolds as a promising potential product for skin wound healing applications from a 
material standpoint. Further investigation based on biological characterizations is detailed in the 
next chapters. 
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Chapter 4. In Vitro Biocompatibility of Electrospun SPI/PEO Scaffolds 
 
4.1. Introduction 
 
After developing an electrospun SPI/PEO scaffold with desirable physical and mechanical 
properties, we aimed to determine its suitability in biomedical applications by investigating its 
biocompatibility in vitro. Typically, scaffolds are tested in culture with the cell type of the organ 
the scaffold is intended for in its design. Since our intended application is skin regeneration, we 
used primary human dermal fibroblasts for cell culture studies. We investigated the attachment, 
spreading and proliferation of these fibroblasts on electrospun SPI/PEO and other substrates 
including zein, gelatin as a natural animal-derived protein for comparison, and PLGA as a 
well-characterized (Li et al., 2006; Blackwood et al., 2008) synthetic material for comparison. We 
also developed the first skin equivalent based on electrospun SPI/PEO. 
 
4.2. Materials and Methods 
 
4.2.1 In vitro biocompatibility 
 
4.2.1.1. Cell culture: Primary human dermal fibroblasts (HDF) from neonatal foreskin (Clonetics, 
San Diego, CA) were cultured in T-75 culture flasks in DMEM with 4.5 g/L glucose supplemented 
with 10% FBS and 50 I.U./ml penicillin, 50 µg/ml streptomycin (complete medium, from 
Mediatech) and used at passages 18 to 20. Flasks were kept in humidified incubators at 37 ⁰C and 
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5% CO2; the culture medium was changed twice per week. At confluence, cells were detached 
from flasks by incubating in 0.25% trypsin/2.21 mM EDTA (Mediatech) for 5 min. Complete 
medium was added to allow the FBS to terminate the enzymatic action of trypsin. The cell 
suspension was centrifuged for 10 min at 800 rpm and the pellet was resuspended in fresh 
complete medium prior to counting the cells and seeding them onto scaffolds. 
 
4.2.1.2. Seeding of fibroblasts onto scaffolds: Scaffolds were sterilized by immersion in a 1:10 
dilution of antibiotic-antimycotic solution (ABAM, from Mediatech) in 1X PBS for 48 h, followed 
by immersion in a 1:50 dilution of ABAM for 24 h. Scaffolds were then washed thrice with 1X PBS 
without calcium and magnesium to remove traces of ABAM before transferring to 24-well plates 
using sterile forceps inside a laminar flow hood and securing with Viton O-rings (Cole-Parmer, 
Vernon Hills, IL) (Li et al., 2006; Han et al., 2011). 
 
Fibroblasts were seeded at a density of 30,000 cells per well in 200 µl volumes onto scaffolds in 
triplicate in a 24-well plate. For each type of scaffold, one was kept with no cells as a blank, i.e. 
to compensate for any effect of scaffold material on the alamarBlue™ readings (see below, 
Section 4.2.1.3). Soy protein scaffolds were prepared from 5%, 6%, 7% and 8% SPI, each with 
0.05% PEO; zein scaffolds were prepared at 35%, 40% and 45% (w/v) zein. Cells were also seeded 
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in triplicate onto scaffolds electrospun from 20% poly(lactic-co-glycolic acid) (PLGA) and 8% 
gelatin as synthetic and natural control materials respectively, and onto glass cover slips and 
directly into the well, as standard controls. 
 
4.2.1.3. alamarBlue™ assay: Prior to seeding cells onto scaffolds electrospun onto 15 mm 
diameter glass coverslips and placed inside 24-well plates, fluorescence spectrophotometric 
reading was calibrated against cells grown at a range of densities from 1,000 – 500,000 cells per 
well on tissue culture polystyrene (TCPS) inside a 24-well plate to determine the appropriate 
seeding density for the experiment. This was determined to be 30,000 cells per well. 
 
Cell proliferation was determined using the alamarBlue™ assay, as previously described 
(Nikolaychik et al., 1996; Li et al., 2005, 2006; Guo et al., 2007; Han et al., 2011). After allowing 
the cells to attach to the scaffolds for 1 h, complete medium with 10% (v/v) alamarBlue™ (BD 
Bioscience, Franklin Lakes, NJ) was added to each well to a total volume of 0.5 ml. Plates were 
incubated at 37℃, 5% CO2 for 3 h before 200 µl supernatant from each well was transferred in 
duplicate to a 96-well plate. alamarBlue™ fluorescence was read on a Cytofluor fluorescence 
microplate reader (Perseptive Biosystems, Framingham, MA) (excitation λ=530 nm and emission 
λ= 580 nm). Medium was removed from the 24-well plate and replaced with fresh medium. On 
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days 2, 4, 6 and 8 of culture, 10% (v/v) alamarBlue™ was added to each well and incubated for 3 
h before taking the fluorescence readings. Values were averaged for each condition and the 
corresponding blanks subtracted from the averages. 
 
4.2.1.4. Visualization of cell morphology on scaffolds: The morphology of cells on the scaffolds 
was assessed by fluorescence microscopy and SEM, as previously described (Li et al., 2005, 2006; 
Han et al., 2011). For fluorescence microscopy, the specimens were fixed in 3.7% 
paraformaldehyde (Fisher) for 10 minutes, washed three times with 1X PBS, and stained with 4 
µg/ml Hoechst 33258 (BBZ, bisBenzimide from Sigma) and 2 µg/ml TRITC-conjugated rhodamine 
phalloidin (phalloidin tetramethyl-rhodamine B isothiocyanate, from Sigma) in 1X PBS with 0.2% 
Triton-X100 (Sigma) for 15 min for staining nuclei and F-actin cytoskeleton, respectively. Samples 
were visualized in a Leica DMRX upright microscope equipped with the appropriate fluorescence 
filters. Digital images were acquired with a Leica DC 300FX camera. For SEM visualization, the 
samples were fixed with 2.5% glutaraldehyde in PBS for 1 h at 4 ℃, washed three times with 1X 
PBS, and dehydrated in a gradient of ethanol at 15%, 30%, 50%, 75%, 85%, 90%, 95% and 100%, 
as previously described (Li et al., 2005, 2006). Dehydrated samples were critical point dried and 
mounted onto stubs for SEM visualization. 
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4.2.2. Skin equivalent organotypic co-culture of fibroblasts and keratinocytes 
 
4.2.2.1. Cell culture: Primary human dermal fibroblasts were cultured as described earlier. 
Primary human epidermal keratinocytes (NHEK) from neonatal foreskin (a generous gift from Dr. 
David Moscatello at the Coriell Institute, Camden, NJ) were cultured in progenitor cell targeted 
(PCT) medium (Millipore, Billerica, MA) in cell culture flasks coated with 0.67 µg/cm2 collagen 
type IV from human placenta (Sigma). Keratinocyte cultures were weaned to defined 
keratinocyte serum-free medium (D-KSFM, Invitrogen, Carlsbad, CA) by switching to 75:25 PCT 
medium:D-KSFM, then 50:50, then 25:75 respectively with each medium change before 
switching completely to D-KSFM. D-KSFM included supplements of bovine pituitary extract (BPE) 
and epidermal growth factor (EGF). Upon confluence, keratinocytes were detached by first 
washing with 1X PBS and incubating with Versene (Invitrogen) for 3 min before incubating with a 
1:5 dilution of trypsin/EDTA for 5 – 10 min at 37⁰C and 5% CO2. The trypsin was inactivated by 
adding an equal volume of 1 mg/ml soybean trypsin inhibitor (Amresco, Solon, OH). The 
suspension was centrifuged for 10 min at 800 rpm. Keratinocytes were used between passages 
4 – 6. 
 
4.2.2.2. Skin equivalent co-culture: Scaffolds electrospun from solutions of 7% SPI, 0.05% PEO in 
HFP were cut into rectangular pieces approximately 25 mm x 30 mm and sterilized using serial 
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dilutions of ABAM as described earlier. Scaffolds were then placed onto 3.0 µm cell culture 
inserts (BD Bioscience) in 6-well deep well plates (BD). Co-culture of fibroblasts and 
keratinocytes was performed following the protocol of Gangatirkar et al. (2007) with a few 
modifications adapted from the literature for electrospun scaffolds (Boehnke et al., 2007; Powell 
et al., 2008). Briefly, dermal fibroblasts were seeded onto SPI/PEO scaffolds at a density of 5 x 
104 cells/cm2 and kept submerged in DMEM + 10% FBS for 2 days. Epidermal keratinocytes were 
then seeded onto the fibroblast-populated scaffold at a density of 1 x 105 cells/cm2 and kept 
submerged in a mixture of DMEM:Ham’s F-12 medium with the appropriate supplements (per 
500 ml, the following were added: 9.75 ml NaHCO3, 0.4 ml hydrocortisone (500 µg/ml), 1 ml ITT 
(2.5 mg/ml insulin, 2.5 mg/ml transferrin, 1 x 10-8 M tri-iodothyronine), 1 ml EOP (50 mM 
ethanolamine, 50 mM phosphorylethanolamine), 1 ml adenine (90 mM), 1 ml selenium (2.65 
nM), 0.25 ml gentamicin (50 mg/ml) and 0.25 ml amphotericin B, 1 ml CaCl2 (0.94 M), 1.5 ml FBS, 
1 ml progesterone (1 µM)) for 1 week during its epidermalization phase before lifting the culture 
onto an air-liquid interface on a transwell. The culture was kept at the air-liquid interface for a 
further 2 weeks while it cornified and was maintained in this mature state. Modifications 
included a shortened pre-cultivation time of the dermal component before seeding the 
keratinocytes, based on thorough observations by Boehnke et al. (2007) that pre-cultivation of 
dermal fibroblasts in a fleecy, non-woven hyaluronic acid-based scaffold Hyalograft® for 7 days 
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did not result in better stratification of mature epidermis than pre-cultivation in the same 
scaffold for just 2 days. 
 
4.2.2.3. Histological observation of skin equivalents: At days 7 and 14 of co-culture, scaffolds 
were cut into strips and fixed in 10% buffered formalin (Fisher) before embedding in paraffin 
blocks. Samples were cut into sections 4 – 7 µm thick using a Leica RM2255 microtome (Leica 
Microsystems GmbH, Wetzlar, Germany) and collected onto glass coverslips coated with 
poly-L-lysine (Sigma). These sections were rehydrated in a gradient of xylene (EMD Chemicals, 
Gibbstown, NJ) and ethanol (EMD) and stained with hematoxylin (EMD) and eosin (EMD). 
Stained sections were visualized using a Leica DMRX upright microscope and digital images were 
acquired with a Leica DC 300FX camera. 
 
4.3. Results and Discussion 
 
4.3.1. Electrospun SPI/PEO scaffolds support the attachment, growth and proliferation of 
primary human dermal fibroblasts 
 
4.3.1.1. Proliferation of primary human dermal fibroblasts on electrospun SPI/PEO and other 
substrates: Primary human dermal fibroblasts were seeded onto electrospun SPI/PEO and zein 
scaffolds and cultured for 8 days until confluence. For comparison, the same cells were also 
97 
 
seeded on electrospun gelatin and PLGA scaffolds, as well as glass and tissue culture treated 
polystyrene (TCPS) surfaces as non-electrospun, standard controls. Fibroblasts cultured on 
various substrates proliferated steadily over 8 days to confluence. As shown in Figure 4.1, cells 
on all substrates showed approximately 2- to 5.5-fold alamarBlue™ fluorescence by day 4 
compared to day 0, and approximately 3- to 7.5-fold by day 8 compared to day 0. While cells on 
all substrates followed a similar trend of increasing alamarBlue™ fluorescence indicative of 
proliferation over the 8 days in culture, the cells on the scaffolds tested demonstrated a trend 
towards higher normalized fluorescence values than the “gold standard”, TCPS. The somewhat 
higher AB fluorescence of cells on the electrospun scaffolds might indicate that the 3-D structure 
and porosity of the scaffolds might favor the formation of multilayered cell assemblies. 
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Figure 4.1. Increase in alamarBlue™ fluorescence with time normalized to fluorescence readings 
on day 0. Asterisks indicate statistically significant (p<0.05) increase compared to TCPS for each 
timepoint (n = 3). 
 
 
 
4.3.1.2. Fibroblasts exhibit cytotypic morphology and spreading behavior on electrospun 
SPI/PEO: At confluence, fluorescent staining for filamentous actin (F-actin) cytoskeleton revealed 
similar cytotypic elongated “fibroblast-like” morphologies on all scaffolds (Figure 4.2). No 
differences were seen in the morphology of cells cultured on scaffolds electrospun from 
different concentrations of SPI/PEO (Fig. 4.2 a, b) and zein (Fig. 4.2c), or between the two “green” 
materials. Inspection of the cultures by SEM showed that the cells fully spread over the scaffolds, 
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expressed lamellipodia and secreted their native extracellular matrix (Figure 4.3). 
 
 
 
 
Figure 4.2. Human dermal fibroblasts grew to confluence on Day 8 of culture on various scaffolds. 
a) 5% SPI, 0.05% PEO; b) 8% SPI, 0.05% PEO; c) 40% zein; d) gelatin; e) PLGA; f) glass. (Nuclei, 
blue; F-actin cytoskeleton, red; original magnifications 200x). 
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Figure 4.3. Scanning electron micrograph of primary human dermal fibroblasts cultured on 
electrospun SPI/PEO on Day 8. Fibers are intact and fibroblasts have secreted native extracellular 
matrix (arrows) on the scaffold. Scale bar 5 µm. 
 
 
 
The biocompatibility of SPI fibers, formed by wet spinning, has recently been demonstrated by 
Reddy and Yang (2009) from the University of Nebraska using NIH-3T3 mouse fibroblasts. Their 
fibers ranged from 50 to 150 µm in diameter, thus many cells spread over a single fiber, and 
proliferated until confluence. As a biomaterial, the effects of SPI as a biofilm were investigated 
on normal human fibroblasts and keratinocytes separately (Curt et al., 2009). Both cell types 
showed cytotypic morphology and proliferation, although fibroblasts were more affected than 
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keratinocytes by the formaldehyde used to cross-link the films, with reduced proliferation as 
formaldehyde concentration increased from 1% to 3%. SPI biofilms promoted the up-regulation 
of interleukin-6 (IL-6) and IL-8 mRNA expression in fibroblasts and tumor necrosis factor alpha 
(TNFα) mRNA expression in keratinocytes after 4 days of culture. 
 
Yang’s group at the University of Nebraska also electrospun zein nanofibers and cross-linked 
them using citric acid in order to enhance their water stability (Jiang et al., 2010). They 
demonstrated the cytocompatibility of these scaffolds with NIH-3T3 cells. They also observed 
that cross-linked zein scaffolds promoted up to 7-fold greater cell attachment and approximately 
4- to 7-fold greater cell proliferation than uncross-linked electrospun zein scaffolds. This 
difference in cell behavior was attributed to the greater stiffness of the cross-linked scaffolds, as 
will be discussed in more detail. 
 
Lowery et al. (2010) used electrospun poly(ε-caprolactone) (PCL) fibrous mats of varying fiber 
diameters and pore sizes to elucidate a balance between cellular infiltration and ECM deposition 
between fibers. In general, with bead-free continuous fibers, pore size increases linearly with 
fiber diameter. In their study, pore sizes were varied from approximately 1 to 40 µm while fiber 
diameters were kept within a similar range of nanometers, 2 µm or 8 µm. By co-electrospinning 
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PCL with PEO of different molecular weights and then removing the PEO by immersing the 
scaffolds in water for 7 days, they were able to reduce pore sizes by 50 to 80% while shrinking 
the fiber diameters only by 10 to 25%. Although larger pores and larger fibers encouraged 
greater proliferation of primary human dermal fibroblasts, ECM deposition by these cells was 
delayed on scaffolds with large pores, compared to almost immediate on scaffolds with pore 
sizes less than 15 µm. This reflects their preference for infiltration rather than growing on the 
surface of scaffolds with large gaps between fibers. 
 
Fibroblasts are a suitable cell type for scaffold biocompatibility studies not only because they are 
the main dermal cell type in our case, but also because they are robust and therefore not as 
sensitive to general culture conditions when the scaffold is the variable of interest. van Aalst et 
al. (2008) electrospun primary human dermal fibroblasts and human adipose-derived stem cells 
with a solution of polyvinyl alcohol (PVA) to incorporate the cells into the nanofibers, and found 
that both cell types retained their viability (approximately 30 – 65% for fibroblasts and 22% for 
stem cells). The PVA nanofibers were then solubilized and the cells cultured until confluence. 
However, while fibroblasts were able to proliferate, the adult stem cells were not. As a control 
group, the same cells were electrosprayed rather than electrospun to account for the effects of 
mechanical stress and burst force alone. Fibroblasts also did not proliferate under this condition. 
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In a study by Milleret et al. (2009) investigating the cyto- and hemocompatibility of Degrapol 
fibers, mouse embryonic fibroblasts (NIH-3T3) or human umbilical vein endothelial cells (HUVECs) 
were cultured on Degrapol® fleeces (mats) and their proliferation compared to that of the same 
cells cultured on PLGA or Degrapol fleeces that were pre-adsorbed with fibronectin or collagen I. 
After 8 days, NIH-3T3 cultured on Degrapol proliferated less than those on PLGA, comparably to 
those on Degrapol pre-adsorbed with collagen I, and more than those on Degrapol pre-adsorbed 
with fibronectin. However, NIH-3T3 showed the highest proliferation when cultured on glass. 
HUVECs, on the other hand, did not proliferate on Degrapol and barely proliferated on PLGA, but 
responded similarly well to fibronectin- or collagen-adsorbed surfaces and glass. This again 
illustrates how fibroblasts adhere to foreign substrates more readily than certain other cell 
types. 
 
Scaffold or substrate stiffness has been shown to moderate fibroblast proliferation (Hadjipanayi 
et al., 2009; Jiang et al., 2010) in 2-D culture, with fibroblasts proliferating more on stiffer 
matrices that induce them to produce greater contractile forces corresponding to wound healing 
by granulation tissue. Cells growing on stiffer substrates produce more actin stress fibers and 
spread more than they do on softer substrates. We see this when comparing the morphology of 
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fibroblasts on gelatin (Figure 4.2d) compared to glass (Figure 4.2f). Fibroblasts show the most 
pronounced actin fibers and stretching, as well as aligning to each other, on glass. On gelatin, the 
softest of the substrates compared, fibroblast alignment appears the least directional. 
 
Fernández et al. (2006) modeled the spreading fibroblast (using NIH-3T3s in deformation 
experiments) as a nonlinear gel, with viscoelastic behavior. They show that regardless of whether 
the cell is generating force due to actin filament contraction or experiencing force due to 
external stretching, the viscoelastic moduli of cells are solely dependent on this force and not on 
changes in length during stretching. In addition, fibroblasts exhibit “stress stiffening” and may 
reorganize their cytoskeleton, rearranging connection points inside the cytoskeletal network. 
Solon et al. (2007) interpret that cells do not have a pre-defined stiffness, as they will alter their 
internal stiffness depending on the stiffness of their substrate, thus regulating their morphology 
and motility. Cells also tend to migrate from areas of lesser stiffness to areas of greater stiffness, 
a phenomenon known as durotaxis, as modeled by Lazopoulos and Stamenović (2008) for 
two-dimensional cultures. Here, actin stress fibers are represented as pre-stressed elastic line 
elements, that transmit tension to the substrate via focal adhesions. Stress fibers stiffen with 
increasing tension. Since stiffness is inversely proportional to strain, assuming pre-stress is 
constant, then at the boundary between a softer substrate and a stiffer substrate, a fibroblast 
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will receive feedback from its lamellipodia that the strain in the part of the cell that is on the 
stiffer substrate is smaller than the strain in the part that is on the softer substrate. Thus, the 
total potential energy of the stress fiber is less than it originally was when the whole cell was on 
the softer substrate, and stability criteria dictate that the system is at equilibrium when total 
potential energy is at a global minimum. This shift in potential energy continues as the cell 
migrates (perceiving greater stability as a greater area of the cell senses decreased strain), until 
eventually the whole cell has moved to the stiffer substrate (Lazopoulos and Stamenović, 2008). 
 
In our case, substrates are assumed not to confer any directional strain, and fibroblasts are seen 
to align mostly to each other (Figure 4.2). This is coherent with the work of Bischofs and Schwarz 
(2003), who explain the observation that “cells orient themselves in the direction of maximal 
stiffness of the environment” with the theory that cells optimize their interaction with their 
environment for force pattern that minimizes the work required from the cell in order to achieve 
a certain force at the contact. Considering the extracellular environment as isotropic and linearly 
elastic, they propose that since the cell probes its environment using many contacts 
simultaneously (Figure 4.4, Bischofs and Schwarz, 2003), if stiffness at certain contacts in one 
direction is larger than at the other contacts, the cell will orient in that direction in order to 
minimize the work required to generate the same force at each contact. 
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Figure 4.4. Model of an adherent cell spreading on an isotropic (a) and an anisotropic (b) 
substrate. The cell-substrate contacts are represented by linearly elastic springs with different 
spring constants. From Bischofs and Schwarz (2003). 
 
 
 
As in our case, and with electrospun scaffolds with random fibers in general, alignment cues are 
not characteristic of the scaffold but rather generated by the cells themselves. Bischofs and 
Schwarz (2003) also address the observation that cells align to each other by attributing it to 
how “the mechanical activity of one cell triggers the activity of the other cell, thereby forming a 
positive feedback loop”. When a single cell orients itself to a fiber underneath it, it develops a 
traction that then serves as a cue to adjacent cells that may not have adhered as tightly, creating 
anisotropic strain fields in an otherwise isotropic topography. We see morphological evidence of 
this as well, with fibroblasts probing in different directions when cultured on an electrospun 
SPI/PEO scaffold on Day 2 (Figure 4.5a), aligning to each other as they form cell-cell contacts and 
becoming uniformly aligned by confluence at Day 8 (Figure 4.5b). 
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Figure 4.5. Primary human dermal fibroblasts cultured on electrospun SPI/PEO scaffold on Day 2 
(a) and Day 8 (b). At Day 2, fibroblasts have not defined their alignment and are still probing in 
random directions. By confluence at Day 8, they have aligned fully to each other. (Nuclei, blue; 
F-actin cytoskeleton, red. Original magnifications 200x.) 
 
 
 
By contrast to 2-D, in 3-D culture, cells have been shown to proliferate better in less stiff 
matrices. Bott et al. (2010) cultured human dermal fibroblasts in collagen or poly(ethylene glycol) 
(PEG) hydrogels with elastic shear moduli (G’) varying from approximately 240 to 1200 Pa, and 
saw DNA fold change to be approximately 6-fold vs. 2-fold respectively. In 3-D, cells face physical 
barriers in every direction, which prevent migration. In PEG gels that were designed to be 
cleavable by matrix metalloproteases (MMPs), proliferation was much higher (~6-fold vs. 3-fold) 
in gels with G’ = 241 Pa, less so (~3-fold vs. 2-fold) in gels with G’ = 637 Pa, and similar in gels 
with G’ = 1201 Pa. This highlights the role of MMPs in matrix remodeling, discussed further in 
Chapter 5, but also the limit of their influence on cell proliferation in high stiffness 3-D matrices. 
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4.3.2. Electrospun SPI/PEO scaffolds support the histotypic co-culture of primary human 
dermal fibroblasts and primary human epidermal keratinocytes 
 
Following the protocol of Gangatirkar et al. (2007) for skin equivalent co-culture with 
modifications to shorten the pre-cultivation time of the dermal component based on 
observations by Boehnke et al. (2007), we developed a skin equivalent based on electrospun 
SPI/PEO scaffolds (Figure 4.6). These constructs remained stable for up to 28 days in culture at 
an air-liquid interface. 
 
 
 
 
Figure 4.6. Electrospun SPI/PEO scaffold-based skin equivalents at Day 7 of 
fibroblast/keratinocyte co-culture. Samples shown are being fixed in 10% formalin in a 6-well 
plate prior to embedding for histological analysis. 
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At Day 7 of co-culture, cells are covering the surface of the SPI/PEO scaffold and stratification can 
be seen, although cell types are indistinguishable by routine histology with hematoxylin and 
eosin staining (Figure 4.7a). By Day 14, the layers are more discernible (Figure 4.7b). The cells 
remain on the surface of the scaffold without infiltrating. Although in-depth characterization of 
the fibroblasts and keratinocytes in this construct is beyond the scope of this thesis, we have 
shown that our SPI/PEO scaffold is suitable as a base for skin equivalent co-culture. This carries 
implications for future wound healing applications as well as for new in vitro skin equivalent 
models. 
 
 
 
 
Figure 4.7. Tissue engineered skin equivalent based on the SPI/PEO scaffold. Human dermal 
fibroblasts (D) and epidermal keratinocytes (E) were co-cultured on multi-layered electrospun 
SPI/PEO scaffolds (S), following the procedure of Gangatirkar et al., 2007. The epidermal 
stratification at the air-liquid interface is clearly visible (arrows) on Day 7 (a) and Day 14 (b). H&E 
stained histological section, original magnifications 200x. 
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The original model for organotypic skin co-culture consisted of a collagen gel embedded with 
fibroblasts, allowed to contract (Bell et al., 1979) and then seeded with epidermal cells that 
differentiate and keratinize on the dermal construct (Bell et al., 1981). These grafts were 
cultured from rat cells ex vivo and re-implanted into the rat donors, and shown to incorporate 
well, inhibit wound contraction and become well vascularized in the host. Bell et al. determined 
that the pre-contraction of the dermal construct was a pre-requisite to graft acceptance. They 
founded Organogenesis Inc., Canton, MA in 1985 to market this technology as Apligraf®, which 
was approved by the Food and Drug Administration (FDA) for the treatment of venous ulcers in 
2000. 
 
The collagen gel model, while useful, had many limitations such as poor mechanical stability and 
early degeneration, and the tendency to contract made the dimensions harder to control. To 
better mimic the structure of native ECM and provide more matching mechanical properties to 
the tissue, fibrous materials were later also used to create skin equivalents. 
 
Stark et al. (2006) cultured skin equivalents using nonwoven esterified hyaluronic acid fibers 
(Hyalograft-3D) by first creating a dermal construct with human dermal fibroblasts in fibrin gel 
seeded into the fleece, then seeding keratinocytes onto the dermal construct after one week 
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and then exposing the surface to an air-liquid interface one day later. They found that these skin 
equivalent co-cultures achieved many characteristics of tissue homeostasis, specifically 
maturation of the dermal component including basement membrane (BM) structures, 
polarization of BM components, and enhanced deposition of collagen VII in the BM by 3 weeks. 
Faster epidermal regeneration and better organized epidermal architecture, with polarization of 
keratinocytes at 2 and 3 weeks of culture, was observed on fibrous dermal constructs compared 
to collagen gel dermal constructs. The uppermost, cornified keratinocyte layer, the stratum 
corneum, continued to thicken over 12 weeks. Expression of the differentiation-specific keratin 
marker K10 indicated that it was still differentiating as well as proliferating. Tissue homeostasis 
was also evidenced by the co-expression of keratins K10 and K1, both early differentiation 
markers, and the downregulation of K16 over time, since K16 is expressed during skin wound 
regeneration but not in healthy epidermis. 
 
While the structure of the dermal equivalent appears to impact the “organotypic” success of the 
co-culture, the material does not seem to be a key factor in the organization of the cellular 
components in a scaffold-based skin equivalent. Sun et al. (2005) used electrospun polystyrene 
(PS) to demonstrate that even without biochemical cues, cells could organize themselves 
according to their organotypic assembly. They co-cultured fibroblasts, keratinocytes and 
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endothelial cells together in one single suspension onto electrospun PS fibers of approximately 
10 µm width—the diameter of a single cell—and exposed the surface to an air-liquid interface 
18 h after seeding. By 2 weeks, the endothelial cells and fibroblasts had infiltrated the fibers, 
while the keratinocytes formed a thick top layer. This spatial assembly was attributed to the 
air-liquid interface. 
 
Fibroblasts, by virtue of regulating keratinocyte proliferation and migration, as well as secretion 
of the ECM required for skin regeneration, appear to dictate the outcome of the skin equivalent. 
Boehnke et al. (2007) attempted to quantify the minimum amount of fibroblasts required to 
form a continuous, stable skin equivalent, as well as the optimal time between fibroblast and 
keratinocyte seeding. Using Hyalograft-3D as the scaffold base, they investigated fibroblast 
seeding densities of 5 x 103/cm2, 5 x 104/cm2 and the “standard” 2 x 105/cm2 for 3 x 105 
keratinocytes/cm2. Skin equivalents attempted with no fibroblasts showed “poorly differentiated 
atrophic epithelium”. The lowest amount of fibroblasts investigated, 5 x 103 cells/cm2, allowed 
for a well-developed epithelium as well as expression of collagen VII and integrin β4 marking a 
dermo-epidermal junction—however, these features did not as fully resemble the in vivo 
structure as they did when 5 x 104 fibroblasts/cm2 was used. They determined 5 x 104 
fibroblasts/cm2 to be optimal, yielding tissue quality equal to that formed with the higher 
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density. These skin equivalents were stable for at least 12 weeks in culture, with no shrinkage 
observed. 
 
In terms of precultivation time for dermal equivalents, 2 days was found to be as effective as the 
standard 7 days for epidermal regeneration and differentiation as marked by expression of 
keratins K1 and K10, distribution of collagen IV and linear deposition of collagen VII in the BM. 
Surprisingly, a 14-day precultivation period yielded underdevelopment in both epidermal and 
dermal components, which was attributed to proteolytic degradation by fibroblasts in the 
absence of epithelial-mesenchymal interactions with keratinocytes (Boehnke et al., 2007). 
 
Rnjak et al. (2009) investigated the interactions of primary human dermal fibroblasts with 
electrospun tropoelastin scaffolds, specifically the effects of fiber diameter and consequently 
spaces between fibers on fibroblast attachment, spreading, proliferation and infiltration. The 
cross-linked fibers varied from 3.4 ± 0.8 µm for denser scaffolds to 3.6 ± 0.8 µm and 5.5 ± 1.6 µm 
for more “open-weave” scaffolds, and correspondingly, fibroblasts infiltrated more through the 
scaffolds as fiber diameter and inter-fiber spacing increased. 
 
In our case, fibroblasts did not infiltrate the SPI/PEO scaffolds, but spread across the surface and 
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deposited their own ECM (Figure 4.3). Although this is not undesirable for in vitro skin 
equivalents, it may be beneficial for this or other applications to have cells evenly distributed 
throughout the scaffold to provide signaling factors. To achieve this for electrospun scaffolds, 
Yang et al. (2009) developed a novel approach using layer-by-layer deposition of electrospun 
fibers and cells. PCL/collagen nanofibers with average diameter 454.5 ± 84.9 nm were 
electrospun onto the grounded surface of cell culture medium in a vertical setup, and human 
dermal fibroblasts were seeded onto this layer of nanofibers. The next layer was then 
electrospun directly onto the cell layer after draining the medium, and fibroblasts deposited 
again. This process was repeated until the desired constructs were formed—10 layers of 
alternating fibroblasts and fibers for a dermal equivalent or 18 layers of fibroblasts and fibers 
plus 2 layers of keratinocytes and fibers for a full skin equivalent. Encouragingly, they also used 
HFP as their solvent and showed that even with electrospinning directly into the medium, no 
significant cytotoxicity was found even when the medium was collected and tested specifically 
for such. 
 
As fibroblasts attached and elongated along the separate layers, the constructs became more 
compact and layers became visually indistinguishable by 7 days of culture. The dermal constructs 
also continued to contract over 14 days, more than 40%, while bilayer constructs contracted 
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approximately 20% between days 3 and 7 but no further between days 7 and 14. For the bilayer 
construct, the keratinocyte layers were also seeded onto the fibroblast layers without 
precultivation of the latter (Yang et al., 2009). 
 
4.4 Conclusions 
 
We have shown that electrospun SPI/PEO scaffolds support the attachment, spreading and 
proliferation of human dermal fibroblasts comparably to other natural and synthetic electrospun 
materials. Fibroblasts appeared to receive directional cues from each other rather than from the 
scaffold, as evidenced by aligning to each other on a randomly oriented scaffold. Fibroblasts did 
not infiltrate the scaffold, but spread over the surface and deposited their native ECM. Not only 
has the SPI/PEO scaffold been shown to be biocompatible with fibroblasts, it also supports the 
co-culture of fibroblasts with epidermal keratinocytes in a histotypic skin equivalent model. The 
next chapter investigates some of the possible mechanistic interactions of the fibroblasts with 
the SPI/PEO scaffold. 
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Chapter 5. Interactions of Human Dermal Fibroblasts with SPI Substrates 
 
5.1. Introduction 
 
Mammalian cells attach to natural substrates (e.g. extracellular matrix proteins) mainly via a 
class of transmembrane receptors called integrins (Ingber, 1991; Assoian and Klein, 2008). 
Specifically, human dermal fibroblasts use α2β1 to bind collagens, αvβ3 and αvβ5 for vitronectin, 
and at least αvβ1, α4β1, α5β1, and αvβ3 for fibronectin; αvβ3 also binds fibrinogen (Noszczyk et 
al., 2002). These integrin-ligand interactions play a key role in contraction during wound healing 
(Sethi et al., 2002). In human wound explants, α2, αv and β1 were upregulated early (6 – 7 days) 
after dermal injury, in the area of dermal scar formation (Noszczyk et al., 2002). Integrin α1β1, 
involved in negative feedback regulation of collagen synthesis, has been shown to be more 
highly expressed in fibroblasts explanted from keloids and hypertrophic scars than normal 
human skin (Szulgit et al., 2002). 
 
Although cell-matrix interactions have been well characterized in different cell types with their 
native ECM components, little is known about how human or animal cells interact with foreign 
materials. Initial adhesion appears to depend on electrostatic interactions and wettability of the 
surfaces (van der Valk et al., 1983). In order to elucidate possible roles of integrins in adhesion to 
foreign substrates, several studies have been done by blocking specific integrin subunits and 
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measuring the reduction in number of adhered cells. The adhesion of human osteoblasts to 
PLGA copolymers 2 h after plating was reduced by approximately 70% when β1 and α5β1 
complexes were selectively blocked (Di Toro et al., 2004). By contrast, adhesion was reduced by 
only approximately 30% when integrin αv was blocked. Even the same materials with different 
surface treatments can induce differential integrin receptor expression by cells. Human nasal 
chondrocytes were shown to preferentially express αvβ3 vitronectin (VN) and α5β1 fibronectin 
(FN) receptors on gas plasma treated films of high molecular weight (1000 g/mol) PEG with 
70/30 poly(ethylene glycol)-terephthalate/poly(butylene terephthalate) (PEGT/PBT), compared 
to the same films without gas plasma treatment (Woodfield et al., 2006). Likewise, a lower 
molecular weight PEG (300 g/mol) with 55/45 PEGT/PBT also promoted greater cell adhesion 
and expression of αvβ3 and α5β1 both with and without gas plasma treatment. 
 
Siebers et al. (2008) investigated the effect of blocking β1 and β3 integrins on primary rat 
osteoblast-like cells from bone marrow, cultured on calcium phosphate (CaP)-coated and non 
coated titanium (Ti). On non coated Ti, pre-treatment with anti-integrin β1 antibodies did not 
affect initial attachment. However, pre-treatment with anti-integrin β3 resulted in approximately 
30% decrease in adhesion after 30 and 60 min (p<0.05). On CaP coated substrates, blocking β1 
did have an effect, decreasing attachment by approx. 30% after 30 min (p<0.05), and 20-30% 
118 
 
after 60 and 240 min and after 1 day (p<0.05). Blocking β3 decreased attachment by approx. 
40-50% after 30 min (p<0.01), 60 and 240 min (p<0.05), 1 day (p<0.01), and 3 days (p<0.05). 
Interestingly, on both substrates, pre-treatment with either anti-integrin β1 or anti-integrin β3 
increased mRNA expression of integrin β1. Conversely, pre-treatment with either antibody 
resulted in decreased mRNA expression of integrin β3 in one run and increased expression in 
another run after 3 days of culture on non coated Ti substrates. On CaP coated substrates, 
pre-treatment with either antibody decreased the mRNA expression of integrin β3. Taken 
together, the attachment of osteoblast-like cells onto CaP coated substrates was attributed to β1 
integrin (Siebers et al., 2008). 
 
The study by Siebers et al. (2008), like ours, was done in serum-free medium. However, Chastain 
et al. (2006) have shown that the initial adhesion of mesenchymal stem cells to synthetic 
polymers poly(caprolactone) (PCL) and poly(lactic-co-glycolic acid) (PLGA) are differentially 
mediated by the ECM proteins vitronectin and type I collagen respectively, derived from the 
serum in the cell culture medium. This supports the hypothesis that cells attach to tissue 
engineered scaffolds by binding to the proteins that have adsorbed onto the surfaces from the 
serum. Since these ECM proteins can differentially adsorb onto different substrates, the 
adhesion of cells will also vary by substrate as an indirect effect of this. 
119 
 
 
Based on the hypothesis that initial adhesion of human dermal fibroblasts to SPI/PEO substrates 
is at least partially mediated by integrins and/or other specific cell adhesion molecules, we 
profiled the expression of genes related to human extracellular matrix (ECM) and adhesion 
molecules using targeted PCR arrays from SABiosciences (now QIAGEN), when fibroblasts were 
cultured on SPI or collagen I substrates. We then targeted the expression of individual genes 
shown to be upregulated or highly expressed on these substrates. 
 
5.2. Materials and Methods 
 
5.2.1. Real-time reverse transcriptase polymerase chain reaction (RT-PCR) analysis of 
fibroblast-scaffold interactions 
 
In preliminary experiments, individual integrins were targeted based on the body of available 
literature describing the subunits associated with human dermal fibroblast adhesion in the 
context of adhesion to ECM, or wound healing, as mentioned in Section 5.1. 
 
5.2.1.1. Substrates for initial PCR experiments: Solutions of SPI/PEO were prepared as for 
electrospinning and diluted in HFP to a final concentration of 0.1% (w/v) SPI with 0.001% (w/v) 
PEO. Glass coverslips, 15 mm in diameter, were coated with this diluted solution by dropwise 
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pipetting and allowing the solvent to evaporate in a fume hood overnight. These substrates were 
then sterilized by UV exposure for 30 min, transferred into a 24-well plate and immersed in 500 
µl of 1X PBS without calcium and magnesium to equilibrate pH. For comparison, 0.1% PLGA, 
human dermal fibronectin, collagen type I from rat tail, and bovine gelatin substrates were also 
used. PLGA substrates were prepared in the same way as SPI substrates. For fibronectin (Sigma), 
collagen (BD Bioscience) and gelatin (Sigma) substrates, 200 µl of a 10 µg/ml solution of each of 
these natural proteins was pipetted dropwise into triplicate wells of the same 24-well plate and 
allowed to bind for at least 30 min in a humidified incubator at 37⁰C and 5% CO 2. All wells were 
aspirated and washed twice with 1X PBS prior to cell seeding. 
 
5.2.1.2. RNA isolation for initial PCR experiments: Primary human dermal fibroblasts were 
seeded onto coated substrates in triplicate wells at a density of approximately 20,000 cells per 
well in serum-free DMEM. Cells were also seeded onto uncoated glass coverslips and TCPS (bare 
wells) as controls. At 1 h post-seeding, the medium was removed and the cells were washed 
twice with ice-cold 1X PBS with calcium and magnesium and lysed with TRIzol LS reagent 
(Invitrogen) for RNA isolation using the phenol-chloroform method. Briefly, 0.2 ml of chloroform 
per 1 ml of TRIzol was added to separate the aqueous and organic phases of the mixture. 0.5 ml 
of isopropyl alcohol per 1 ml of TRIzol was then added to the aqueous phase to precipitate the 
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RNA. RNA was purified by centrifuging through RNase-free spin filters (Mo Bio, Carlsbad, CA) and 
washing with 70% ethanol (200 proof, Spectrum, New Brunswick, NJ) twice before removing 
excess ethanol residue by further centrifugation and reconstituting in nuclease-free water 
(Ambion, Austin, TX). 
 
5.2.1.3. RNA quantification: RNA concentration was determined using a NanoDrop ND-1000 
spectrophotometer (Thermo Scientific, West Palm Beach, FL) spectrophotometer and 
ND-1000v3.2.1 software. 2 µl of reconstituted RNA was pipetted onto the Nanodrop and 
measured. Nuclease-free water was used as a blank. RNA samples with a ratio of absorbance at 
260 nm to absorbance at 280 nm (260/280 ratio) between 1.7 and 2.0, indicating absence of 
genomic contamination, were deemed sufficiently pure to use in experiments. 
 
5.2.1.4. cDNA synthesis: Complementary DNA (cDNA) was synthesized from purified RNA using 
the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Carlsbad, CA). Mixtures of 
RNA and cocktail in 0.2 ml thin-walled microcentrifuge tubes (Ambion) were subjected to a 
thermal denaturation and annealing process of 94⁰C for 5 min  followed by 25 cycles of 94⁰C for 
30s, 55⁰C for 30s, and 72⁰C for 30s, ending with 72⁰C for 7 min  and cooling to 4⁰C.  Thermal 
cycling was performed in a GeneAmp® PCR System 9700 (Applied Biosystems). 
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5.2.1.5. PCR: PCR was performed on a StepOne™ Real-Time PCR System (Applied Biosystems) 
using the TaqMan® Fast Universal PCR Master Mix (Applied Biosystems) and inventoried 
TaqMan® primers for human integrins α1 (Hs00235030_m1; NCBI reference sequence 
NM_181501.1), α2 (Hs00158127_m1; NM_002203.3), α5 (Hs01547673_m1; NM_002205.2), αv 
(Hs00233808_m1; NM_002210.3), β1 (Hs00236976_m1; NM_002211.3) and β3 
(Hs00183924_m1; NM_014288.3) (Applied Biosystems). Human peptidyl-prolyl cis-trans 
isomerase A (PPIA) (Hs99999904_m1; NM_021130.3) was used as the endogenous control. 
Samples were subjected to a “fast” thermal cycle of 95。C for 20 s followed by 40 cycles of 95。C 
for 1s and then 60。C for 20 s. Results were generated with StepOne software v2.0. Gene 
expression values for each substrate were normalized to values for glass (as controls for SPI- and 
PLGA-coated glass substrates) or TCPS (as controls for natural proteins coated on bare wells). 
 
5.2.1.6. Substrates for PCR array analysis: Solutions of SPI/PEO were prepared as for 
electrospinning and then diluted in HFP to a final concentration of 0.1% (w/v) SPI with 0.001% 
(w/v) PEO for the purposes of coating. Glass cover slips, 15 mm in diameter, were coated with 
this diluted solution by drop-wise pipetting and allowing the solvent to evaporate in a fume 
hood overnight. These substrates were then sterilized by UV exposure for 30 min, transferred 
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into a 24-well plate and immersed in 500 µl of 1X PBS to equilibrate pH. For collagen substrates, 
200 µl of a 10 µg/ml solution of collagen type I from rat tail (BD Bioscience) was pipetted 
drop-wise into each well of the same 24-well plate containing sterile glass cover slips and 
allowed to bind for 30 min in a humidified incubator at 37⁰C and 5% CO 2. All wells were 
aspirated and washed twice with 1X PBS prior to cell seeding. 
 
5.2.1.7. RNA isolation for PCR array analysis: Primary human dermal fibroblasts were seeded 
onto coated substrates in triplicate wells of 24-well plates at a density of approximately 150,000 
cells per well in serum-free DMEM. At 2 h and 24 h post-seeding, respectively, the medium was 
removed and the cells were washed and lysed for RNA isolation using the QIAGEN RNeasy Mini 
Kit (QIAGEN, Valencia, CA), as per the manufacturer’s instructions. 
 
5.2.1.8. RNA quantification and determination of purity: RNA concentration and purity were 
quantified using a NanoDrop ND-1000 spectrophotometer as described earlier in Section 5.2.1.3. 
As a further check for the absence of genomic or other contamination, denaturing agarose gel 
electrophoresis was performed and the gel was imaged on a Kodak imaging system (Eastman 
Kodak Company, Rochester, NY) to confirm intact RNA by ethidium bromide staining (not shown) 
of bands at 18S and 28S ribosomal RNA but absence of a third, lower band that would indicate 
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organic contamination or possibly “small RNAs”. 
 
5.2.1.9. Focused PCR arrays for human extracellular matrix (ECM) and adhesion molecules: 
One microgram of high-quality RNA obtained as above was used to synthesize complementary 
DNA (cDNA) using the RT² Nano PreAMP cDNA Synthesis Kit (SABiosciences, Frederick, MD); 
cDNA was diluted, added to the RT² SYBR® Green qPCR Master Mix (SABiosciences) according to 
manufacturer’s instructions, and loaded into each well of a 96-well PCR array plate targeting 
human extracellular matrix and cellular adhesion molecules (PAHS-013, SABiosciences). PCR was 
performed on a Stratagene MX3000P (Agilent Technologies, La Jolla, CA) using a thermal cycle 
program of 95 ºC for 10 min followed by 45 cycles of (95 ºC, 15 s; 60 ºC, 60 s). The data were 
analyzed using RT2 Profiler PCR Array Data Analysis software (SABiosciences) and 
MultiExperiment Viewer software (MeV v4.5, Dana-Farber Cancer Institute, Boston, MA) (Saeed 
et al., 2006). 
 
5.2.1.10. Validation of PCR array data: To validate the microarray data, we assessed differential 
gene expression of select target mRNA species using quantitative real time PCR. Fibroblasts were 
cultured, as above, on glass cover slips coated with SPI, PLGA, collagen type I solutions and on 
uncoated glass cover slips for 2 h and 24 h. At each time point, the cells were lysed with TRIzol 
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(Invitrogen) and RNA was isolated by the phenol-chloroform method as described earlier in 
Section 5.2.1.2. cDNA was synthesized using the High Capacity cDNA Reverse Transcription Kit 
(Applied Biosystems) and PCR was performed on a Stratagene MX3000P (Agilent) using the 
TaqMan® Fast Universal PCR Master Mix (Applied Biosystems) and inventoried TaqMan® primers 
(Applied Biosystems) with FAM reporter dye for the following human genes: matrix 
metallopeptidase 10 (MMP-10) (Hs00233987_m1; NCBI reference sequence NM_002425.1), 
MMP-1 (Hs00899660_g1; NM_001145938.1), integrin alpha-1 (ITGA2) (Hs00158127_m1; 
NM_002203.3), collagen type VII alpha 1 (COL7A1) (Hs01574741_g1; NM_000094.3) and laminin 
beta-3 (LAMB3) (Hs00165078_m1; NM_001017402.1) (Applied Biosystems). These genes were 
chosen, as they were identified as highly upregulated using the PCR arrays. Gene expression was 
normalized to that of peptidylprolyl isomerase A (PPIA) (Hs99999904_m1; NM_021130.3) as 
invariant housekeeping gene. 
 
5.2.1.11 Statistical analysis 
 
All experiments were repeated at least three times in triplicate. Data are expressed as mean ± 
standard deviation, where applicable. One-way analysis of variance (ANOVA) was used to 
determine statistical significance (p<0.05). The Holm-Sidak method for post hoc testing was 
employed using SigmaStat software (Systat Software, Chicago, IL). 
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5.3. Results and Discussion 
 
5.3.1. Homogeneity of protein substrate coating: Our coating methods produce homogeneous 
coatings of SPI (Fig. 5.1a) and collagen I (Fig. 5.1b) on glass coverslips, as confirmed by 
fluorescence microscopy of eosin staining. Thus, the substrates are suitable for studies involving 
cell surface receptor binding to substrates. 
 
 
 
 
Figure 5.1. Homogeneity of protein coatings. Eosin staining of (a) SPI and (b) collagen type I 
coatings on glass coverslips, showing homogeneity of protein distribution. Original 
magnifications 200x. 
 
 
 
5.3.2. Preliminary targeting of integrin mRNA expressed by primary human dermal fibroblasts 
cultured on SPI or collagen I substrates:  
Surprisingly, integrin mRNA expression was not more highly expressed by fibroblasts after 1h 
attachment on ECM proteins than on SPI or PLGA. It had been expected that α2 would be most 
highly expressed on collagen I and α5 most highly expressed on fibronectin, with β1 showing 
127 
 
high expression on ECM proteins and β3 possibly showing higher expression on fibronectin than 
on other substrates. However, none of these results were seen—rather, no significant differences 
were seen in the expression of any of the targeted integrins across all substrates tested (Figure 
5.2). Standard deviations were larger for integrin α1 than for other integrins on all substrates. Of 
note, integrin gene expression was similar on the foreign substrates SPI and PLGA as on the ECM 
proteins. Although these preliminary results were encouraging in that they suggest SPI may elicit 
a similar initial adhesion response from fibroblasts as native matrix proteins, a more 
comprehensive set of data was required in order to draw any conclusions. 
 
 
 
 
Figure 5.2. Expression of mRNA of various integrins by human dermal fibroblasts on different 
substrates after 1 h attachment. 
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5.3.3. Differential expression of human ECM and adhesion related genes by fibroblasts on SPI 
and collagen type I substrates after 2 h and 24 h attachment: 
Primary human dermal fibroblasts were seeded onto glass cover slips that had been coated with 
either SPI or collagen type I solutions, and allowed to attach for 2 h or 24 h. The early time point 
of 2 h was used in order to allow for a more stable expression level of mRNA after the cells had 
equilibrated to their microenvironment. We then evaluated differential expression of mRNA 
species for a number of integrins, ECM proteins and matrix metalloproteinases (MMPs) using a 
targeted PCR array (SA Biosciences). The comprehensive list of genes and their functional 
categories is shown in the Appendix. Overall, we found minimal qualitative differences between 
the various substrates, i.e., in no case did we find any gene that was upregulated on SPI to be 
downregulated on collagen or vice versa; the differences were rather quantitative in nature. As 
expected there was significant upregulation of a number of ECM-related genes (Table 5.1) on SPI 
and collagen type I after 24 h compared to the same substrates at 2 h. For both these substrates, 
upregulation of matrix metalloproteinase 10 (MMP-10) was the highest, followed by MMP-1, 
integrin α2, collagen type VII alpha 1, and laminin β3. 
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Table 5.1. Time-dependent upregulation of select genes upregulated in primary human dermal 
fibroblasts cultured on SPI and collagen type I substrates. Data are presented as the ratio of fold 
upregulation at 24h vs. 2h of culture on the two substrates.  
Gene 
Symbol 
Description 
PCR arrays PCR validation 
Fold Regulation (p-value) Fold Regulation (p-value) 
SPI Col I SPI Col I 
MMP10 
Matrix metallopeptidase 10 
(stromelysin 2) 
1152.7255 
(0.0232) 
471.4083 
(0.0525) 
554.4832 
(0.0131) 
996.1905 
(0.011) 
MMP1 
Matrix metallopeptidase 1 
(interstitial collagenase) 
53.7242 
(0.0068) 
36.7796 
(0.039) 
236.6591 
(0.0078) 
196.2660 
(0.0533) 
ITGA2 
Integrin, alpha 2 (CD49B, alpha 
2 subunit of VLA-2 receptor) 
16.8052 
(0.001) 
12.5606 
(0.0245) 
30.0821 
(0.0046) 
81.1177 
(0.0071) 
COL7A1 Collagen, type VII, alpha 1 
6.6231 
(0.0008) 
6.0106 
(0.0085) 
7.0902 
(0.0222) 
8.2344 
(0.0897) 
LAMB3 Laminin, beta 3 
6.4718 
(0.0002) 
7.0494 
(0.0078) 
6.5375 
(0.1086) 
5.6016 
(0.055) 
 
 
 
To validate the PCR array data we also performed quantitative real time PCR for select genes and 
compared their expression in fibroblasts seeded at similar densities on the same substrates (SPI 
and collagen I) for 2 and 24 h. As seen in Table 5.1, RT-PCR analysis yielded qualitatively similar 
patterns as the gene arrays, albeit somewhat lower absolute values for the expression and 
upregulation of ECM related genes after 24 h, with, respectively, MMP-10 again showing the 
highest levels (~ 500- to 1000-fold), collagen VII alpha 1 and laminin beta 3 showing the lowest 
levels (~5- to 8-fold) and little difference between cells plated on the various substrates. In 
addition to SPI and collagen, PLGA (also coated on glass) and bare glass coverslips were also 
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investigated for comparison. Figure 5.3 shows similar ranges of values and trends across all 
substrates, corroborating our PCR array profiling data. 
 
 
 
 
Figure 5.3. Differential upregulation of targeted genes expressed by fibroblasts on various 
substrates after 24h compared to 2h of attachment. Similar trends are seen across all substrates. 
 
 
 
Other genes that were identified by the PCR arrays to be upregulated include MMP-3, -7, -8, -9, 
-13 and -14. Of the TIMPs, only TIMP-1 was highly expressed and slightly upregulated (2.44- and 
2.38-fold on SPI and collagen, respectively). Integrin subunit β3 was also upregulated (3.57-fold 
on SPI and 2.47-fold on collagen), although its usually corresponding subunit αv was neither 
upregulated nor downregulated. Integrin subunit α4 was downregulated 3.2- and 4.11-fold on 
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SPI and collagen respectively. This subunit is not associated with dermal fibroblasts or wound 
healing. 
 
The combined upregulation of MMP-1 and -10 together with MMP-7 has previously been 
associated with intestinal wound healing as expressed by migrating enterocytes in ischemic 
colitis-associated ulcers (Salmela et al., 2004). Dermal fibroblasts also up-regulate MMP-10 as 
well as MMP-1, -3, -8 and MT5-MMP (membrane-type MMP-24) in response to stratifin, a 
protein molecule secreted by differentiated keratinocytes that may play a role in preventing 
hyperproliferative disorders by mediating MMP expression profile in wound healing (Medina et 
al., 2007). Expression of MMP-1 and -3 in human periodontal ligament cells is also stimulated by 
basic fibroblast growth factor (bFGF), suggesting that these MMPs are involved in the ECM 
degradation required to initiate mineralization in periodontal regeneration (Hakki et al., 2009). In 
the absence of stimuli from other cell types, cell-cell contact between human dermal fibroblasts 
in vitro activates an inflammatory response that leads to non-apoptotic programmed cell death, 
correlating with a high upregulation of MMP-10 (106-fold, as compared to non-contact activated 
fibroblasts, Sirén et al., 2006). In our case, a similar mechanism may have been responsible for 
the high upregulation of MMP-10 on different kinds of substrates, since this was also observed 
when cells were cultured on PLGA and uncoated glass for 2 h and 24 h. 
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MMP-1 is commonly associated with skin wound healing as well as cancer, and is often 
expressed by normal fibroblasts in vitro (Pardo and Selman, 2005). In vivo, normal MMP-1 
expression is approximately 8-fold higher in old (>80 years old) compared to young (21 – 30 
years old) dermis, and this correlated with the fragmented collagen matrix of the aged dermis 
(Fisher et al., 2009). In vitro, culture of dermal fibroblasts with medium conditioned by bone 
marrow-derived fibrocytes “reprogrammed” by the deprivation of transforming growth factor 
beta (TGF-β) significantly increased MMP-1 expression and reduced type I collagen expression, 
showing an anti-fibrotic response that may increase the tissue remodeling capacity of these 
fibroblasts (Medina and Ghahary, 2010). 
 
In the presence of keratinocytes, in organotypic skin equivalent coculture, fibroblasts appear to 
regulate certain genes in a manner to prevent fibrosis. At 2 days of air-liquid interface coculture 
in a 3-D collagen gel, these genes were significantly regulated by keratinocytes: urokinase-type 
plasminogen activator (uPA), MMP-1, and MMP-3 were up-regulated in fibroblasts, while 
connective tissue growth factor (CTGF), collagen I, collagen III, fibronectin, plasminogen activator 
inhibitor-1 (PAI-1), tissue inhibitor of matrix metalloprotease-2 (TIMP-2), TIMP-3, and alpha 
smooth muscle actin (α-SMA) were down-regulated (Koskela et al., 2010). These changes reflect 
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anti-fibrosis and suppression of myofibroblast differentiation. The authors chose 2 days as their 
analysis time point because it had been previously shown that the “more significant changes in 
gene expression occurred after 2–4 days compared with 6 days of air-exposure culturing, which 
reflects an altered keratinocyte activity and/or fibroblast susceptibility with time.” Gene 
regulation was also more pronounced in collagen gel cocultured fibroblasts than in cultures on 
plastic, which the authors attributed to the mechanical stresses conferred by the stiffer 
substrates diminishing the effect of keratinocytes. 
 
From our data it appears that the response of fibroblasts does not differ between substrates 
upon initial adhesion at the early time point at 2 h, when interactions between cells and 
substrates are largely dependent on electrostatic parameters (van der Valk et al., 1983) or after 
equilibrating with the environment at the later time point of 24 h. The high upregulation of 
MMPs suggests active breakdown of substrate protein, followed by the expression of native ECM 
components collagen type VII and laminin β3, as well as natural receptors for ECM, especially 
the collagen receptor integrin α2. Integrin α2β1, a predominant collagen receptor, is also more 
highly expressed in aged dermis compared to young dermis, and its activation may be the cause 
of the increased expression of MMP-1 (Fisher et al., 2009). Integrin α subunits are more 
specialized than β subunits, as one β subunit can combine with one or several different α 
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subunits (Noszczyk et al., 2002). Integrins α2β1 and α1β1 play opposite roles in collagen 
regulation—when α2β1 binds to its ligand collagen I, the synthesis of collagen is further 
upregulated; conversely, α1β1 is a feedback inhibitor of collagen synthesis (Szulgit et al., 2002). 
It should be noted that integrin α2β1 is often associated with MMP-1 expression, and has a 
contrasting role to integrin α1β1 in the activation of human hepatic stellate cells from 
quiescence to myofibroblast-like cells (Znoyko et al., 2006). Integrin α2β1 upregulates and 
integrin α1β1 downregulates MMP-1 mRNA expression and MMP1 promoter activity, and the 
stimulation of α2β1 or the inhibition of α1 both promoted the development of well-developed 
multicellular networks (Znoyko et al., 2006). In the context of early dermal wound healing, 
fibroblasts transiently express mainly α2 and αv subunits associated with upregulation of the β1 
subunit (Noszczyk et al., 2002). 
 
In addition to the aggressive proteolytic activity, the moderate upregulation of collagen type VII 
suggests the concomitant occurrence of the constructive side of the remodeling process. 
Collagen type VII is a necessary component of the anchoring fibrils at the dermal-epidermal 
junction, and in disorders where it is absent, such as dystrophic epidermolysis bullosa (DEB), it 
has been shown in mouse models to be restored by the delivery of allogenic fibroblasts 
(Woodley et al., 2007; Wong et al., 2008). In a full-thickness mouse wound model, normal 
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human dermal fibroblasts, which express collagen VII, or human fibroblasts genetically modified 
to overexpress collagen VII were injected intravenously 8-10 h after wound infliction. Both cell 
types homed to the wound site and integrated into the newly formed basement membrane zone, 
but no human collagen VII was seen in unwounded skin or the skin of unwounded mice who 
received the same treatment (Woodley et al., 2007). Wong et al. (2008) took this further, into 
human subjects with recessive DEB, and found that allogeneic fibroblasts injected intradermally 
could promote sustained increase in collagen VII at the dermal-epidermal junction, although 
apparently due to increased expression in the patients’ own COL7A1 gene. 
 
In vitro, cultured human dermal fibroblasts have been shown to upregulate collagen VII in 
response to TGF-β1, PDGF, IL-1β, and TNF-α but not TGF-α (Amano et al., 2007). Collagen VII 
synthesis did not vary with the age of cell donors, ranging from newborn to 91 years old. 
 
Taken together, the gene array and the RT-PCR data show good quantitative and qualitative 
agreement, suggesting that fibroblasts seeded onto SPI will deposit and remodel their own ECM 
substrates in a manner similar to that on other established substrates, such as collagen and PLGA. 
These data from our in vitro studies suggest that SPI is a useful biomaterial that will induce a 
cellular tissue remodeling response similar to that of native ECM proteins. 
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It must be stressed that even though fibroblasts showed a very similar response on SPI, collagen 
I, PLGA and glass surfaces, they do not indiscriminately attach to and grow on any and all 
substrates. This was demonstrated by Machida-Sano et al. (2009) with human dermal fibroblasts 
on alginate films with either ferric ions or calcium ions incorporated (Fe-alginate and Ca-alginate 
respectively). In serum-free conditions, adhesion was low, ~35% on Fe-alginate and ~25% on 
Ca-alginate respectively after 4 h. With the addition of 10% FBS, Fe-alginate demonstrated 
~100% adhesion with spreading, while Ca-alginate barely improved, with a similar level of 
adhesion as without serum and no spread cells. This difference was attributed to the 10.35-fold 
greater ability of Fe-alginate to adsorb serum proteins, including fibronectin and vitronectin, 
which correlates with its greater hydrophobicity. 
 
The direct correlation between hydrophilicity and the inhibition of adhesion of human dermal 
fibroblasts was demonstrated by Groth et al. (2002). Acrylonitrile was copolymerized with 5%, 
20% or 30% (w/w) of hydrophilic N-vinylpyrrolidone (NVP) to form membranes. Fibroblasts 
attached and spread well on the 5% NVP membranes, but were significantly inhibited on 20% 
and 30% NVP, and cells tended to grow in islands. 
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In further support of the role of integrins in cellular attachment to foreign substrates, several 
studies have shown inhibition of attachment when integrins were blocked. The ability of 
hTERT-BJ1 human foreskin fibroblast cells to adhere onto nanopatterned topography as well as 
flat surfaces of polycarbonate was reduced when the cells were blocked with anti-integrin α1 
antibody (Curtis et al., 2006). The number of attached cells after 2h was reduced by over 50% on 
both nanopatterned and flat surfaces after blocking integrin α1. Wood et al. (2008) showed that 
inhibiting β1 integrin on hTERT-BJ1 cells actually increased their ability to “nanoimprint”, or 
conform to the shapes of nanopatterned silicon substrates after 12 h. Inhibiting β3 integrin had 
the opposite effect, reducing their ability to nanoimprint. The potential role of β3 integrin in the 
binding of cells to nanopatterned substrates was also investigated by Walter et al. (2006), who 
revealed a correlation between the density of integrin ligands on nanopatterned gold substrates 
and the adhesion force of the integrin-substrate bond during the first 10 min of adhesion in rat 
embryonic fibroblasts. Each gold nanoparticle functionalized with the cyclic RGD peptide 
c(-RGDfK-) could bind a single αvβ3 integrin. They found the force required to detach an integrin 
using magnetic tweezers to decrease non-linearly with increasing distance between ligands 
(Walter et al., 2006). 
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Integrin αvβ3 may also be crucial for rigidity sensing of fibronectin substrates by fibroblasts 
through the complex it forms with a receptor-like protein tyrosine phosphatase, RPTPα, at the 
leading edge early in spreading. Mouse fibroblasts were plated for 15 h on soft (0.03% bis/8% 
acrylamide) or rigid (0.4% bis/8% acrylamide) substrates coated with fibronectin. It was 
observed that in normal fibroblasts, spread area was much greater on the rigid surface (~2800 
µm2) than on the soft surface (~800 µm2). However, in RPTPα-/- fibroblasts, both substrates 
promoted a similar spread area (~1500 µm2). When normal fibroblasts were incubated with 
monoclonal antibody against αvβ3, cells also showed no difference in spread area on both 
substrates (Jiang et al., 2006). 
 
At the single-integrin level, α2β1 binding with collagen-coated atomically flat substrates has 
been shown to mediate adhesion during the first 60 s of contact for Chinese hamster ovary (CHO) 
cells (Taubenberger et al., 2007). Wild-type CHO cells do not express integrin α2, but can be 
transfected with human α2 to determine its isolated effect on adhesion. The force required to 
break a α2β1-collagen bond was measured to be 47 ± 13 pN. However, after 60 s, the force 
required to rupture a cell-collagen bond is greater than that measured at the single-integrin level, 
suggesting cooperativity between integrin receptors. The cells enter into an “activated” adhesion 
state, and over a period of up to 600 s, the force required to detach a transfected cell increased 
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nonlinearly from several hundred piconewtons to ~20 nN. Taubenberger et al. identified three 
stages of adhesion formation—initiation, reinforcement, and maturation. During initiation (< 60 
s), detachment forces increased slowly to about 3 nN; during reinforcement (60-180 s), they 
increased rapidly by to about 10 nN, after which during maturation (> 180 s), forces increase 
slowly by another 2-3 nN. 
 
Cai et al. (2009) blocked the β1 integrin on the surface of porcine esophageal fibroblasts (PEFs) 
and showed that adhesion to fibronectin was inhibited during the first 90 minutes, resulting in 
less spreading. However, this difference diminishes by 120 minutes and by 240 minutes, the 
spreading was very similar between β1-blocked and non-blocked cells. This initial effect may be 
realized through focal adhesion formation and actin cytoskeleton remodeling. Blocking β1 
integrin increased the lag time between cell deposition and focal adhesion formation by 30 min 
from 30 min for unblocked cells to 60 min. Although spreading equilibrates with time, the 
maximum adhesion strength achieved by the cells over the 240 min does not, with the strengths 
of non-blocked and β1-blocked cells being 52.8 and 34.4 Pa, respectively. 
 
Zlatanov et al. (2005) measured the migration velocity of clusters of β1 integrins in human 
dermal fibroblasts, as identified by fluorescent anti-integrin antibodies. They compared 
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hydrophilic (clean glass) and hydrophobic (octadecyl-silanized; i.e., ODS) surfaces, both coated 
with fibronectin, and found that the wettability of the glass still had a significant impact on β1 
integrin activity. They identified 3 populations of integrins with different speeds (82.76% 
immobilized, 13.08% fast, and 4.16% slow) on hydrophilic glass and only 2 populations (83.36% 
immobilized and 16.64% fast) on hydrophobic ODS. Surprisingly, the percentage of immobilized 
cells on both substrates was similar (approx. 83%). 
 
Hannafin et al. (2006) cultured canine fibroblasts derived from anterior cruciate ligament (ACL) 
and medial collateral ligament (MCL) on TCPS, type I collagen, elastin, laminin and fibronectin 
and quantified their expression of integrins β1, β3 and α5 using flow cytometry. Conditions 
varied from static to 2h or 22h of 5% uniaxial cyclic strain daily for 3 days. Up-regulation of 
subunits with cyclic strain was seen to be substrate-dependent (summarized in Table 5.2). No 
significant differences were seen between 2 h and 22 h. 
 
 
Table 5.2. Summary of substrate-dependent increase in integrin subunit expression of canine 
ACL and MCL fibroblasts after 2 h of cyclic strain daily for 3 days, compared to static controls 
(data from Hannafin et al., 2006). 
α5 β1 β3 α5 β1 β3
Collagen I 33% 33% 39% 54%
Laminin 32% 44% 52% 32% 37% 48%
Fibronectin 36% 45% 34% 40%
Elastin
TCPS
Substrate
ACL MCL
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Taken together, these studies suggest that cellular responses to their microenvironment, 
whether native or foreign, are mediated at least partially by integrins and these changes can be 
measured at the single-integrin level. As such, effect on integrin expression may be another 
factor to take into consideration when tailoring scaffold material properties to its application. 
 
5.4. Conclusions 
 
We have investigated cell surface interactions of human dermal fibroblasts with SPI compared to 
other substrates including collagen I, PLGA and glass, and found qualitatively similar 
up-regulation of certain genes related to cell adhesion across these substrates. The highest 
up-regulated gene was MMP-10, followed by MMP-1, suggesting aggressive proteolytic activity 
toward remodeling the immediate matrix microenvironment. The lesser, but still significant, 
up-regulation of integrins and ECM proteins points to the constructive aspect of the remodeling 
process. Our results suggest that SPI as a biomaterial promotes a favorable initial cellular 
response, similar to other well-characterized biomaterials. 
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Chapter 6. In Vivo Evaluation of SPI/PEO Scaffolds Using a Full-thickness Excision 
Wound Model 
 
6.1. Introduction 
 
So far, no in vitro or computational model exists that can replicate the complex and dynamic 
wound environment at the organism level. Thus an in vivo model is required to evaluate the 
efficacy of new scaffolds, as well as identify any systemic effects such as inflammatory response. 
The rat is a widely used animal model for skin wound healing (Birch et al., 2005; Weingarten et 
al., 2006, 2008; García-Esteo et al., 2007; Garcia et al., 2008). Weingarten et al. used the 
established streptozotocin (STZ)-induced diabetic rat model to validate near infrared (NIR) and 
diffuse reflectance spectroscopy (DRS) as reliable non-invasive optical technologies to measure 
the healing of diabetic wounds over time. Garcia et al. (2008) used full-thickness skin wounds in 
male Sprague-Dawley rats to test the efficacy of collagen gel scaffolds on wound healing, based 
on analysis of parameters such as wound closure, epithelialization, angiogenesis, inflammatory 
response and scarring. 
 
Rat skin and human skin have in common an epidermis, dermis, basement membrane, and hair 
follicles. However, unlike humans, rats have loose skin that does not adhere to underlying 
structures, lack apocrine and eccrine glands, and do not form keloid or hypertrophic scars 
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(Dorsett-Martin and Wysocki, 2008). In a full-thickness wound model, both the epidermis and 
dermis are removed to the panniculus carnosus. A fibrin clot is formed from the base, followed 
by invasion by granulation tissue. Epithelialization occurs from the margins, with migration along 
the interface between the granulation tissue and the clot (Dorsett-Martin and Wysocki, 2008). 
 
We evaluated our electrospun SPI/PEO scaffolds with an established protocol based on these 
well-described models and our surgical and technological expertise at Drexel University in 
collaboration with surgeons at Drexel University College of Medicine. Hairless rats are chosen 
because hair interferes with the study of wound healing as shaving can further inflame and 
infect the wounds (Papazoglou et al., 2008). Male rats are preferred to avoid any hormonal 
fluctuations that are known to affect wound healing (Birch et al., 2005), as estrogen deficiency is 
associated with impaired cutaneous healing and also because the thicker skin of male rats allows 
for less healing by contraction than in females (Dorsett-Martin and Wysocki, 2008). As further 
rationale, in humans, elderly males are more pre-disposed to chronic ulceration and heal acute 
skin wounds more slowly (Gilliver et al., 2009). 
 
Previously, our collaborators developed a fast, portable, non-invasive and reliable diagnostic 
device for the measurement of wound healing based on near infrared (NIR) spectroscopy and 
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diffuse reflectance spectroscopy (Papazoglou et al., 2005, 2008; Weingarten et al., 2006, 2008, 
2010). Briefly, NIR optical measurements were first validated to correlate with wound area 
reduction over time and could distinguish between diabetic and non-diabetic wounds in a rat 
model. More recently, a portable frequency domain diffuse optical tomography instrument that 
noninvasively measures the optical properties, i.e. amplitude and phase shift of light, of tissue at 
depths of several millimeters was implemented (Weingarten et al., 2008) and can assess oxy- 
and deoxy-hemoglobin and water in the wound. NIR absorption coefficients correlated with 
blood vessel ingrowth (confirmed by lectin staining) over time and DRS scattering data 
correlated with collagen concentration (confirmed by Gomori’s trichrome staining) in the 
wounds, in both diabetic and control rats. 
 
We first confirmed that electrospun SPI/PEO scaffolds do not interfere with optical 
measurements, when probed against an optical phantom. This has significant implications in our 
favor in that the scaffold will not need to be removed from the wound in our animal model when 
measurements are taken to determine wound healing over time. 
 
We hypothesized that electrospun SPI/PEO scaffolds will promote an enhanced wound healing 
response in an adult rat model compared to control treatment, as assessed by accelerated 
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wound closure and re-epithelialization, and/or reduced scarring. In our study, we investigated 
the efficacy of SPI/PEO scaffolds in promoting wound healing, and identified improvements to 
the rat model. 
 
6.2. Materials and Methods 
 
6.2.1. Animal model: Hairless Sprague-Dawley rats (CD Hairless, Charles River Laboratories, 
Wilmington, MA) aged approximately 11 weeks were chosen as the animal model for 
full-thickness skin excision wounding due to their docility and the absence of the need for 
shaving fur, which causes local irritation. 
 
6.2.2. Surgery: According to our protocol approved by the Institutional Animal Care and Use 
Committee (IACUC) of Drexel University (#18284), animals were anesthetized using 2% 
isoflurane gas and square full-thickness excision wounds of approximately 2 cm x 2 cm were 
created on the dorsum. In the initial pilot study to optimize wound location, only one wound was 
inflicted on each animal, and animals were randomized to either treatment with SPI/PEO 
scaffold or with Tegaderm™ (3M, Minneapolis, MN) polyurethane dressing as a control. Ten rats 
were used in this study and one died during anesthesia, so 6 rats (3 male, 3 female) were treated 
with SPI/PEO and 3 rats (1 male, 2 female) were treated with Tegaderm™. In the second pilot 
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study, 10 rats (all male) each received 2 wounds symmetric along the dorsal midline, and one 
side was treated with SPI/PEO scaffold and secured with Tegaderm™ while the other side 
received Tegaderm™ alone (Figure 6.1). SPI/PEO scaffolds were sterilized by exposure to UV for 
30 minutes on each side before application to wounds. 
 
 
 
 
Figure 6.1. Full-thickness skin excision model in the rat. Wounds were treated with SPI/PEO 
scaffold on one side (a) and Tegaderm™ dressing on the other side (b, image shows wound 
before application of Tegaderm™). 
 
 
 
6.2.3. Measurement of wound healing parameters: Digital photographs were taken of the 
wounds next to a ruler 2 to 3 times per week and the images were analyzed using University of 
Texas Health Science Center at San Antonio (UTHSCSA) ImageTool 3.0 software. Pixels were 
converted to metric units to determine wound area at each time-point. Wound closure was 
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assessed by calculating the area relative to the original wound area: 
% wound closure = 100 × (wound area at day 0 – wound area at day N)/wound area at day 0. 
Functional near infrared (fNIR) spectroscopy was also used to quantify wound healing according 
to methods described by Weingarten et al. (2006, 2008), correlating optical absorption to 
oxyhemoglobin content. It was first determined that the SPI/PEO scaffold, when hydrated, was 
optically transparent to the fNIR sensors. Thus, the scaffold would not interfere with wound 
measurements. The sensor was calibrated on an optical phantom before each set of 
measurements (Figure 6.2). The sensor was placed at the wound center as well as the edge for 
measurement, and unwounded skin on the flank was used as a control site. Rats were fully 
conscious during all measurements. 
 
 
 
 
Figure 6.2. Calibration of fNIR sensor on an optical phantom (a) and measurement of a wound 
edge (b). 
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6.2.4. Histology: At day 31 post-operatively, 5 animals from each group were sacrificed and 
biopsies were taken of the wound sites for histological analysis. Samples were embedded in 
paraffin following a dehydration gradient of ethanol (EMD) and xylene (EMD) and cut into 
sections mounted on glass slides coated with poly-L-lysine (Sigma). Sections were rehydrated 
and stained with hematoxylin and eosin as well as Gomori’s trichrome (Sigma) to identify 
interstitial collagen. Stained sections were visualized using a Leica DMRX upright microscope and 
digital images were acquired with a Leica DC 300FX camera. 
 
6.2.5. Statistical analysis: Using power analysis we determined that with 5 animals per group we 
would be able to assess a 20% improvement of treatment over control even with 15% variability. 
Statistical significance in the difference between wound closure of control vs. experimental 
groups was determined by two-tailed, unpaired Student’s t-test (p < 0.05 taken as significant). 
Data are expressed as mean ± standard deviation, where applicable. 
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6.3. Results and Discussion 
 
6.3.1. SPI/PEO scaffolds promote quantitatively similar wound healing response as standard 
control 
Wound closure was slightly, but not statistically significantly, faster in the SPI/PEO treatment 
group than the control group (Figure 6.3). The largest difference between groups was detected 
at postoperative day 2, when wounds were 71.5% ± 15.4% and 80.0% ± 6.9% of original wound 
area for SPI/PEO treated and control groups, respectively. Wounds were completely healed by 
postoperative day 18, although the neodermis continued to be replaced by thicker scar tissue up 
to the end of our study at day 31. This trend correlates with the model proposed by Cross et al. 
(1995) based on general observations of untreated full-thickness excision wounds in the rat, 
where wound healing occurs in 3 phases: a lag phase lasting approx. 2 days, followed by a sharp 
decrease in wound area during the contraction phase until approx. day 12, ending with the 
consolidation phase (Figure 6.4, Cross et al., 1995). 
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Figure 6.3. Wound area as percentage of original wound area over time. The SPI-PEO treated 
wounds healed slightly, but not significantly, faster than control treated wounds, especially on 
day 2. Wounds were closed by day 18. Data normalized from n = 15 SPI-PEO and n = 14 control. 
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Figure 6.4. Healing of full-thickness wounds in the rat model. The timeline is divided into three 
phases, with an initial lag phase during the first 2 days (a), followed by a contraction phase until 
approximately day 10 (b), ending with the consolidation phase until approximately day 15 (c). 
Figure taken from Cross et al., 1995. 
 
 
 
NIR measurements at wound and control sites corroborated our interpretation that the SPI/PEO 
promotes only slight quantitative improvement in wound healing over control. Figure 6.5 shows 
the variation of absorption at wavelength 685 nm over the healing period. This is in the range of 
wavelengths at which hemoglobin is a major chromophore. Wounds have a higher concentration 
of oxygenated blood than unwounded tissue, due to increased vascularization as part of the 
early healing process. Thus, healing wounds will show a downward slope of NIR absorption over 
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time as wound inflammation and angiogenesis decrease with remodeling, while non-healing 
wounds may show a constant or even upward slope (Weingarten et al., 2010). Our normalized 
data show a very similar trend between treatment and control groups, with no statistically 
significant difference. 
 
 
 
 
Figure 6.5. Variation of fNIR absorption at 685nm at the wound site with time. 
 
 
 
6.3.2. Qualitative benefits of SPI/PEO scaffold over Tegaderm™ (control) 
Although quantitatively, the SPI-PEO scaffold performs very similarly to the control, qualitative 
differences could be seen with the naked eye. By nature of the submicron-scale fibrous structure, 
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the SPI-PEO scaffold absorbed wound fluids and integrated itself with the wound, serving as a 
“breathable” interface between the raw wound and the external environment. The wicking 
action of the scaffold prevented excessive oozing of inflammatory wound exudates, which was 
still occurring on day 2 in control wounds (Figure 6.6). 
 
The SPI/PEO scaffold thus functions initially as a permanent scaffold, rather than as a removable 
wound dressing. However, by day 7 it is detached naturally as part of the encrustation. To 
translate this phenomenon to a clinical setting, where wounds are surgically “cleaned” 
approximately weekly by debridement of necrotic tissue, the SPI/PEO scaffold or any remainder 
thereof would presumably be removed in this procedure and replaced with a new scaffold, and 
this process would be repeated until the wound is healed to a point where a scaffold is no longer 
necessary. 
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Figure 6.6. Macroscopic progression of wound healing in a single rat. 
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The qualitative differences between SPI/PEO treated and control groups may be attributed to 
fundamental differences in the properties of our electrospun SPI/PEO scaffold and Tegaderm™ 
(Table 6.1). Tegaderm™, used in standard wound care practice, is designed to be an occlusive 
dressing to keep wounds moist and sterile, by providing a barrier to pathogens and other 
external stressors while preventing moisture loss. It may be changed daily or as often as required, 
adheres to the area of unwounded skin surrounding the wound, and does not promote any 
cellular interaction. By contrast, our SPI/PEO scaffold is intended as a permanent scaffold that 
incorporates directly into the wound, in order to provide structural and molecular cues to the 
cells active in each stage of wound healing. The integration of SPI/PEO scaffold into the wound 
creates a dual effect of promoting cellular interaction and absorbing excess exudates, which may 
aid in accelerating homeostasis. 
 
The mechanical properties of Tegaderm™, measured using the same methods as described in 
Chapter 3, Section 3.2.2.3, also differ significantly from those of electrospun SPI/PEO. The 
ultimate tensile strength (UTS) of Tegaderm™ is over two orders of magnitude greater than that 
of electrospun SPI/PEO, while the strain to break is approx. 2.5-fold greater (Table 6.1). While 
neither device closely matches the tensile properties of human skin, with UTS ~7.7 MPa 
(Adekogbe and Ghanem, 2005) and strain to break ~100% (Diridollou et al., 2000), the SPI/PEO 
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scaffold resembles human skin much more closely. 
 
 
 
Table 6.1. Comparison of properties of SPI/PEO scaffold with Tegaderm™. 
Property SPI/PEO Tegaderm™ 
Type of device Permanent scaffold Temporary dressing 
Function Promote healing response 
through cellular interaction; 
absorb excess fluid 
Barrier to external environment 
Material Natural; plant-derived (soy 
protein) 
Synthetic (polyurethane) 
Structure Fibrous/porous Membrane 
Permeability Breathable Occlusive 
Mechanical properties† UTS: 0.10 ± 0.05 MPa 
Strain at break: 83.3 ± 21.2 % 
UTS: 38.4 ± 3.0 MPa 
Strain at break: 203.7 ± 28.6% 
Biodegradability Biodegradable Not biodegradable 
Interface with wound Absorbent Adhesive 
Bioactivity Potentially bioactive Inert 
UTS, ultimate tensile strength 
†For SPI/PEO, values are given for hydrated conditions. 
 
 
 
Histologically, by the end of study at day 31 no differences could be seen between SPI/PEO 
treated and control groups (Figure 6.7). Wounds are fully re-epithelialized and underlying dermal 
tissue is well vascularized. From this we can simply conclude that in the long term, wounds 
treated with SPI/PEO scaffold reach a tissue structure similar to those of wounds treated with 
Tegaderm™. 
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Figure 6.7. Histological sections at post-operative day 31. a) wound treated with SPI/PEO scaffold; 
b) unwounded area from the same SPI-PEO treated animal; c) wound treated with control, 
Tegaderm™; d) unwounded area from the same control treated animal. 5µm sections stained 
with hematoxylin and Gomori’s trichrome (Nuclei: Black; Normal muscle myofibrils: Green-blue 
with distinct A and I bands; Intermyofibrillar muscle membranes and keratin: Red; Interstitial 
collagen: Green). Original magnifications 200x. 
 
 
 
6.3.3. Improvements to our wound healing model 
Several studies have used full-thickness excision wounds in a rat model to test electrospun and 
other scaffolds. For example, Waldeck et al. (2007) used a single ~1 x 1 cm2 full-thickness wound 
on the dorsum of each approx. 3-month-old female Sprague-Dawley rat to compare unmodified 
gelatin interpenetrating networks (IPN) with RGD-modified IPN with keratinocyte growth factor 
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(RGD-IPN+KGF) and control, conventional dressing. IPN solutions were applied as a liquid and 
photopolymerized using UV in situ. At 2 days, 1 week, 2 weeks and 3 weeks, wounds were 
excised and histological sections were examined for inflammation, angiogenesis and capsule 
thickness. IPN inhibited wound contraction compared to the unrestricted control, since the 
wounds only had physical space to contract when the material degraded. In addition, 
RGD-IPN+KGF filled the wound and increased cellular growth compared to unmodified IPN and 
control, also decreasing wound closure by contraction. Initially, at 2 days, RGD-IPN+KGF induced 
the greatest neutrophil numbers, indicating a high inflammatory response; however, neutrophil 
numbers decreased significantly over 3 weeks of healing. 
 
In our initial pilot study, we observed that female rats had thinner skin and thus accelerated 
contraction compared to male rats, in line with reports by Cross et al. (1995), although we did 
not compare these parameters between genders and the number of rats was not large enough 
to draw any significant conclusions. The thicker skin of male rats may be more resistant to 
underlying fibroblast contractile forces, allowing for a greater role of epithelialization in healing. 
We also found male rats to be generally more docile and easier to handle by virtue of their larger 
size, and continued further studies with only male rats. 
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Rats heal mainly by wound contraction, decreasing the healing time compared to animals that 
heal more by re-epithelialization, and this causes difficulties in assessing the efficacy of a 
treatment over a longer time frame (Dorsett-Martin and Wysocki, 2008). Aged rats are a model 
for delayed wound healing (Cross et al., 1995), and we investigated our SPI/PEO scaffold in an 
“old” male rat (approx. 7 months) following the same procedure (see Section 6.2.2) as for the 
younger rats, with two wounds, one on either side of the dorsal midline. 
 
Only two aged rats were available from Charles River Laboratories when we requested them 
over a period of months, and one died during anesthesia before the operation. Therefore, only 
one rat was available for our experiment. All procedures were performed by Kimberly Wasko, 
CVT, RLAT. 
 
Similar to the results from the pilot study with younger rats, healing by wound closure was 
closely similar in the two wounds in the old rat (Figure 6.8). Between days 1 and 14, the control 
wound appears to heal faster. This may be due to the presence of the scaffold creating a physical 
resistance to wound closure by contraction in the SPI/PEO treated wound. 
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Figure 6.8. Wound area as percentage of original wound area over time for an aged rat. Healing 
trends are closely similar between the SPI/PEO treated and control wounds, with no statistically 
significant differences at any time point. Day 31 measurements were taken of the remaining scar. 
 
 
 
Macroscopically, SPI/PEO treated and control wounds healed in a similar fashion, much like in 
the study with younger rats (Figure 6.9). Complete wound closure was not reached until after 
day 21, delayed compared to days 14-18 in younger rats. Although one rat is not enough to draw 
any conclusions, we have seen that the SPI/PEO scaffold promotes similar healing as Tegaderm™ 
in both young and aged models. 
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Due to the difficulty in obtaining aged rats, as vendors do not usually have them available, we 
investigated a model of physically impaired wound healing, by using an acrylic ring to splint open 
the wound. This model has been reported in the literature as an effective method to prevent 
contraction in rodents, allowing for healing completely by granulation tissue formation and 
re-epithelialization (Galiano et al., 2004; Shinzawa et al., 2007), and has even been termed 
“humanized” (Wong et al., 2010) as human wounds, like porcine wounds, heal primarily by 
re-epithelialization rather than by contraction. The same model has also been used in the 
miniature Bama pig for the same purpose (Ma et al., 2007). This type of “manipulated” wound is 
recommended where differences in healing between species, e.g. rat and human, are due to 
anatomical characteristics such as the presence of the panniculus carnosus in rodents, which 
separates the dermis from the sub-dermal tissue, resulting in a large amount of contraction 
when a section of full-thickness skin is removed (Lindblad, 2008). The physical barrier imposed 
by the ring allows for granulation tissue to form, more closely simulating the human condition. 
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Figure 6.9. Macroscopic progression of wound healing in an aged rat. 
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Galiano et al. (2004) quantified the delay in wound healing imposed by the circular splint in a 
mouse model. Full-thickness excisions were made on the dorsum of healthy and diabetic mice. 
In both cases, splinted wounds healed more slowly than unsplinted wounds (12.7 days ± 0.96 vs. 
7.81 ± 0.78 in healthy mice and 22.6 days ± 1.44 vs. 12.4 ± 0.96 in diabetic mice, respectively). 
Granulation tissue continued to form until wounds were completely re-epithelialized. 
 
In order to increase granulation in the healing wound, Shinzawa et al. (2007) inhibited 
contraction in their full-thickness wound model using two 30mm-diameter wounds on the back 
of each male Sprague-Dawley rat. An acrylic ring of the same diameter was placed in each 
wound. Granulation tissue was seen to proliferate up to day 14, followed by fibrosis instead of 
epithelialization. Neovasculature could be seen at day 7 and the number of vessels was greatest 
on day 14, decreasing afterwards with increasing vessel thickness during the observation period 
up to day 28. 
 
Wong et al. (2010) followed a similar procedure to investigate the efficacy of a pullulan-collagen 
hydrogel on dermal wound healing in a mouse model. Excisional wounds were splinted and 
treated with either the hydrogel or simply Tegaderm™ alone. Hydrogel-treated wounds closed 
significantly faster than non-treated wounds, being 86.4% ± 1.6% vs. 91.7% ± 1.0% of original 
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wound area on day 3 and 59.4% ± 3.6% vs. 73.2% ± 2.5% on day 5, respectively. Granulation 
tissue formation was significantly greater in hydrogel-treated wounds on day 3, but this 
difference was no longer significant by day 5. 
 
In our proof-of-concept experiment for this model, two wounds 20 mm in diameter were made 
bilaterally along the dorsal midline (Figure 6.10). Wounds were splinted with an acrylic ring and 
treated with either electrospun SPI/PEO scaffold or Tegaderm™. By day 15, the SPI/PEO scaffold 
was still present in the wound as it was not contracted and therefore did not detach (Fig. 6.10c). 
In the control wound, granulation tissue had formed but the wound had not re-epithelialized, 
and was still “raw” (Fig. 6.10d). 
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Figure 6.10. Splinted wound model in a hairless rat. a) Wounds were treated with SPI/PEO 
scaffold (right) or left untreated (left). b) Wounds measure approx. 20 mm in diameter (approx. 
0.8 inches on the scale). c) SPI/PEO treated wound on day 15. d) Control wound on day 15. 
 
 
 
These preliminary experiments have demonstrated that electrospun SPI/PEO scaffold invokes a 
similar wound healing response as Tegaderm™, or standard wound care, in the rat model. 
Further experiments may be able to identify benefits that manifest during the early stages of 
wound healing, such as during the acute inflammatory phase during the first 2 days 
post-wounding (Birch et al., 2005). Derrick et al. (2008) analyzed gene expression of wound 
tissue at day 2 post-wounding of 17-22 week-old male Zucker diabetic fatty (ZDF) rats. Each rat 
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received a 3cm-diameter full-thickness wound on the dorsum. In this model of impaired healing, 
rats received one of three treatments: vacuum-assisted closure, gauze under suction, or moist 
wound healing (control group). The control group was similar to ours, with the wound simply 
covered with Tegaderm™. Genes involved in pathways associated with inflammation mediated 
by cytokine and chemokine signaling, integrin signaling, B-cell activation, interleukin signaling, 
platelet-derived growth factor (PDGF) signaling, cytoskeletal regulation by Rho guanosine 
triphosphatase (Rho GTPase) and angiogenesis were significantly over-represented in all three 
groups. 
 
It will be valuable to study more carefully the immune response induced by soy protein scaffolds 
at early time points, as soy protein contains immunogenic components. Soybean β-conglycinin 
includes a tridecapeptide sequence (MITLAIPVNKPGR) termed soymetide, which stimulates 
phagocytosis of human neutrophils (Tsuruki et al., 2003). Although very little research has been 
done on soymetides and interest has been in effects of their oral ingestion, they may be relevant 
as direct stimuli to cells in wounds if they are released. 
 
Soy protein also contains major anti-inflammatory components. Lunasin, the 5 kDa, 43-amino 
acid peptide known for its anti-cancer activity based on its cell-binding RGD motif, also inhibits 
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inflammation by suppressing the NF-κB pathway in RAW 264.7 macrophages in vitro, completely 
inhibiting IL-6 production and significantly inhibiting IL-1β production with an IC50 of 13 µM (de 
Mejia and Dia, 2009). Lunasin also inhibits the production of reactive oxygen species (ROS) and 
the release of tumor necrosis factor alpha (TNF-α) as well as IL-6 in RAW 264.7 macrophages 
(Hernández-Ledesma et al., 2009). 
 
Valsecchi et al. (2010) showed the in vivo anti-inflammatory properties of the soy isoflavone 
genistein, by treating diabetic mice with subcutaneous injections of 3 or 6 mg/kg of genistein 
daily for 3 weeks. After 3 weeks, the sciatic nerves were assayed for IL-1β, IL-6 and TNF-α levels. 
The production of these cytokines was elevated in diabetic mice, but was reverted to the normal 
level of non-diabetic controls with treatment with 3 or 6 mg/kg genistein. In the sciatic nerves as 
well as the brain and liver, a 50% higher level of ROS was seen in diabetic mice, but this was also 
reverted to non-diabetic levels by 3 mg/kg genistein. This study shows that while genistein does 
not affect the condition of chronic hyperglycemia in diabetes, it is effective in attenuating the 
inflammatory and oxidative state (Valsecchi et al., 2010). 
 
It is also important to assess wound vascularization in more detail, since angiogenesis is a critical 
part of the early wound healing process. Histological staining shows blood vessels 
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macroscopically. Quantitative methods include analysis of vascular endothelial growth factor 
(VEGF) expression levels (e.g. Scherer et al., 2009; Wong et al., 2010), and immunohistochemical 
staining of angiogenesis markers such as platelet endothelial cell adhesion molecule 1 (PECAM-1) 
(Scherer et al., 2009) or lectin, a sugar that binds to endothelial cells and thus can reveal overall 
vascular structure (Papazoglou et al., 2008). Blood vessel density can be calculated from 
fluorescent micrographs by counting the number of vessels visualized in each high powered field 
of interest. 
 
Investigation of how the electrospun SPI/PEO scaffold affects the early wound healing events of 
inflammation and vascularization will help us to understand some of the potential mechanisms 
of interaction between the scaffold and the cellular wound environment, and identify potential 
benefits of the scaffold in early wound healing. 
 
6.4. Conclusions 
 
We have demonstrated in preliminary pilot studies that electrospun SPI/PEO scaffolds are fully 
biocompatible and promote a similar wound healing response as the standard of care in vivo in a 
rat model. SPI/PEO scaffolds provide qualitative benefits of absorbing wound exudates and 
integrating easily into the wound defect. As such, they merit further investigation as a potential 
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new treatment modality, especially by assessing inflammation and angiogenesis during the early 
stage of wound healing. 
 
It is widely acknowledged that there is no real “chronic” wound model to mimic the non-healing 
wounds that humans suffer. Therefore, at least to simulate aspects of the chronic wound 
environment, a model that limits contraction and allows for re-epithelialization would be more 
suitable. We have demonstrated this in a proof of concept using the splinted wound model. 
Larger animal models such as the pig, where feasible, may also provide a more valuable platform 
to evaluate the efficacy of electrospun SPI/PEO scaffolds. 
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Chapter 7. Conclusions and Recommendations for Future Work 
 
7.1. Conclusions 
 
The work in this thesis aimed to fulfill 3 specific aims as laid out in Chapter 2: 
 
1) Fabricate a novel soy protein-based electrospun fibrous scaffold and characterize its 
mechanical properties, degradation behavior and in vitro biocompatibility. 
  
2) Identify initial adhesion mechanisms of human dermal fibroblasts to SPI/PEO. 
  
3) Evaluate electrospun SPI/PEO scaffolds in vivo using a rat wound healing model. 
 
Specific Aim 1 was fulfilled by optimization of a solvent system, component ratios and 
electrospinning parameters in order to develop an electrospun fibrous scaffold based on soy 
protein isolate (SPI) as a renewable, abundant raw material with well-documented bioactive 
properties, with minimal addition of synthetic poly(ethylene oxide) (PEO) to increase chain 
entanglements in solution and facilitate polymerization. Parametric studies revealed an optimal 
concentration of 7% (w/v) SPI with 0.05% (w/v) PEO, using 1,1,1,3,3,3 Hexafluoro-2-propanol 
(HFP) as a solvent. This solvent system provided the benefits of producing protein solutions with 
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an indefinite shelf life, a reduction in the concentration of PEO required to produce consistent 
electrospun fibers compared to aqueous solvents such as NaOH, and ductile fibrous scaffolds 
that possess the important advantage of being stable in aqueous media without the need for 
further cross-linking. Just as importantly, they are capable of being degraded proteolytically. Also, 
the process of electrospinning does not alter the molecular weight distribution of native SPI, 
suggesting that the molecular structure remains intact throughout the simple fabrication process 
using HFP as a solvent. Electrospinning is the preferred fabrication method for our application of 
creating a scaffold for skin tissue regeneration due to its ability to generate a fibrous structure in 
the sub-micron to micron range that mimics the structure of native ECM, as well as its potential 
for scaling up in manufacturing. Electrospinning is highly suitable when a thin (~0.1 – 0.2 mm 
thickness) scaffold with a large surface area is desired, such as for skin repair. 
 
The differential behavior of soy protein in HFP compared to NaOH may be at least partially 
attributed to HFP being a more effective solvent than NaOH, allowing for enhanced opening of 
the soy protein structure followed by the formation of more intricate physical bonds that serve 
to crosslink the fibers in the electrospun SPI/PEO scaffold. While stable physical crosslinking is 
not observed among other proteins electrospun from solutions in HFP, the presence of disulfide 
bridges that is characteristic of soy protein may contribute to this phenomenon. The presence of 
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disulfide bridges increases the size of aggregating peptides (Kuipers and Gruppen, 2008), and the 
breaking of these bonds may expose more surface area for chain entanglements to form. 
 
Electrospun SPI/PEO scaffolds had fiber diameters in the range of 852 ± 373 nm when dry and 
1473 ± 328 nm when hydrated for 3 h in 1X PBS. The tensile properties of electrospun SPI/PEO 
scaffolds are compatible with those of human skin. When dry, SPI/PEO scaffolds have an ultimate 
tensile strength (UTS) of 0.91 ± 0.39 MPa and strain to break of 7.53 ± 1.29 %. When wet, they 
have a UTS of 0.10 ± 0.05 MPa and ductility increases with a strain to break of 83.33 ± 21.18 %. 
These values are comparable to those reported for human skin, with a UTS of approx. 7.7 MPa 
(Adekogbe and Ghanem, 2005) and strain to break of approx. 100% (Diridollou et al., 2000). The 
tensile properties of SPI/PEO scaffolds remain similar after 14 days of hydration in aqueous 
media. Macroscopically, hydrated electrospun SPI/PEO scaffolds are “skin-like” in appearance 
and easy to handle, store and sterilize, making them attractive for use in a clinical setting. 
 
In vitro, electrospun SPI/PEO scaffolds were shown to be biocompatible with human dermal 
fibroblasts alone and in co-culture with human epidermal fibroblasts. The proliferation rate and 
cytotypic morphology of fibroblasts were similar on SPI/PEO scaffolds as on other 
well-characterized biomaterials such as electrospun PLGA (synthetic) and gelatin (natural, animal 
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protein-derived), as well as on electrospun zein, another plant protein-derived scaffold. 
Fibroblasts attached and spread on all substrates, apparently receiving directional cues from 
each other instead of their randomly oriented fibrous substrates. Fibroblasts deposited their 
native extracellular matrix (ECM) onto SPI/PEO scaffolds, a response that is crucial to the tissue 
remodeling process. Thus, electrospun SPI/PEO scaffolds have been shown to be biocompatible 
as a scaffold for skin tissue regeneration, and a suitable platform for organotypic skin equivalent 
co-culture in in vitro models of skin. 
 
Specific Aim 2 was approached by a global analysis of gene expression related to human ECM 
and adhesion molecules, using targeted PCR arrays, followed by validation with PCR analysis of 
specific genes up-regulated or highly expressed by fibroblasts on SPI and collagen I coated 
substrates after 2 h and 24 h of seeding. No substrate-significant differences were found at 
either time point. However, on both substrates, certain genes were similarly up-regulated at 24 h 
compared to 2 h. MMP-10 was the most highly up-regulated, approx. 1152-fold on SPI and 
471-fold on collagen I. MMP-1 was also very highly up-regulated, although by orders of 
magnitude lower than MMP-10, 54-fold on SPI and 37-fold on collagen I. Tissue inhibitors of 
MMPs (TIMPs) were not significantly up-regulated at these time points. ECM proteins collagen 
and laminin, as well as integrin subunit α2, the predominant cell surface receptor for collagen, 
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were also up-regulated at 24 h. Taken together, these results point to an aggressive remodeling 
response by the fibroblasts to their immediate extracellular environment, a process necessary in 
the early stages of wound healing that is usually aided by macrophages and neutrophils that 
infiltrate the wound site. Importantly, SPI elicited a similar cellular response as the native ECM 
protein collagen and synthetic PLGA, suggesting that SPI as a biomaterial may be as suitable as 
these other well-established materials. 
 
In the initial phase of remodeling, degradation occurs more rapidly than deposition of new ECM 
(Badylak et al., 2009). This is reflected in the cellular response observed in our experiments. 
However, it is not known whether the upregulation of integrin subunit α2 is in response to the 
substrate material directly, or to the presence of newly synthesized ECM proteins adsorbed onto 
the substrates. In the case of SPI, it may be possible that the intrinsic RGD motif contained in the 
peptide lunasin provides a specific adhesion site for the fibroblasts; however, unless this 
integrin-ligand interaction is specifically investigated, it cannot be assumed, and the very similar 
adhesion behavior across the substrates we tested suggests that adsorption of new ECM 
secreted by the fibroblasts may play a large role in the initial adhesion process. 
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Specific Aim 3 was fulfilled at a preliminary level in evaluations that were carried out to the end 
of study at complete wound closure. Electrospun SPI/PEO scaffolds were evaluated against 
Tegaderm™ wound dressing, a standard in wound care, as a control in a full-thickness excision 
wound model in the hairless rat. SPI/PEO scaffolds promoted a slightly but not significantly faster 
initial wound closure than the control, although wounds in both groups healed completely by 
post-operative day 18, while the neodermis continued to be replaced by thicker scar tissue up to 
the end of our study at day 31. The similar quantitative response in both groups was 
corroborated by non-invasive optical measurements using functional near infrared spectroscopy 
(fNIR). SPI/PEO scaffolds were optically transparent to the fNIR sensors and did not present any 
background signal, which was a desirable advantage in using optical techniques for 
measurement as absorbance at the wound site could be measured directly through the scaffold 
without the need to remove the scaffold. 
 
Electrospun SPI/PEO scaffolds provided qualitative benefits over the control, by virtue of its 
natural, plant protein-derived material and electrospun fibrous structure. The tensile properties 
of SPI/PEO scaffolds were a much closer match to native skin than those of Tegaderm™, and 
SPI/PEO scaffolds were much more compliant to the wound shape, absorbing wound exudates 
and thus preventing irritation at the wound site. SPI/PEO scaffolds integrated well with the 
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wound and detached naturally with the formed encrustation at day 7 that occurred in both 
treatment groups. 
 
Clinically, electrospun SPI/PEO scaffolds would be applied in a single procedure, avoiding the 
complications of repeat applications such as with commercial composite skin substitutes. The 
presence of the scaffold may aid in retaining moisture; however, as it dries, it becomes part of 
the encrustation or scab that forms, and this may or may not interfere with granulation tissue 
formation underneath the scaffold and keratinocyte migration into the healing wound. If the 
wound needs to be surgically cleaned regularly, the scaffold may need to be removed with the 
debrided tissue, and a fresh scaffold re-applied, until the wound is sufficiently healed to 
continue the process without the support of the scaffold. 
 
These scaffolds provide a “breathable” interface between the wound and the external 
environment, which allow for a normal course of healing without the disadvantages of occlusive 
dressings that do not come in direct contact with the open wound. By design as a permanent 
scaffold, electrospun SPI/PEO is able to present structural and molecular cues to the cells in a 
regenerating wound environment. It is therefore promising as a new type of treatment for 
non-healing wounds, and further studies will help to elucidate potential mechanisms by which it 
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promotes wound healing at a cellular and/or molecular level. 
 
SPI as a raw material provides several advantages over other materials such as collagen, as it 
bypasses the concerns raised with animal-derived proteins, is abundantly available and 
renewable, and comes at a significantly lower cost. Its versatility in processing, its 
biodegradability and bioactivity also render it preferable to synthetic materials. Therefore, it 
serves as a viable alternative to currently available, more expensive materials used in wound 
healing scaffolds. 
 
7.2. Recommendations for future work 
 
While our results have been encouraging in that electrospun SPI/PEO scaffolds promote a similar 
response from human dermal fibroblasts in vitro and in a full-thickness excision wound in vivo in 
comparison to well-established standard materials, further investigation is needed to correlate 
cellular responses to the properties of the scaffold. In vitro, function-blocking studies may be 
performed using disintegrins (Marcinkiewicz, 2005; Surażyński et al., 2005; Sarkar, 2006) or 
antibodies to specific integrins (e.g. Choi et al., 2007; Kim et al., 2008) identified as potentially 
highly involved in mediating initial cellular adhesion to foreign substrates, as discussed in 
Chapter 5. Since integrin α2β1 is the predominant receptor for collagen (Sethi et al., 2002) and 
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α2 was the most highly up-regulated integrin subunit on SPI and collagen at 24 h, this integrin is 
a worthwhile target for inhibition assays. In vitro, integrin α2β1 mediates collagen gel 
contraction, and application anti-α2β1 antibody to fibroblasts reverts their attached morphology 
from elongated and bipolar to rounded within 1 h (Fujimura et al., 2007). It would be valuable to 
investigate whether blocking integrins produces such a significant effect on fibroblast 
attachment to SPI. 
 
It would also be worthwhile to clarify whether fibroblasts are attaching to foreign substrates via 
integrins directly or to ECM adsorbed onto the substrates. The rate of deposition of new ECM by 
fibroblasts onto SPI and other foreign substrates, including glass (which is inert and hydrophilic 
but without biochemical cues), would first need to be established, and this time course would 
then be correlated with the time progression of expression of integrin receptor subunits by 
fibroblasts attaching on these substrates. 
 
In vivo, the wound healing events occurring at the early stage of inflammation, during the first 2 
days, needs to be investigated in more detail to identify the differences between SPI/PEO treated 
and control groups. Acute inflammatory responses, if they occur, could be detected within 24 
hours post-wounding (Birch et al., 2005). IL-6 and IL-1β are commonly targeted as measures of 
179 
 
inflammatory response, important for cell recruitment (e.g. de Mejia and Dia, 2009; Valsecchi et 
al., 2010), as is tumor necrosis factor alpha (TNF-α) (e.g. Hernández-Ledesma et al., 2009). These 
cytokines may be assayed from wound fluids or supernatants of homogenized wound tissue 
using enzyme-linked immunosorbent assays (ELISA) or RT-PCR. Analysis time points may be 
extended to encompass days 1, 2, 4, 7, 14 and 21 post-wounding as well as end of study, to track 
the progression of wound healing (Birch et al., 2005). Recruitment of inflammatory cells may be 
detected from histological biopsies by staining for CD45-positive cells (Scherer et al., 2009). 
 
As discussed in Chapter 6, vascularization should be assessed at the same time points to 
determine whether SPI/PEO scaffolds promote this response to a greater extent than the control. 
While fNIR provides indirect measurements of vascularity by correlating optical absorbance to 
hemoglobin concentration, more direct methods may also be employed, such as RT-PCR analysis 
of VEGF expression in wound tissue homogenate (Scherer et al., 2009; Wong et al., 2010), or 
immunofluorescent staining for platelet endothelial cell adhesion molecule 1 (PECAM-1) 
(Scherer et al., 2009) or lectin (Papazoglou et al., 2008). 
 
Further experiments in the rat should also be done incorporating the splinted ring model 
(Shinzawa et al., 2007; Wong et al., 2010) in order to prevent contraction and allow for healing 
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by granulation tissue formation and re-epithelialization. This model not only simulates the 
human wound scenario more closely, but also increases the time window in which to detect 
differences between treatment groups at each of the stages in wound healing that might be 
missed in the regular rat model where contraction is the dominant mechanism of healing. 
 
Histological biopsies at earlier time points would also show the formation of granulation tissue 
and the migration of keratinocytes in wounds treated with or without the scaffold, to detect 
whether the new growth integrates with the scaffold, and whether the rate of new growth is 
affected by the presence of the scaffold. Image analysis of the biopsies would show whether the 
scaffold serves as a support structure to enhance growth or whether it acts as a physical barrier 
to slow down growth of new skin tissue in the wound. 
 
While beyond the scope of this thesis, a larger animal model, especially the pig, is highly 
encouraged in further evaluations of electrospun SPI/PEO scaffolds in wound healing. The pig is 
a desirable model in simulating human wound healing because pig skin and human skin have a 
comparable dermal-epidermal thickness ratio ranging from 10:1 to 13:1, with similar epidermal 
turnover time (Sullivan et al., 2001). The large surface of pigs allows them to receive multiple 
experimental wounds, which along with frequent handling causes great physiological stress, 
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which may also simulate the condition of wounded patients with severe illnesses (Sullivan et al., 
2001). Data from a pig model may also correlate better with a human scenario, as comparisons 
of animal models revealed that out of 25 wound therapies, the pig model was in agreement with 
human studies 78% of the time compared with 53% for small-mammal studies (Sullivan et al., 
2001). 
 
  
182 
 
List of References 
 
 
 
 
Adekogbe I, Ghanem A. Fabrication and characterization of DTBP-crosslinked chitosan scaffolds 
for skin tissue engineering. Biomaterials. 2005 Dec;26(35):7241-50. 
 
Amano S, Ogura Y, Akutsu N, Nishiyama T. Quantitative analysis of the synthesis and secretion of 
type VII collagen in cultured human dermal fibroblasts with a sensitive sandwich enzyme-linked 
immunoassay. Exp Dermatol. 2007 Feb;16(2):151-5. 
 
Armstrong WB, Wan XS, Kennedy AR, Taylor TH, Meyskens FL Jr. Development of the 
Bowman-Birk inhibitor for oral cancer chemoprevention and analysis of Neu 
immunohistochemical staining intensity with Bowman-Birk inhibitor concentrate treatment. 
Laryngoscope. 2003 Oct;113(10):1687-702. 
 
Assoian RK, Klein EA. Growth control by intracellular tension and extracellular stiffness. Trends 
Cell Biol. 2008, 18:347-352. 
 
Ayres CE, Jha BS, Sell SA, Bowlin GL, Simpson DG. Nanotechnology in the design of soft tissue 
scaffolds: innovations in structure and function. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 
2010 Jan;2(1):20-34. 
 
Badylak SF, Freytes DO, Gilbert TW. Extracellular matrix as a biological scaffold material: 
Structure and function. Acta Biomater. 2009 Jan;5(1):1-13. 
 
Baum CL, Arpey CJ. Normal cutaneous wound healing: clinical correlation with cellular and 
molecular events. Dermatol Surg. 2005 Jun;31(6):674-86; discussion 686. 
 
Bawadi HA, Antunes TM, Shih F, Losso JN. In vitro inhibition of the activation of Pro-matrix 
Metalloproteinase 1 (Pro-MMP-1) and Pro-matrix metalloproteinase 9 (Pro-MMP-9) by rice and 
soybean Bowman-Birk inhibitors. J Agric Food Chem. 2004 Jul 28;52(15):4730-6. 
 
  
183 
 
Bell E, Ivarsson B, Merrill C. Production of a tissue-like structure by contraction of collagen 
lattices by human fibroblasts of different proliferative potential in vitro. Proc. Natl. Acad. Sci. USA 
Vol. 76, No. 3, pp. 1274-1278, March 1979. 
 
Bell E, Ehrlich HP, Buttle DJ, Nakatsuji T. Living tissue formed in vitro and accepted as 
skin-equivalent tissue of full thickness. Science. 1981 Mar 6;211(4486):1052-4. 
 
Bhardwaj N, Kundu SC. Electrospinning: a fascinating fiber fabrication technique. Biotechnol Adv. 
2010 May-Jun;28(3):325-47. 
 
Birch M, Tomlinson A, Ferguson MW. Animal models for adult dermal wound healing. Methods 
Mol Med. 2005, 117:223-235. 
 
Bischofs IB, Schwarz US. Cell organization in soft media due to active mechanosensing. Proc Natl 
Acad Sci USA 100 (2003), pp. 9274–9279. 
 
Blackwood KA, McKean R, Canton I, Freeman CO, Franklin KL, Cole D, Brook I, Farthing P, Rimmer 
S, Haycock JW, Ryan AJ, MacNeil S. Development of biodegradable electrospun scaffolds for 
dermal replacement. Biomaterials. 2008, 29:3091-3104. 
 
Boehnke K, Mirancea N, Pavesio A, Fusenig NE, Boukamp P, Stark HJ. Effects of fibroblasts and 
microenvironment on epidermal regeneration and tissue function in long-term skin equivalents. 
Eur J Cell Biol. 2007, 86:731-746. 
 
Bott K, Upton Z, Schrobback K, Ehrbar M, Hubbell JA, Lutolf MP, Rizzi SC. The effect of matrix 
characteristics on fibroblast proliferation in 3D gels. Biomaterials. 2010 Nov;31(32):8454-64. 
 
Böttcher-Haberzeth S, Biedermann T, Reichmann E. Tissue engineering of skin. Burns. 2010 
Jun;36(4):450-60. 
 
Brownlee C. Role of the extracellular matrix in cell-cell signalling: paracrine paradigms. Curr Opin 
Plant Biol. 2002 Oct;5(5):396-401. 
 
Cai N, Wong CC, Tan SC, Chan V, Liao K. Temporal effect of functional blocking of beta1 integrin 
on cell adhesion strength under serum depletion. Langmuir. 2009 Sep 15;25(18):10939-47. 
184 
 
Caillard R, Remondetto GE, Mateescu MA, Subirade M. Characterization of amino cross-linked 
soy protein hydrogels. J Food Sci. 2008 Jun;73(5):C283-91. 
 
Caillard R, Mateescu MA, Subirade M. Maillard-type cross-linked soy protein hydrogels as 
devices for the release of ionic compounds: an in vitro study. Food Res Int. 2010 
Dec;43(10):2349-55. 
 
Cao B, Yin J, Yan S, Cui L, Chen X, Xie Y. Porous scaffolds based on cross-linking of poly(L-glutamic 
acid). Macromol Biosci. DOI: 10.1002/mabi.201000389 
 
Carrino DA, Sorrell JM, Caplan AI. Age-related changes in the proteoglycans of human skin. Arch 
Biochem Biophys. 2000 Jan 1;373(1):91-101. 
 
Chastain SR, Kundu AK, Dhar S, Calvert JW, Putnam AJ. Adhesion of mesenchymal stem cells to 
polymer scaffolds occurs via distinct ECM ligands and controls their osteogenic differentiation. J 
Biomed Mater Res A. 2006, 78:73-85. 
 
Chen H, Huang J, Yu J, Liu S, Gu P. Electrospun chitosan-graft-poly (ɛ-caprolactone)/poly 
(ɛ-caprolactone) cationic nanofibrous mats as potential scaffolds for skin tissue engineering. Int J 
Biol Macromol. 2011 Jan 1;48(1):13-9. 
 
Chen L, Remondetto G, Rouabhia M, Subirade M. Kinetics of the breakdown of cross-linked soy 
protein films for drug delivery. Biomaterials. 2008, 29:3750-56. 
 
Chen L, Subirade M. Elaboration and characterization of soy/zein protein microspheres for 
controlled nutraceutical delivery. Biomacromolecules. 2009 Dec 14;10(12):3327-34. 
 
Chen L, Hébrard G, Beyssac E, Denis S, Subirade M. In vitro study of the release properties of 
soy-zein protein microspheres with a dynamic artificial digestive system. J Agric Food Chem. 
2010 Sep 8;58(17):9861-7. 
 
Chen P, Parks WC. Role of matrix metalloproteinases in epithelial migration. J Cell Biochem. 2009 
Dec 15;108(6):1233-43. 
 
 
185 
 
Choi S, Vilaire G, Marcinkiewicz C, Winkler JD, Bennett JS, DeGrado WF. Small molecule inhibitors 
of integrin alpha2beta1. J Med Chem. 2007, 50:5457-62. 
 
Chung TW, Chang YL. Silk fibroin/chitosan-hyaluronic acid versus silk fibroin scaffolds for tissue 
engineering: promoting cell proliferations in vitro. J Mater Sci Mater Med. 2010 
Apr;21(4):1343-51. 
 
Clark GB, Thompson G Jr, Roux SJ. Signal transduction mechanisms in plants: an overview. Curr 
Sci. 2001 Jan 25;80(2):170-7. 
 
Coimbra P, Ferreira P, de Sousa HC, Batista P, Rodrigues MA, Correia IJ, Gil MH. Preparation and 
chemical and biological characterization of a pectin/chitosan polyelectrolyte complex scaffold for 
possible bone tissue engineering applications. Int J Biol Macromol. 2011 Jan 1;48(1):112-8. 
 
Cross SE, Naylor IL, Coleman RA, Teo TC. An experimental model to investigate the dynamics of 
wound contraction. Br J Plast Surg. 1995 Jun;48(4):189-97. 
 
Cui W, Zhou Y, Chang J. Electrospun nanofibrous materials for tissue engineering and drug 
delivery. Sci. Technol. Adv. Mater. 11 (2010) 014108 (11pp) doi:10.1088/1468-6996/11/1/014108 
 
Curciarello R, Lareu JF, Fossati CA, Docena GH, Petruccelli S. Immunochemical characterization of 
Glycine max L. Merr. var Raiden, as a possible hypoallergenic substitute for cow's milk-allergic 
patients. Clin Exp Allergy. 2008 Sep;38(9):1559-65. 
 
Curt S, Subirade M, Rouabhia M. Production and in vitro evaluation of soy protein–based 
biofilms as a support for human keratinocyte and fibroblast culture. Tissue Eng Part A. 2009 
Jun;15(6):1223-32. 
 
Curtis AS, Dalby MJ, Gadegaard N. Nanoprinting onto cells. J R Soc Interface. 2006 Jun 
22;3(8):393-8. 
 
Davidson JM. Animal models for wound repair. Arch Dermatol Res. 1998, 290 Suppl:S1-11. 
 
de Lumen BO. Lunasin: a cancer-preventive soy peptide. Nutr Rev. 2005 Jan;63(1):16-21. 
 
186 
 
de Lumen BO, Galvez AF. Soybean protein nutraceuticals. Patent US 6,391,848 B1 (May 21, 2002) 
 
de Mejia EG, Dia VP. Lunasin and lunasin-like peptides inhibit inflammation through suppression 
of NF-kappaB pathway in the macrophage. Peptides. 2009 Dec;30(12):2388-98. 
 
Derrick KL, Norbury K, Kieswetter K, Skaf J, McNulty AK. Comparative analysis of global gene 
expression profiles between diabetic rat wounds treated with vacuum-assisted closure therapy, 
moist wound healing or gauze under suction. Int Wound J 2008;5:615–624. 
 
Dhandayuthapani B, Krishnan UM, Sethuraman S. Fabrication and characterization of 
chitosan-gelatin blend nanofibers for skin tissue engineering. J Biomed Mater Res B Appl 
Biomater. 2010 Jul;94(1):264-72. 
 
Di Toro R, Betti V, Spampinato S. Biocompatibility and integrin-mediated adhesion of human 
osteoblasts to poly(DL-lactide-co-glycolide) copolymers. Eur J Pharm Sci. 2004, 21:161-169. 
 
Dia VP, Berhow MA, Gonzalez De Mejia E. Bowman-Birk inhibitor and genistein among soy 
compounds that synergistically inhibit nitric oxide and prostaglandin E2 pathways in 
lipopolysaccharide-induced macrophages. J Agric Food Chem. 2008 Dec 24;56(24):11707-17. 
 
Diridollou S, Patat F, Gens F, Vaillant L, Black D, Lagarde JM, Gall Y, Berson M. In vivo model of the 
mechanical properties of the human skin under suction Skin Res Technol. 2000 
Nov;6(4):214-221. 
 
Dittmann K, Löffler H, Bamberg M, Rodemann HP. Bowman-Birk proteinase inhibitor (BBI) 
modulates radiosensitivity and radiation-induced differentiation of human fibroblasts in culture. 
Radiother Oncol. 1995 Feb;34(2):137-43. 
 
Dorsett-Martin WA, Wysocki AB. 2008, ‘Rat models of skin wound healing’, in Sourcebook of 
Models for Biomedical Research, ed. Conn PM, Humana Press Inc., Totowa, NJ; 631-638. 
 
Emmerson E, Campbell L, Ashcroft GS, Hardman MJ. The phytoestrogen genistein promotes 
wound healing by multiple independent mechanisms. Mol Cell Endocrinol. 2010 Jun 
10;321(2):184-93. 
 
187 
 
Enoch S, Shaaban H, Dunn KW. Informed consent should be obtained from patients to use 
products (skin substitutes) and dressings containing biological material. J Med Ethics. 2005 
Jan;31(1):2-6. 
 
Fernández P, Pullarkat PA, Ott A. A master relation defines the nonlinear viscoelasticity of single 
fibroblasts. Biophys J. 2006 May 15;90(10):3796-805. 
 
Fisher GJ, Quan T, Purohit T, Shao Y, Cho MK, He T, Varani J, Kang S, Voorhees JJ. Collagen 
fragmentation promotes oxidative stress and elevates matrix metalloproteinase-1 in fibroblasts 
in aged human skin. Am J Pathol. 2009 Jan;174(1):101-14. 
 
Fonder MA, Lazarus GS, Cowan DA, Aronson-Cook B, Kohli AR, Mamelak AJ. Treating the chronic 
wound: A practical approach to the care of nonhealing wounds and wound care dressings. J Am 
Acad Dermatol. 2008 Feb;58(2):185-206. 
 
Fong H, Chun I, Reneker DH. Beaded nanofibers formed during electrospinning. Polymer 40 
(1999) 4585–4592. 
 
Fujimura T, Moriwaki S, Imokawa G, Takema Y. Crucial role of fibroblast integrins alpha2 and 
beta1 in maintaining the structural and mechanical properties of the skin. J Dermatol Sci. 2007 
Jan;45(1):45-53. 
 
Fung WY, Yuen KH, Liong MT. Characterization of fibrous residues from agrowastes and the 
production of nanofibers. J Agric Food Chem. 2010 Jul 14;58(13):8077-84. 
 
Gailit J, Clark RA. Studies in vitro on the role of alpha v and beta 1 integrins in the adhesion of 
human dermal fibroblasts to provisional matrix proteins fibronectin, vitronectin, and fibrinogen. 
J Invest Dermatol. 1996, 106:102-108. 
 
Gailit J, Clarke C, Newman D, Tonnesen MG, Mosesson MW, Clark RA. Human fibroblasts bind 
directly to fibrinogen at RGD sites through integrin alpha(v)beta3. Exp Cell Res. 1997, 
232:118-126. 
 
Galiano RD, Michaels J 5th, Dobryansky M, Levine JP, Gurtner GC. Quantitative and reproducible 
murine model of excisional wound healing. Wound Repair Regen. 2004 Jul-Aug;12(4):485-92. 
188 
 
Galvez AF, Chen N, Macasieb J, de Lumen BO. Chemopreventive property of a soybean peptide 
(lunasin) that binds to deacetylated histones and inhibits acetylation. Cancer Res. 2001 Oct 
15;61(20):7473-8. 
 
Gangatirkar P, Paquet-Fifield S, Li A, Rossi R, Kaur P. Establishment of 3D organotypic cultures 
using human neonatal epidermal cells. Nat Protoc. 2007, 2:178-186. 
 
Garcia Y, Wilkins B, Collighan RJ, Griffin M, Pandit A. Towards development of a dermal rudiment 
for enhanced wound healing response. Biomaterials. 2008, 29:857-868. 
 
García-Esteo F, Pascual G, Gallardo A, San-Román J, Buján J, Bellón JM. A biodegradable 
copolymer for the slow release of growth hormone expedites scarring in diabetic rats. J Biomed 
Mater Res B Appl Biomater. 2007, 81:291-304. 
 
Gelse K, Pöschl E, Aigner T. Collagens--structure, function, and biosynthesis. Adv Drug Deliv Rev. 
2003 Nov 28;55(12):1531-46. 
 
Gilliver SC, Ruckshanthi JP, Hardman MJ, Zeef LA, Ashcroft GS. 5alpha-dihydrotestosterone (DHT) 
retards wound closure by inhibiting re-epithelialization. J Pathol. 2009 Jan;217(1):73-82. 
 
Gong S, Wang H, Sun Q, Xue ST, Wang JY. Mechanical properties and in vitro biocompatibility of 
porous zein scaffolds. Biomaterials. 2006 Jul;27(20):3793-9. 
 
Gong SJ, Sun SX, Sun QS, Wang JY, Liu XM, Liu GY. Tablets Based on Compressed Zein 
Microspheres for Sustained Oral Administration: Design, Pharmacokinetics, and Clinical Study. J 
Biomater Appl. 2010 Apr 23. DOI: 10.1177/0885328210363504 
 
Gottrup F, Apelqvist J, Price P. Outcomes in controlled and comparative studies on non-healing 
wounds: recommendations to improve the quality of evidence in wound management. J Wound 
Care. 2010 Jun;19(6):237-68. 
 
Gran B, Tabibzadeh N, Martin A, Ventura ES, Ware JH, Zhang GX, Parr JL, Kennedy AR, Rostami 
AM. The protease inhibitor, Bowman-Birk Inhibitor, suppresses experimental autoimmune 
encephalomyelitis: a potential oral therapy for multiple sclerosis. Mult Scler. 2006 
Dec;12(6):688-97. 
189 
 
Groth T, Seifert B, Malsch G, Albrecht W, Paul D, Kostadinova A, Krasteva N, Altankov G. 
Interaction of human skin fibroblasts with moderate wettable polyacrylonitrile--copolymer 
membranes. J Biomed Mater Res. 2002 Aug;61(2):290-300. 
 
Guo R, Xu S, Ma L, Huang A, Gao C. The healing of full-thickness burns treated by using plasmid 
DNA encoding VEGF-165 activated collagen-chitosan dermal equivalents. Biomaterials. 2011 
Feb;32(4):1019-31. 
 
Guo Y, Li M, Mylonakis A, Han J, MacDiarmid AG, Chen X, Lelkes PI, Wei Y. Electroactive 
oligoaniline-containing self-assembled monolayers for tissue engineering applications. 
Biomacromolecules. 2007 Oct;8(10):3025-34. 
 
Hadjipanayi E, Mudera V, Brown RA. Close dependence of fibroblast proliferation on collagen 
scaffold matrix stiffness. J Tissue Eng Regen Med. 2009 Feb;3(2):77-84. 
 
Hakki SS, Hakki EE, Nohutcu RM. Regulation of matrix metalloproteinases and tissue inhibitors of 
matrix metalloproteinases by basic fibroblast growth factor and dexamethasone in periodontal 
ligament cells. J Periodontal Res. 2009 Dec;44(6):794-802. 
 
Han CM, Zhang LP, Sun JZ, Shi HF, Zhou J, Gao CY. Application of collagen-chitosan/fibrin glue 
asymmetric scaffolds in skin tissue engineering. J Zhejiang Univ Sci B. 2010 Jul;11(7):524-30. 
 
Han J, Lazarovici P, Pomerantz C, Chen X, Wei Y, Lelkes PI. Co-Electrospun Blends of PLGA, Gelatin, 
and Elastin as Potential Nonthrombogenic Scaffolds for Vascular Tissue Engineering. 
Biomacromolecules. 2011 Feb 14;12(2):399-408. 
 
Hannafin JA, Attia EA, Henshaw R, Warren RF, Bhargava MM. Effect of cyclic strain and plating 
matrix on cell proliferation and integrin expression by ligament fibroblasts. J Orthop Res. 2006 
Feb;24(2):149-58. 
 
Helary C, Bataille I, Abed A, Illoul C, Anglo A, Louedec L, Letourneur D, Meddahi-Pellé A, 
Giraud-Guille MM. Concentrated collagen hydrogels as dermal substitutes. Biomaterials. 2010 
Jan;31(3):481-90. 
 
  
190 
 
Henderson PW, Nagineni VV, Harper A, Bavinck N, Sohn AM, Krijgh DD, Jimenez N, Weinstein AL, 
Spector JA. Development of an acellular bioengineered matrix with a dominant vascular pedicle. 
J Surg Res. 2010 Nov;164(1):1-5. 
 
Hernández-Ledesma B, Hsieh CC, de Lumen BO. Lunasin, a novel seed peptide for cancer 
prevention. Peptides. 2009, 30:426-30. 
 
Holzbeierlein JM, McIntosh J, Thrasher JB. The role of soy phytoestrogens in prostate cancer. 
Curr Opin Urol. 2005, 15:17-22. 
 
Hua Y, Yuang Y, Qiu A, Liu X. Properties of soy protein isolate prepared from aqueous alcohol 
washed soy flakes, Food Res Int. 2005, 38: 273-9. 
 
Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell. 2002 Sep 20;110(6):673-87. 
 
Ingber D. Integrins as mechanochemical transducers. Curr Opin Cell Biol. 1991, 3:841-8. 
 
Jiang G, Huang AH, Cai Y, Tanase M, Sheetz MP. Rigidity sensing at the leading edge through 
alphavbeta3 integrins and RPTPalpha. Biophys J. 2006 Mar 1;90(5):1804-9. 
 
Jiang H, Zhao P, Zhu K. Fabrication and characterization of zein-based nanofibrous scaffolds by an 
electrospinning method. Macromol Biosci. 2007 Apr 10;7(4):517-25. 
 
Jiang Q, Reddy N, Yang Y. Cytocompatible cross-linking of electrospun zein fibers for the 
development of water-stable tissue engineering scaffolds. Acta Biomater. 2010 
Oct;6(10):4042-51. 
 
Jiang Y, Tang C-H, Wen Q-B, Li L, Yang X-Q. Effect of processing parameters on the properties of 
transglutaminase-treated soy protein isolate films, Innovat Food Sci Emerg Tech. 2007, 8: 218-25 
 
Kao B, Kadomatsu K, Hosaka Y. Construction of synthetic dermis and skin based on a 
self-assembled peptide hydrogel scaffold. Tissue Eng Part A. 2009 Sep;15(9):2385-96. 
 
Kim HK, Oh DS, Lee SB, Ha JM, Joe YA. Antimigratory effect of TK1-2 is mediated in part by 
interfering with integrin alpha2beta1. Mol Cancer Ther. 2008, 7:2133-41. 
191 
 
Kluger PJ, Wyrwa R, Weisser J, Maierle J, Votteler M, Rode C, Schnabelrauch M, Walles H, 
Schenke-Layland K. Electrospun poly(D/L-lactide-co-L-lactide) hybrid matrix: a novel scaffold 
material for soft tissue engineering. J Mater Sci Mater Med. 2010 Sep;21(9):2665-71. 
 
Koombhongse S, Liu W, Reneker DH. Flat polymer ribbons and other shapes by electrospinning, J 
Polymer Sci: Part B: Polymer Phys. 2001, 39: 2598–2606. 
 
Koskela A, Engström K, Hakelius M, Nowinski D, Ivarsson M. Regulation of fibroblast gene 
expression by keratinocytes in organotypic skin culture provides possible mechanisms for the 
antifibrotic effect of reepithelialization. Wound Repair Regen. 2010 Sep-Oct;18(5):452-9. 
 
Kuipers BJ, Gruppen H. Identification of strong aggregating regions in soy glycinin upon 
enzymatic hydrolysis. J Agric Food Chem. 2008 May 28;56(10):3818-27. 
 
Kumbar SG, Nukavarapu SP, James R, Nair LS, Laurencin CT. Electrospun poly(lactic 
acid-co-glycolic acid) scaffolds for skin tissue engineering. Biomaterials. 2008 Oct;29(30):4100-7. 
 
Lai LF, Guo HX. Preparation of new 5-fluorouracil-loaded zein nanoparticles for liver targeting. Int 
J Pharm. 2011 Feb 14;404(1-2):317-23. 
 
Lazopoulos KA, Stamenović D. Durotaxis as an elastic stability phenomenon. J Biomech. 
2008;41(6):1289-94. 
 
Lee JW, Serna F, Nickels J, Schmidt CE. Carboxylic acid-functionalized conductive polypyrrole as a 
bioactive platform for cell adhesion. Biomacromolecules. 2006 Jun;7(6):1692-5. 
 
Lee YK, Kim SY, Kim KH, Chun BH, Lee KH, Oh DJ, Chung N. Use of soybean protein hydrolysates 
for promoting proliferation of human keratinocytes in serum-free medium. Biotechnol Lett. 2008 
Nov;30(11):1931-6. 
 
Lelkes PI, Li M, Perets A, Lin L, Han J, Woerdeman DL. 2008, ‘Electrospinning of natural proteins 
for tissue engineering scaffolding’ in Handbook of Natural-based Polymers for Biomedical 
Applications, ed. Reis RL, Woodhead Publishing Ltd, Cambridge, UK; 446-482. 
 
  
192 
 
Leong MF, Lim TC, Chian KS. Manufacturing three-dimensional scaffolds using electrospinning at 
low temperatures. Patent Cooperation Treaty (PCT) Application, PCT/SG2007/000413, 2006. 
 
Leong MF, Rasheed MZ, Lim TC, Chian KS. In vitro cell infiltration and in vivo cell infiltration and 
vascularization in a fibrous, highly porous poly(D,L-lactide) scaffold fabricated by cryogenic 
electrospinning technique. J Biomed Mater Res A. 2009 Oct;91(1):231-40. 
 
Leong MF, Chan WY, Chian KS, Rasheed MZ, Anderson JM. Fabrication and in vitro and in vivo cell 
infiltration study of a bilayered cryogenic electrospun poly(D,L-lactide) scaffold. J Biomed Mater 
Res A. 2010 Sep 15;94(4):1141-9. 
 
Li B, Davidson JM, Guelcher SA. The effect of the local delivery of platelet-derived growth factor 
from reactive two-component polyurethane scaffolds on the healing in rat skin excisional 
wounds. Biomaterials. 2009 Jul;30(20):3486-94. 
 
Li M, Mondrinos MJ, Gandhi MR, Ko FK, Weiss AS, Lelkes PI. Electrospun protein fibers as 
matrices for tissue engineering. Biomaterials. 2005 Oct;26(30):5999-6008. 
 
Li M, Guo Y, Wei Y, MacDiarmid AG, Lelkes PI. Electrospinning polyaniline-contained gelatin 
nanofibers for tissue engineering applications. Biomaterials. 2006 May;27(13):2705-15. 
 
Liang WH, Kienitz BL, Penick KJ, Welter JF, Zawodzinski TA, Baskaran H. Concentrated 
collagen-chondroitin sulfate scaffolds for tissue engineering applications. J Biomed Mater Res A. 
2010 Sep 15;94(4):1050-60. 
 
Lindblad WJ. Considerations for selecting the correct animal model for dermal wound-healing 
studies. J Biomater Sci Polym Ed. 2008;19(8):1087-96. 
 
Liu BS, Yao CH, Fang SS. Evaluation of a non-woven fabric coated with a chitosan bi-layer 
composite for wound dressing. Macromol Biosci. 2008 May 13;8(5):432-40. 
 
Liu X, Sun Q, Wang H, Zhang L, Wang JY. Microspheres of corn protein, zein, for an ivermectin 
drug delivery system. Biomaterials. 2005 Jan;26(1):109-15. 
 
 
193 
 
Liu Y, Dammann C, Bhattacharyya MK. The matrix metalloproteinase gene GmMMP2 is activated 
in response to pathogenic infections in soybean. Plant Physiol. 2001 Dec;127(4):1788-97. 
 
Losso JN, Munene CN, Bansode RR, Bawadi HA. Inhibition of matrix metalloproteinase-1 activity 
by the soybean Bowman-Birk inhibitor. Biotechnol Lett. 2004 Jun;26(11):901-5. 
 
Lowery JL, Datta N, Rutledge GC. Effect of fiber diameter, pore size and seeding method on 
growth of human dermal fibroblasts in electrospun poly(ε-caprolactone) fibrous mats. 
Biomaterials 31 (2010) 491–504. 
 
Luo LH, Zhang YF, Wang XM, Wan YQ, Chang PC, Anderson DR, Chen Y. Preparation, 
characterization, and in vitro and in vivo evaluation of cellulose/soy protein isolate composite 
sponges. J Biomater Appl. 2010 Feb;24(6):503-26. 
 
Ma L, Shi Y, Chen Y, Zhao H, Gao C, Han C. In vitro and in vivo biological performance of 
collagen-chitosan/silicone membrane bilayer dermal equivalent. J Mater Sci Mater Med. 2007 
Nov;18(11):2185-91. 
 
Machida-Sano I, Matsuda Y, Namiki H. In vitro adhesion of human dermal fibroblasts on iron 
cross-linked alginate films. Biomed Mater. 2009 Apr;4(2):025008. 
 
Magee PJ, Rowland IR. Phyto-oestrogens, their mechanism of action: current evidence for a role 
in breast and prostate cancer. Br J Nutr. 2004 Apr;91(4):513-31. 
 
Mallikarjun Gouda KG, Gowda LR, Rao AG, Prakash V. Angiotensin I-converting enzyme inhibitory 
peptide derived from glycinin, the 11S globulin of soybean (Glycine max). J Agric Food Chem. 
2006 Jun 28;54(13):4568-73. 
 
Maltais A, Remondetto GE, Subirade M. Mechanisms involved in the formation and structure of 
soya protein cold-set gels: A molecular and supramolecular investigation. Food Hydrocolloids. 
2007, 22: 550-9. 
 
Maltais A, Remondetto GE, Subirade M. Tabletted soy protein cold-set hydrogels as carriers of 
nutraceutical substances. Food Hydrocolloids. 2010 Jul;24(5):518-24. 
 
194 
 
Marcinkiewicz C. Functional characteristic of snake venom disintegrins: potential therapeutic 
implication. Curr Pharm Des. 2005, 11:815-27. 
 
Margadant C, Charafeddine RA, Sonnenberg A. Unique and redundant functions of integrins in 
the epidermis. FASEB J. 2010 Nov;24(11):4133-52. 
 
Mauri A N, Añon M C. Effect of solution pH on solubility and some structural properties of 
soybean protein isolate films. J Sci Food Agric. 2006, 86:1064-72. 
 
McGrath JA, Eady RAJ, Pope FM. 2004, ‘Anatomy and organization of human skin’ in Rook's 
textbook of dermatology, 7th Ed., eds. Burns T, Breathnach S, Cox N, Griffiths C, Blackwell 
Publishing, Oxford, UK; 45-128. 
 
Medina A, Ghaffari A, Kilani RT, Ghahary A. The role of stratifin in fibroblast-keratinocyte 
interaction. Mol Cell Biochem. 2007 Nov;305(1-2):255-64. 
 
Menke NB, Ward KR, Witten TM, Bonchev DG, Diegelmann RF. Impaired wound healing. Clin 
Dermatol. 2007 Jan-Feb;25(1):19-25. 
 
Metcalfe AD, Ferguson MW. Tissue engineering of replacement skin: the crossroads of 
biomaterials, wound healing, embryonic development, stem cells and regeneration. J R Soc 
Interface. 2007 Jun 22;4(14):413-37. 
 
Milleret V, Simonet M, Bittermann AG, Neuenschwander P, Hall H. Cyto- and hemocompatibility 
of a biodegradable 3D-scaffold material designed for medical applications. J Biomed Mater Res B 
Appl Biomater. 2009 Oct;91(1):109-21. 
 
Miyoshi S, Ishikawa H, Kaneko T, Fukui F, Tanaka H, Maruyama S. Structures and activity of 
angiotensin-converting enzyme inhibitors in an alpha-zein hydrolysate. Agric Biol Chem. 1991 
May;55(5):1313-8. 
 
Morihara K, Takai S, Takenaka H, Sakaguchi M, Okamoto Y, Morihara T, Miyazaki M, Kishimoto S. 
Cutaneous tissue angiotensin-converting enzyme may participate in pathologic scar formation in 
human skin. J Am Acad Dermatol. 2006 Feb;54(2):251-7. 
 
195 
 
Nielsen, NC. 1985, ‘Structure of soy proteins’ in New protein foods (Vol. 5), eds. Altschul AA, 
Wilcke HL, Academic Press, NY, USA; 27-64. 
 
Nikolaychik VV, Samet MM, Lelkes PI. A new method for continual quantitation of viable cells on 
endothelialized polyurethanes. J Biomater Sci Polym Ed. 1996;7(10):881-91. 
 
Nolte SV, Xu W, Rennekampff HO, Rodemann HP. Diversity of fibroblasts--a review on 
implications for skin tissue engineering. Cells Tissues Organs. 2008;187(3):165-76. 
 
Noszczyk BH, Klein E, Holtkoetter O, Krieg T, Majewski S. Integrin expression in the dermis during 
scar formation in humans. Exp Dermatol. 2002 Aug;11(4):311-8. 
 
Oliveira LO, Nam YW, Jung R, Nielsen NC. Processing and assembly in vitro of engineered 
soybean beta-conglycinin subunits with the asparagine-glycine proteolytic cleavage site of 11S 
globulins. Mol Cells. 2002 Feb 28;13(1):43-51. 
 
Papazoglou ES, Zubkov L, Zhu L, Weingarten MS, Tyagi S, Pourrezaei K. Monitoring diabetic 
wound healing by NIR spectroscopy. Conf Proc IEEE Eng Med Biol Soc. 2005, 6:6662-6664. 
 
Papazoglou ES, Weingarten MS, Zubkov L, Neidrauer M, Zhu L, Tyagi S, Pourrezaei K. Changes in 
optical properties of tissue during acute wound healing in an animal model. J Biomed Opt. 2008 
Jul-Aug;13(4):044005. 
 
Pardo A, Selman M. MMP-1: the elder of the family. Int J Biochem Cell Biol. 2005 
Feb;37(2):283-8. 
 
Park JH, Jeong HJ, Lumen BO. In vitro digestibility of the cancer-preventive soy peptides lunasin 
and BBI. J Agric Food Chem. 2007 Dec 26;55(26):10703-6. 
 
Pickard BG. "Second extrinsic organizational mechanism" for orienting cellulose: modeling a role 
for the plasmalemmal reticulum. Protoplasma. 2008;233(1-2):7-29. 
 
Powell HM, Supp DM, Boyce ST. Influence of electrospun collagen on wound contraction of 
engineered skin substitutes. Biomaterials. 2008 Mar;29(7):834-43. 
 
196 
 
Powell HM, Boyce ST. Engineered human skin fabricated using electrospun collagen-PCL blends: 
morphogenesis and mechanical properties. Tissue Eng Part A. 2009 Aug;15(8):2177-87. 
 
Prost-Squarcioni C. [Histology of skin and hair follicle]. Med Sci (Paris). 2006 Feb;22(2):131-7. 
 
Pukstad BS, Ryan L, Flo TH, Stenvik J, Moseley R, Harding K, Thomas DW, Espevik T. Non-healing 
is associated with persistent stimulation of the innate immune response in chronic venous leg 
ulcers. J Dermatol Sci. 2010 Aug;59(2):115-22. 
 
Reddy N, Yang Y. Novel protein fibers from wheat gluten. Biomacromolecules. 2007 
Feb;8(2):638-43. 
 
Reddy N, Yang Y. Soyprotein fibers with high strength and water stability for potential medical 
applications. Biotechnol Prog. 2009 Nov-Dec;25(6):1796-802. 
 
Reddy N, Jiang Q, Yang Y. Novel wheat protein films as substrates for tissue engineering. J 
Biomater Sci Polym Ed. 2010 Oct 27. PMID: 21029519 
 
Reed CC, Iozzo RV. The role of decorin in collagen fibrillogenesis and skin homeostasis. Glycoconj 
J. 2002 May-Jun;19(4-5):249-55. 
 
Reed MJ, Ferara NS, Vernon RB. Impaired migration, integrin function, and actin cytoskeletal 
organization in dermal fibroblasts from a subset of aged human donors. Mech Ageing Dev. 2001 
Aug;122(11):1203-20. 
 
Reid RR, Said HK, Mogford JE, Mustoe TA. The future of wound healing: pursuing surgical models 
in transgenic and knockout mice. J Am Coll Surg. 2004 Oct;199(4):578-85. 
 
Rnjak J, Li Z, Maitz PK, Wise SG, Weiss AS. Primary human dermal fibroblast interactions with 
open weave three-dimensional scaffolds prepared from synthetic human elastin. Biomaterials. 
2009 Nov;30(32):6469-77. 
 
Saeed AI, Bhagabati NK, Braisted JC, Liang W, Sharov V, Howe EA, Li J, Thiagarajan M, White JA, 
Quackenbush J. TM4 microarray software suite. Methods Enzymol. 2006;411:134-93. 
 
197 
 
Salmela MT, Pender SL, Karjalainen-Lindsberg ML, Puolakkainen P, Macdonald TT, Saarialho-Kere 
U. Collagenase-1 (MMP-1), matrilysin-1 (MMP-7), and stromelysin-2 (MMP-10) are expressed by 
migrating enterocytes during intestinal wound healing. Scand J Gastroenterol. 2004 
Nov;39(11):1095-104. 
 
Sarkar S. Fibronectin mediated ES-D3 differentiation. Unpublished thesis (M.S.). 2006, Drexel 
University. 
 
Scherer SS, Pietramaggiori G, Matthews J, Perry S, Assmann A, Carothers A, Demcheva M, 
Muise-Helmericks RC, Seth A, Vournakis JN, Valeri RC, Fischer TH, Hechtman HB, Orgill DP. 
Poly-N-acetyl glucosamine nanofibers: a new bioactive material to enhance diabetic wound 
healing by cell migration and angiogenesis. Ann Surg. 2009 Aug;250(2):322-30. 
 
Schindler M, Meiners S, Cheresh DA. RGD-dependent linkage between plant cell wall and plasma 
membrane: consequences for growth. J Cell Biol. 1989 May;108(5):1955-65. 
 
Sell SA, McClure MJ, Garg K, Wolfe PS, Bowlin GL. Electrospinning of collagen/biopolymers for 
regenerative medicine and cardiovascular tissue engineering. Adv Drug Deliv Rev. 2009 Oct 
5;61(12):1007-19. 
 
Selling GW, Sessa DJ, Palmquist DE. Effect of water and tri(ethylene) glycol on the rheological 
properties of zein. Polymer. 2004, 45(12):4249-55. 
 
Selling GW, Biswas A, Patel A, Walls DJ, Dunlap C, Wei Y. Impact of solvent on electrospinning of 
zein and analysis of resulting fibers. Macromol Chem Phys. 2007, 208:1002-10. 
 
Sethi KK, Yannas IV, Mudera V, Eastwood M, McFarland C, Brown RA. Evidence for sequential 
utilization of fibronectin, vitronectin, and collagen during fibroblast-mediated collagen 
contraction. Wound Repair Regen. 2002, 10:397-408. 
 
Shenoy SL, Bates WD, Frisch HL, Wnek GE. Role of chain entanglements on fiber formation 
during electrospinning of polymer solutions: good solvent, non-specific polymer–polymer 
interaction limit. Polymer. 2005, 46:3372-84. 
 
 
198 
 
Shevchenko RV, James SL, James SE. A review of tissue-engineered skin bioconstructs available 
for skin reconstruction. J R Soc Interface. 2010 Feb 6;7(43):229-58. 
 
Shinzawa H, Takeda A, Sone Y, Murashita K, Uchinuma E. Wound healing process of a 
full-thickness skin wound model in rats. Int Surg. 2007 Mar-Apr;92(2):63-72. 
 
Shukla R, Cheryan M. Zein: the industrial protein from corn. Ind Crop Prod. 2001, 13:171-92. 
 
Shutov AD, Kakhovskaya IA, Bastrygina AS, Bulmaga VP, Horstmann C, Müntz K. Limited 
proteolysis of beta-conglycinin and glycinin, the 7S and 11S storage globulins from soybean 
[Glycine max (L.) Merr.]. Structural and evolutionary implications. Eur J Biochem. 1996 Oct 
1;241(1):221-8. 
 
Siebers MC, Walboomers XF, van den Dolder J, Leeuwenburgh SC, Wolke JG, Jansen JA. The 
behavior of osteoblast-like cells on various substrates with functional blocking of integrin-beta1 
and integrin-beta3. J Mater Sci Mater Med. 2008 Feb;19(2):861-8. 
 
Sienkiewicz P, Surazyński A, Pałka J, Miltyk W. Nutritional concentration of genistein protects 
human dermal fibroblasts from oxidative stress-induced collagen biosynthesis inhibition through 
IGF-I receptor-mediated signaling. Acta Pol Pharm. 2008 Mar-Apr;65(2):203-11. 
 
Silva GA, Vaz CM, Coutinho OP, Cunha AM, Reis RL. In vitro degradation and cytocompatibility 
evaluation of novel soy and sodium caseinate-based membrane biomaterials. J Mater Sci Mater 
Med. 2003 Dec;14(12):1055-66. 
 
Silva SS, Santos MI, Coutinho OP, Mano JF, Reis RL. Physical properties and biocompatibility of 
chitosan/soy blended membranes. J Mater Sci Mater Med. 2005 Jun;16(6):575-9. 
 
Sirén V, Salmenperä P, Kankuri E, Bizik J, Sorsa T, Tervahartiala T, Vaheri A. Cell-cell contact 
activation of fibroblasts increases the expression of matrix metalloproteinases. Ann Med. 
2006;38(3):212-20. 
 
Snyders R, Shingel KI, Zabeida O, Roberge C, Faure MP, Martinu L, Klemberg-Sapieha JE. 
Mechanical and microstructural properties of hybrid poly(ethylene glycol)-soy protein hydrogels 
for wound dressing applications. J Biomed Mater Res A. 2007 Oct;83(1):88-97. 
199 
 
Solon J, Levental I, Sengupta K, Georges PC, Janmey PA. Fibroblast adaptation and stiffness 
matching to soft elastic substrates. Biophys J. 2007 Dec 15;93(12):4453-61. 
 
Sousa FF, Luzardo-Alvarez A, Pérez-Estévéz A, Seoane-Prado R, Blanco-Méndez J. Development of 
a novel AMX-loaded PLGA/zein microsphere for root canal disinfection. Biomed Mater. 2010 
Oct;5(5):055008. 
 
Stark HJ, Boehnke K, Mirancea N, Willhauck MJ, Pavesio A, Fusenig NE, Boukamp P. Epidermal 
homeostasis in long-term scaffold-enforced skin equivalents. J Investig Dermatol Symp Proc. 
2006 Sep;11(1):93-105. 
 
Stauffer WR, Cui XT. Polypyrrole doped with 2 peptide sequences from laminin. Biomaterials. 
2006, 27:2405-2413. 
 
Sullivan TP, Eaglstein WH, Davis SC, Mertz P. The pig as a model for human wound healing. 
Wound Repair Regen. 2001 Mar-Apr;9(2):66-76. 
 
Sun QS, Dong J, Lin ZX, Yang B, Wang JY. Comparison of cytocompatibility of zein film with other 
biomaterials and its degradability in vitro. Biopolymers. 2005 Aug 5;78(5):268-74. 
 
Sun LP, Wang S, Zhang ZW, Wang XY, Zhang QQ. Biological evaluation of collagen-chitosan 
scaffolds for dermis tissue engineering. Biomed Mater. 2009 Oct;4(5):055008. 
 
Surazyński A, Sienkiewicz P, Wołczyński S, Pałka J. Differential effects of echistatin and thrombin 
on collagen production and prolidase activity in human dermal fibroblasts and their possible 
implication in beta1-integrin-mediated signaling. Pharmacol Res. 2005 Mar;51(3):217-21. 
 
Szulgit G, Rudolph R, Wandel A, Tenenhaus M, Panos R, Gardner H. Alterations in fibroblast 
alpha1beta1 integrin collagen receptor expression in keloids and hypertrophic scars. J Invest 
Dermatol. 2002 Mar;118(3):409-15. 
 
Taubenberger A, Cisneros DA, Friedrichs J, Puech PH, Muller DJ, Franz CM. Revealing early steps 
of alpha2beta1 integrin-mediated adhesion to collagen type I by using single-cell force 
spectroscopy. Mol Biol Cell. 2007 May;18(5):1634-44. 
 
200 
 
Thélu J, Rossio P, Favier B. Notch signalling is linked to epidermal cell differentiation level in basal 
cell carcinoma, psoriasis and wound healing. BMC Dermatol. 2002 Apr 29;2:7. 
 
Toriseva M, Kähäri VM. Proteinases in cutaneous wound healing. Cell Mol Life Sci. 2009 
Jan;66(2):203-24. 
 
Tsuruki T, Kishi K, Takahashi M, Tanaka M, Matsukawa T, Yoshikawa M. Soymetide, an 
immunostimulating peptide derived from soybean beta-conglycinin, is an fMLP agonist. FEBS 
Lett. 2003 Apr 10;540(1-3):206-10. 
 
Tu J, Wang H, Li H, Dai K, Wang J, Zhang X. 2009, The in vivo bone formation by mesenchymal 
stem cells in zein scaffolds. Biomaterials. 2009 Sep;30(26):4369-76. 
 
Valsecchi AE, Franchi S, Panerai AE, Rossi A, Sacerdote P, Colleoni M. The soy isoflavone genistein 
reverses oxidative and inflammatory state, neuropathic pain, neurotrophic and vasculature 
deficits in diabetes mouse model. Eur J Pharmacol. 2011 Jan 15;650(2-3):694-702. 
 
van Aalst JA, Reed CR, Han L, Andrady T, Hromadka M, Bernacki S, Kolappa K, Collins JB, Loboa 
EG. Cellular incorporation into electrospun nanofibers: retained viability, proliferation, and 
function in fibroblasts. Ann Plast Surg. 2008 May;60(5):577-83. 
 
van der Valk P, van Pelt AW, Busscher HJ, de Jong HP, Wildevuur CR, Arends J. 1983, Interaction of 
fibroblasts and polymer surfaces: relationship between surface free energy and fibroblast 
spreading. J Biomed Mater Res. 1983 Sep;17(5):807-17. 
 
Van Tomme SR, Storm G, Hennink WE. In situ gelling hydrogels for pharmaceutical and 
biomedical applications. Int J Pharm. 2008 May 1;355(1-2):1-18. 
 
Vaz CM, De Graaf LA, Reis RL, Cunha AM. 2003a, Effect of crosslinking, thermal treatment and 
UV irradiation on the mechanical properties and in vitro degradation behavior of several natural 
proteins aimed to be used in the biomedical field. J Mater Sci Mater Med. 2003 
Sep;14(9):789-96. 
 
 
 
201 
 
Vaz CM, De Graaf LA, Reis RL, Cunha AM. 2003b, In vitro degradation behaviour of 
biodegradable soy plastics: effects of crosslinking with glyoxal and thermal treatment, Polymer 
Degrad and Stabil. 2003, 81:65–74. 
 
Vaz CM, van Doeveren PF, Reis RL, Cunha AM. 2003c, Soy matrix drug delivery systems obtained 
by melt-processing techniques. Biomacromolecules. 2003 Nov-Dec;4(6):1520-9. 
 
Vaz CM, van Doeveren PF, Dias GR, Reis RL, Cunha AM. Controlled delivery achieved with bi-layer 
matrix devices produced by co-injection moulding. Macromol Biosci. 2004 Aug 9;4(8):795-801. 
 
Vega-Lugo A, Lim L. Electrospinning of soy protein isolate nanofibers, J Biobased Materials and 
Bioenergy. 2008, 2:223-30. 
 
Waldeck H, Chung AS, Kao WJ. Interpenetrating polymer networks containing gelatin modified 
with PEGylated RGD and soluble KGF: synthesis, characterization, and application in in vivo 
critical dermal wound. J Biomed Mater Res A. 2007 Sep 15;82(4):861-71. 
 
Waller JM, Maibach HI. Age and skin structure and function, a quantitative approach (II): protein, 
glycosaminoglycan, water, and lipid content and structure. Skin Res Technol. 2006 
Aug;12(3):145-54. 
 
Walter N, Selhuber C, Kessler H, Spatz JP. Cellular unbinding forces of initial adhesion processes 
on nanopatterned surfaces probed with magnetic tweezers. Nano Lett. 2006 Mar;6(3):398-402. 
 
Wang F, Li Z, Tamama K, Sen CK, Guan J. Fabrication and characterization of prosurvival growth 
factor releasing, anisotropic scaffolds for enhanced mesenchymal stem cell survival/growth and 
orientation. Biomacromolecules. 2009 Sep 14;10(9):2609-18. 
 
Wang HJ, Gong SJ, Lin ZX, Fu JX, Xue ST, Huang JC, Wang JY. In vivo biocompatibility and 
mechanical properties of porous zein scaffolds. Biomaterials. 2007 Sep;28(27):3952-64. 
 
Wang Q, Zheng YP. Ultrasound biomicroscopy imaging for monitoring progressive trypsin 
digestion and inhibition in articular cartilage. Ultrasound Med Biol. 2009 Sep;35(9):1535-45. 
 
 
202 
 
Wang W, Bringe NA, Berhow MA, Gonzalez de Mejia E. beta-Conglycinins among sources of 
bioactives in hydrolysates of different soybean varieties that inhibit leukemia cells in vitro. J Agric 
Food Chem. 2008 Jun 11;56(11):4012-20. 
 
Wang W, Dia VP, Vasconez M, de Mejia EG, Nelson RL. Analysis of soybean protein-derived 
peptides and the effect of cultivar, environmental conditions, and processing on lunasin 
concentration in soybean and soy products. J AOAC Int. 2008 Jul-Aug;91(4):936-46. 
 
Wang W, Zhang M, Lu W, Zhang X, Ma D, Rong X, Yu C, Jin Y. Cross-linked collagen-chondroitin 
sulfate-hyaluronic acid imitating extracellular matrix as scaffold for dermal tissue engineering. 
Tissue Eng Part C Methods. 2010 Apr;16(2):269-79. 
 
Wang YY, Lü LX, Feng ZQ, Xiao ZD, Huang NP. Cellular compatibility of RGD-modified chitosan 
nanofibers with aligned or random orientation. Biomed Mater. 2010 Oct;5(5):054112. 
 
Weingarten MS, Papazoglou E, Zubkov L, Zhu L, Vorona G, Walchack A. Measurement of optical 
properties to quantify healing of chronic diabetic wounds. Wound Repair Regen. 2006 
May-Jun;14(3):364-70. 
 
Weingarten MS, Papazoglou ES, Zubkov L, Zhu L, Neidrauer M, Savir G, Peace K, Newby JG, 
Pourrezaei K. Correlation of near infrared absorption and diffuse reflectance spectroscopy 
scattering with tissue neovascularization and collagen concentration in a diabetic rat wound 
healing model. Wound Repair Regen. 2008 Mar-Apr;16(2):234-42. 
 
Weingarten MS, Neidrauer M, Mateo A, Mao X, McDaniel JE, Jenkins L, Bouraee S, Zubkov L, 
Pourrezaei K, Papazoglou ES. Prediction of wound healing in human diabetic foot ulcers by 
diffuse near-infrared spectroscopy: a pilot study. Wound Repair Regen. 2010 Mar;18(2):180-5. 
 
Woerdeman DL, Ye P, Shenoy S, Parnas RS, Wnek GE, Trofimova O. Electrospun fibers from wheat 
protein: investigation of the interplay between molecular structure and the fluid dynamics of the 
electrospinning process. Biomacromolecules. 2005 Mar-Apr;6(2):707-12. 
 
Wong T, Gammon L, Liu L, Mellerio JE, Dopping-Hepenstal PJ, Pacy J, Elia G, Jeffery R, Leigh IM, 
Navsaria H, McGrath JA. Potential of fibroblast cell therapy for recessive dystrophic 
epidermolysis bullosa. J Invest Dermatol. 2008 Sep;128(9):2179-89. 
203 
 
Wong VW, Rustad KC, Galvez MG, Neofyotou E, Glotzbach JP, Januszyk M, Major MR, Sorkin M, 
Longaker MT, Rajadas J, Gurtner GC. Engineered pullulan-collagen composite dermal hydrogels 
improve early cutaneous wound healing. Tissue Eng Part A. 2011 Mar;17(5-6):631-44. 
 
Wood MA, Bagnaninchi P, Dalby MJ. The beta integrins and cytoskeletal nanoimprinting. Exp Cell 
Res. 2008 Feb 15;314(4):927-35. 
 
Woodfield TB, Miot S, Martin I, van Blitterswijk CA, Riesle J. The regulation of expanded human 
nasal chondrocyte re-differentiation capacity by substrate composition and gas plasma surface 
modification. Biomaterials. 2006 Mar;27(7):1043-53. 
 
Woodley DT, Remington J, Huang Y, Hou Y, Li W, Keene DR, Chen M. Intravenously injected 
human fibroblasts home to skin wounds, deliver type VII collagen, and promote wound healing. 
Mol Ther. 2007 Mar;15(3):628-35. 
 
Xiao J, Addabbo RM, Lauer JL, Fields GB, Baum J. Local conformation and dynamics of isoleucine 
in the collagenase cleavage site provide a recognition signal for matrix metalloproteinases. J Biol 
Chem. 2010 Oct 29;285(44):34181-90. 
 
Xu YZ, Wu JJ, Chen YP, Liu J, Li N, Yang FY. The use of zein and Shuanghuangbu for periodontal 
tissue engineering. Int J Oral Sci. 2010 Sep;2(3):142-8. 
 
Yang X, Shah JD, Wang H. Nanofiber enabled layer-by-layer approach toward three-dimensional 
tissue formation. Tissue Eng Part A. 2009 Apr;15(4):945-56. 
 
Yao C, Li X, Song T. Electrospinning and crosslinking of zein nanofiber mats. J Appl Polymer Sci. 
2007, 103:380-5. 
 
Zabrodin, I. Design and characterization of a biodegradable, nanofibrous scaffold incorporating 
microspheres for sustained release of soluble proteins. Unpublished thesis (M.S.). 2009, Drexel 
University. 
 
Zawko SA, Schmidt CE. Crystal templating dendritic pore networks and fibrillar microstructure 
into hydrogels. Acta Biomater. 2010 Jul;6(7):2415-21. 
 
204 
 
Zhang X, Min B G, Kumar S. Solution spinning and characterization of poly(vinyl alcohol)/soybean 
protein blend fibers. J Appl Polymer Sci. 2003, 90:716-21. 
 
Zlatanov I, Groth T, Lendlein A, Altankov G. Dynamics of beta1-integrins in living 
fibroblasts--effect of substratum wettability. Biophys J. 2005 Nov;89(5):3555-62. 
 
Znoyko I, Trojanowska M, Reuben A. Collagen binding alpha2beta1 and alpha1beta1 integrins 
play contrasting roles in regulation of Ets-1 expression in human liver myofibroblasts. Mol Cell 
Biochem. 2006 Jan;282(1-2):89-99. 
 
http://en.wikipedia.org/wiki/Image:3DScience_skin_section_labeled.jpg 
 
http://www.che.vt.edu/Wilkes/electrospinning/electrspinning.html 
  
205 
 
Appendix. Human ECM and cell adhesion related genes 
 
 
 
 
96-well PCR array of human extracellular matrix and cell adhesion molecules: 
 
 
The molecules are functionally grouped as follows: 
 
Cell Adhesion Molecules: 
 
Transmembrane Molecules: CD44, CDH1, HAS1, ICAM1, ITGA1, ITGA2, ITGA3, ITGA4, ITGA5, ITGA6, ITGA7, 
ITGA8, ITGAL, ITGAM, ITGAV, ITGB1, ITGB2, ITGB3, ITGB4, ITGB5, MMP14, MMP15, MMP16, 
NCAM1, PECAM1, SELE, SELL, SELP, SGCE, SPG7, VCAM1. 
 
Cell-Cell Adhesion: CD44, CDH1, COL11A1, COL14A1, COL6A2, CTNND1, ICAM1, ITGA8, VCAM1. 
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COL11A1 
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A10  
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COL1A1 
A12  
COL4A2 
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COL6A2 
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COL8A1 
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VCAN 
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CTGF 
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CTNNA1 
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CTNNB1 
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CTNND1 
B11  
CTNND2 
B12  
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HAS1 
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Cell-Matrix Adhesion: ADAMTS13, CD44, ITGA1, ITGA2, ITGA3, ITGA4, ITGA5, ITGA6, ITGA7, ITGA8, ITGAL, 
ITGAM, ITGAV, ITGB1, ITGB2, ITGB3, ITGB4, ITGB5, SGCE, SPP1, THBS3. 
 
Other Adhesion Molecules: CNTN1, COL12A1, COL15A1, COL16A1, COL5A1, COL6A1, COL7A1, COL8A1, 
VCAN, CTGF, CTNNA1, CTNNB1, CTNND2, FN1, KAL1, LAMA1, LAMA2, LAMA3, LAMB1, LAMB3, 
LAMC1, THBS1, THBS2, CLEC3B, TNC, VTN. 
 
Extracellular Matrix Proteins: 
 
Basement Membrane Constituents: COL4A2, COL7A1, LAMA1, LAMA2, LAMA3, LAMB1, LAMB3, LAMC1, 
SPARC. 
 
Collagens & ECM Structural Constituents: COL11A1, COL12A1, COL14A1, COL15A1, COL16A1, COL1A1, 
COL4A2, COL5A1, COL6A1, COL6A2, COL7A1, COL8A1, FN1, KAL1. 
 
ECM Proteases: ADAMTS1, ADAMTS13, ADAMTS8, MMP1, MMP10, MMP11, MMP12, MMP13, MMP14, 
MMP15, MMP16, MMP2, MMP3, MMP7, MMP8, MMP9, SPG7, TIMP1. 
 
ECM Protease Inhibitors: COL7A1, KAL1, THBS1, TIMP1, TIMP2, TIMP3. 
 
Other ECM Molecules: VCAN, CTGF, ECM1, HAS1, SPP1, TGFBI, THBS2, THBS3, CLEC3B, TNC, VTN. 
 
http://www.sabiosciences.com/rt_pcr_product/HTML/PAHS-013A.html 
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